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Abstract 
 
Obesity, defined as a body mass index of 30 kg/m2 or more, has reached 
epidemic proportions globally, with more than one-and-a-half billion adults 
overweight and at least 500 million clinically obese. The prevalence of obesity in 
the UK has increased by over 300% since 1980. In the UK 24% of adult women 
are obese and one in six women at an antenatal booking clinic is obese.  
 
Obesity has the potential for several detrimental effects on both the 
mother and the baby. Obese mothers are more likely to develop pre-eclampsia 
and eclampsia, gestational diabetes and venous thromboembolism. In addition, 
obese pregnant women are more likely to be induced, often resulting in 
complicated deliveries such as emergency Caesarean section and shoulder 
dystocia. Obesity significantly increases the risk of maternal mortality during or 
after pregnancy. Babies born to obese mothers are at an increased risk of 
congenital abnormalities, preterm deliveries and stillbirth, and children exposed 
to maternal obesity are at an increased risk of developing metabolic syndrome 
in later life.  
 
The aim of this work was to assess the extent and potential for the 
prevention of adverse impacts of obesity in pregnancy. The specific objectives 
were to: summarise the literature on maternal obesity and adverse pregnancy 
outcome; perform an epidemiological analysis using local data of obesity in 
pregnancy; conduct a systematic review of existing evidence on lifestyle 
interventions for obesity in pregnancy; and to develop and evaluate a multi-
component pilot study for a community-based intervention for maternal obesity 
in South London.  
 
Analysis of delivery data from South London between January 2004 and 
May 2012 showed the overall prevalence of maternal obesity to be 15%, with 
considerable variation by ethnic group. There was a strong association between 
rising body mass index and risk of adverse pregnancy outcome, especially 
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diabetes. The effect of obesity on diabetes in pregnancy was more pronounced 
in Asians and Orientals compared to other ethnic groups. Calculations of 
population attributable risk fractions showed that, if we were able to prevent 
obesity before pregnancy in this population, around one-third of diabetes in 
pregnancy could be prevented. The data alluded to the fact that the benefit of 
obesity reduction would be greater in Blacks than in other ethnic groups 
because of the higher prevalence of obesity in this group.  
 
A complex community-based lifestyle intervention called the Community 
Activity and Nutrition (CAN) programme was developed for delivery by health 
trainers in children’s/Sure Start centres. The research showed that it is feasible 
to deliver the CAN intervention in children’s/Sure Start centres (Effra in Brixton, 
Jessop in Herne Hill and Jubilee in Tulse Hill) in an Inner London socially 
deprived community. The pilot study encountered problems with recruitment 
resulting from understaffing and lack of participant time. However, once 
recruited, retention on the programme was good. There was some evidence 
that the intervention improved selected clinical outcomes. Further work is 
ongoing to establish the clinical and cost effectiveness of the intervention. If 
CAN is shown to be clinically effective and cost-effective, the translation of this 
research and adoption by policy makers into the wider community may help to 
ameliorate the adverse outcomes associated with obesity in pregnancy.  
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CHAPTER 1: Introduction  
 
1.1. Background  
 
In the past three decades, the prevalence of overweight and obesity in 
women of reproductive age and in pregnant women has increased in most parts 
of the world (1-2) and trebled in the United Kingdom (3-4). Maternal obesity is 
associated with a plethora of complications for the mother, such as increased 
maternal mortality (5), gestational diabetes (6), pre-eclampsia (7), 
thromboembolism (8) and increased Caesarean section rate (9). It is also 
associated with adverse outcome in the newborn child such as macrosomia 
(10-12), preterm delivery (13) and admission to neonatal intensive care unit 
(14); and in later life in the adult offspring, it is associated with increased risk of 
obesity, insulin resistance, dyslipidaemia, hypertension and cardiovascular 
morbidity (15-18). If this adult offspring is a female, she is more likely to enter 
pregnancy obese and thus continue an intergenerational cycle of obesity and its 
adverse outcomes (19). It is of public health importance that interventions be 
developed to intercept this cycle.  
 
1.2. Personal motivation for undertaking the research described in this 
thesis  
 
I became a consultant in 2004 at Guy’s and St Thomas’ NHS foundation 
trust and served a community obstetric clinic based in Peckham, within the 
borough of Southwark, in South East London. I had clinical responsibility for 
looking after pregnant women from Southwark and Lambeth and, based on the 
number of bereaved patients that I needed to see, I assessed that the perinatal 
mortality in this area was higher than in other areas I had worked. In light of this, 
I carried out a study looking at the postcodes where mothers had had stillbirth 
and plotted these on the map of local communities (20). Pictorially (as displayed 
in Figure 1), this showed that there was a cluster of stillbirths in the Peckham 
area and other areas of high deprivation in the local communities that delivered 
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at Guy's and St Thomas' (20). At that time I did not relate these events to the 
populations at risk (all births), but I became interested in researching possible 
factors driving this apparent association. For example, I considered whether the 
apparently high stillbirth rate could be due to increasing age (women over 40 
years), increased proportions of Black and ethnic minority groups, or whether 
this may be linked with increased maternal obesity. I had observed a high BMI 
in these deprived populations and became particularly interested in obesity as a 
possible risk factor for stillbirth and other adverse outcomes during pregnancy 
and at delivery.  
 
Figure 1: The map of Lambeth and Southwark boroughs with the English 
indices of deprivation and distribution of stillbirths. The darker the area, 
the higher the deprivation index. The green dots represent each stillbirth. 
 
 
. 
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In 2006 I proposed the establishment of a community-based obesity 
service. In view of the fact that the Women’s Health Directorate at my trust had 
no new funding to set this up, I applied for a grant application to Guy's and St 
Thomas' Charity requesting funding to set up this new service. This grant was 
rejected and I was advised to reapply in partnership with the diabetic team. I 
reapplied six months later with the diabetic team and, yet again, the application 
was turned down. The reason given was that combining this service with the 
diabetic service would be too cumbersome. 
 
I later reapplied in 2007 to conduct a health needs assessment of obese 
pregnant women in Lambeth and Southwark. I applied for £20,000 which was 
granted. I worked with a local public health group and the report concluded that 
there was an urgent need for an obesity service for obese pregnant women in 
the area and that it was important to develop an effective and feasible 
intervention within this community. I submitted a grant request to Guy’s and St 
Thomas’ Charity in 2008 for funding to develop and evaluate a community-
based intervention for obese pregnant women called CAN (community activity 
and nutrition programme). Funding was awarded in 2009.  
 
Around the same time, in 2009, Professor Lucilla Poston received a grant 
to do a similar but hospital-based study at Guy’s and St Thomas’ NHS 
Foundation Trust called UPBEAT (United Kingdom Better Eating and Activity 
Trial, Appendix F). Professor Poston and I then worked with a team to develop 
the intervention which consisted of nutritional advice and an activity programme 
(21). My role in this was to identify activity and nutrition programmes within the 
local area that obese pregnant women could take part in, and to identify all the 
leisure centres within the communities of Southwark and Lambeth, and the 
markets which have cheap and healthy foods. I attended all the meetings during 
the developmental phase and contributed intellectually, including producing a 
systematic review and meta-analysis of lifestyle interventions in pregnancy (22), 
as well as contributing to the write-up of the intervention manual. I set up the 
trial in the community - negotiating space at three children’s centres in Lambeth 
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and Southwark which became the settings for the CAN intervention. The 
difference between the CAN and UPBEAT studies was that for CAN the 
intervention would be delivered in the community (Sure Start children’s centres 
and participants’ homes), without the collection of blood samples, while for 
UPBEAT the intervention would be delivered in the hospital setting and blood 
samples from participants were to be collected. To minimise competition for 
participants, CAN did not recruit patients from Guy’s and St Thomas’ NHS 
Foundation Trust.  Hence, I approached King’s College Hospital to recruit 
pregnant obese women for the CAN project.   
 
When I was awarded the grant for CAN, I felt the need to undertake 
further training in epidemiology to help me design the study and analyse the 
findings appropriately. I approached Professor Pat Doyle, who had been 
recommended by the public health team at Southwark. With encouragement 
and support from colleagues and family, I registered for a part-time PhD in 
2009. I have funded the PhD part-time myself and have maintained the 
motivation with enormous support from my supervisor, Professor Pat Doyle, and 
the Divisional Head of Women’s Health research professor, Lucilla Poston.  
 
1.3. Structure of the thesis 
 
A schematic diagram illustrating how the chapters link up is displayed 
below (Figure 2). This introductory chapter provides a short précis of my 
background and my motivation for doing this research. The second chapter 
provides a critical review of the literature on obesity and pregnancy, including its 
association with adverse outcomes and interventions that might mitigate these 
effects. Chapter Three provides a rationale for the thesis and presents the 
objectives of this research. Chapter Four describes an epidemiological analysis 
of local data, examining the determinants of obesity, and its effect and impact 
on pregnancy outcome. Chapter Five provides a systematic review of existing 
evidence on lifestyle interventions for obesity in pregnancy. Chapters Six and 
Seven describe the development of a multi-component pilot study for the 
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complex community-based activity and nutrition programme for maternal 
obesity in South London (CAN). Chapters Eight and Nine evaluate the study of 
the CAN intervention in South London. Each of these chapters has its own 
method and discussion sections. Chapter Ten presents a general overview of 
the findings together with the strengths and weaknesses of the research, 
appropriate interpretation and reflection, policy implications and 
recommendations for further research. 
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Figure 2: Schematic diagram of research presented in this thesis to illustrate how it all links up  
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CHAPTER 2:  Literature Review: Maternal Obesity 
  
 
 
 
 
 
2.1 Introduction 
 
This chapter will introduce obesity and its influence on pregnancy 
outcomes. Short-term adverse effects of obesity on the pregnant woman, the 
fetus and the newborn infant, as well as complications in labour and delivery will 
be addressed. This material will encompass a specific focus on the population 
impact of obese pregnancies on maternal, fetal and neonatal outcomes, as well 
as introducing the concept of interventions to improve outcomes associated with 
maternal obesity. 
 
This literature review is a critical personal overview. Online databases 
including Medline (Pubmed and OVID), EMBASE, the Cochrane Library, and 
obesity textbooks were used. Reports from the grey literature were searched, 
including the National Institute of Health and Clinical Excellence (NICE) and the 
Royal College of Obstetricians and Gynaecologists’ websites. The terms used 
in the search are presented in Appendix E and included a wide range of 
adverse obstetric and neonatal outcomes. Restrictions were made with a focus 
on studies and reports written in English and references dating from 1960 to 
2014. The search strategy for MEDLINE (the search strategy was the same for 
the other databases) is displayed in appendix E. Emphasis was placed on 
systematic reviews of evidence, where they existed. 
 
  
 
Publication based on part of this work: 
Oteng-Ntim E and Doyle P, (2012). Maternal outcomes in obese 
pregnancies in maternal obesity. Edition 1, Chapter 4, ed Gillman MW, 
Poston L, Cambridge University Press, United States of America.   
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2.2 Definition of obesity 
 
Obesity is defined as ‘an accumulation of excess body fat to such an 
extent that may impair health’ (23). Total body fat can be measured by direct 
methods such as dual energy X-ray absorptiometry (DEXA) and magnetic 
resonance imaging (24). Both are expensive, cumbersome and impractical to 
do during pregnancy. Moreover, DEXA has the added radiation risk (25).  
 
Hence, obesity is usually measured using indirect methods such as the 
body mass index (BMI), which is an expression of body weight-for-height using 
the formula weight (in kilograms) divided by height (in metres) squared (kg/m2).  
Overweight in adults is defined by the World Health Organisation (WHO) as 
body mass index (BMI) between 25 and less than 30kg/m2, and obesity as BMI 
greater than or equal to 30kg/m2 (Table 1).  
 
Table 1: Definition of Obesity 
BMI (Kg/m2) Weight Status 
<18.5 Underweight 
18.5-24.9 Normal 
25.0-29.9 Overweight 
30.0-34.9 Mild Obesity 
35.0-39.9 Moderate Obesity 
≥40.0 Morbid Obesity 
Adopted from http://www.who.int/nut/#obs (accessed 21st December, 2013) 
 
BMI has been shown by WHO to correlate well with the accumulation of 
body fat and is a good reproducible indicator of metabolic risk (1). It is simple 
and easy to measure, requiring very simple, inexpensive tools for the 
measurement of height and weight. It is accepted as an accurate proxy for body 
fat in the individual, including in pregnancy (23, 26). The limitations are that it 
does not account for variation in body composition or fat distribution (24).  
Secondly, the relationship between the percentage of body fat and BMI is not 
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linear and may differ in the non-pregnant compared to the pregnant state or 
between one ethnic group and another, particularly the Asian population (27).  
As such, BMI as a measure of obesity can introduce misclassification problems 
that may result in a bias in estimating the effect related to obesity (28).   
 
Despite these limitations, BMI is commonly used as the measurement of 
choice in the scientific literature and reports on obesity. Thus, throughout this 
thesis, I will be using the WHO classification of obesity as BMI≥30 kg/m2. 
 
2.3 Global prevalence and trends in adult obesity 
 
The latest projections from the World Health Organisation (WHO) indicate 
that obesity has more than doubled globally over the past 25 years. It is 
estimated that in 2008 approximately 1.5 billion adults (aged 20+) were 
overweight and at least 500 million were obese (WHO obesity and overweight 
website last updated in 2013) (29). Of the 500 million obese adults, 300 million 
were women. The figure of 1.5 billion is predicted to spiral to 2.3 billion in the 
overweight and 700 million in the obese groups by 2015. This phenomenon has 
been described as a global pandemic affecting all six continents. In most 
countries, including the United Kingdom (UK), the increasing trend is 
considered the most pertinent public health threat of this century (30). The 
proportion of obese adults in the United States rose from 15% in the late 1970s 
to approximately 33% in 2008 with the biggest rise being in Mexican women 
based in America (4). The prevalence of obesity in adult women (as depicted in 
Figure 3 and Appendix H) is already 40-70% in the Gulf States and over 20% in 
most of Europe (29-30).  
 
In developing countries the prevalence of obesity is more common in 
urban than rural regions (31). This is because those in rural areas tend to eat a 
low glycaemic index diet, whereas those who live or move into urban areas tend 
to adopt  western diets, high in refined sugars and fat. There is also reduced 
activity in the city and this sedentary lifestyle also contributes to the rising 
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obesity prevalence. Rising obesity prevalence also affects countries such as 
China and Mexico (31). Obesity is a major contributor to the emerging burden of 
non-communicable diseases in developing countries. Two-thirds of the global 
population now live in countries where high body mass index accounts for more 
mortality than underweight (32-34). 
 
Figure 3: WHO, 2011, estimated overweight and obesity prevalence among 
adult women (2010) 
 
        
  
 
World Health Organisation, 2013 
 
2.4 Obesity in pregnancy 
 
The prevalence of obesity in UK adults has increased by over 300% since 
1980 (35-37). Furthermore, this increase has been seen in other countries too 
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Egypt 
 
Egypt 
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Alaska   
 Alaska    
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(38). In 2008 around one-quarter of UK women aged 25-44 were obese (35, 
39). There is also good evidence that obesity among pregnant women is 
increasing in the UK. A study in Glasgow showed a two-fold increase in obesity 
prevalence in pregnancy from 9.4% to 18.9% between 1990 and 2004 (40), and 
a similar trend was noted among pregnant women from Middlesbrough (9.9% to 
16%) (41). A  national sample study showed a rise from 7.6% in 1989 to 15.6% 
in 2007 of maternal obesity in England(3) . The Centre for Maternal and Child 
Enquiries (CMACE) study on maternal obesity in the UK, looking at the 
prevalence of pregnant women with BMI≥35 (severe obesity), showed that the 
prevalence of severe obesity was 5% in 2010. It noted a variation within the UK 
nations such that the prevalence was highest in Wales and lowest in England.  
Within the severe obesity cohort, it showed under-representation of Black and 
ethnic minority groups (representing 14% within the cohort as opposed to 20% 
in the general UK maternity population). It is possible that this could be due to a 
selection bias (42). There is also strong evidence that this picture is also true in 
the United States of America (43) and Australia (38). 
 
2.4.1 Measurement  
 
Most clinical and epidemiological studies use BMI in early pregnancy as 
a proxy for pre-conceptual BMI (44-45). This is for practical reasons, since early 
pregnancy is when height and weight are, or should be, routinely measured and 
recorded (RCOG recommendations 2010) (46). But a limitation of using BMI 
during, rather than before, pregnancy is that changes in maternal body 
composition following conception, as well as the products of conception, will be 
included in the weight measurement. This extra weight will result in an increase 
in BMI and the likelihood of being classified as obese. However, in early 
pregnancy, for example up to 10 weeks gestation, this extra weight is estimated 
to be around only 1.2 kg on average (47). This will increase maternal BMI by 
around 2% overall and will not have a major impact on the proportion of women 
wrongly classified as obese. However, as the pregnancy progresses and 
maternal weight increases, BMI will increase more markedly. For example, at 
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20 weeks, a maternal weight gain of 9kg will increase the BMI of the average 
UK woman of reproductive age by 12% (author’s estimate). This will lead to a 
higher proportion of false positive obese pregnant women using the standard 
definition of obesity, which will increase as the pregnancy progresses. BMI is 
thus not considered a useful index in the second and third trimesters of 
pregnancy.    
 
2.4.2 Excessive Gestational Weight Gain 
  
Women who have excessive weight gain during pregnancy, without 
obesity in early pregnancy, may also be at risk of adverse outcome (48). Whilst  
pre-pregnancy BMI is undoubtedly an independent predictor of many adverse 
outcomes of pregnancy, there is also ample evidence which associates 
gestational weight gain with adverse outcomes for mother and baby (47). The 
influences of excessive weight gain on pregnancy outcome in women with 
normal pre-pregnancy BMI and those who are overweight or obese form the 
basis of the US Institute of Medicine (IOM) guidelines for weight management in 
pregnancy (48). However, most epidemiological research has focused on BMI 
and obesity in early pregnancy. 
 
2.4.3 Determinants of obesity in pregnancy 
 
Age 
 
The prevalence of obesity rises with increasing age in both non-pregnant 
women (49) and pregnant women (41, 50). In a large sample of pregnant 
women in England, Heslehurst showed a trend of increasing age with 
increasing BMI category: from 26.3 years for pregnant women who were 
underweight to 30.2 years for pregnant women who were super morbidly obese 
(3). This data also displayed increasing mean parity with increasing BMI 
category.   
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Parity 
 
Pregnancy is marked by changes to maternal metabolism, particularly in 
the second and third trimesters (51). There is increased insulin resistance. 
Insulin is responsible for controlling glycaemic load; thus, an insulin-resistant 
state results in increased glucose levels, facilitating increased transfer of 
glucose and nutrients to the fetus. The mother counteracts this by releasing 
more insulin into the blood stream, resulting in hyperinsulinaemia. The surplus 
glucose is then converted into fat, leading to weight gain, which may be 
retained, hence creating a phenomenon of rising BMI with each additional 
pregnancy. The interval between births may also have an influence on weight 
gain. Studies comparing women with one birth to those with no births within 10 
years show 60 to 100% increased risk of becoming overweight (52).  
 
Ethnicity 
 
There is evidence that certain ethnic groups are more at risk of becoming 
obese than others. Obesity rates are higher amongst Black Africans and Black 
Caribbean women and lower for Whites and Orientals during pregnancy (3, 53). 
A recent study suggests that for the same BMI, gestational weight gain is more 
pronounced in Blacks than in Whites and it is associated with hypertensive 
disease (54). 
 
Deprivation 
 
There is an association between obesity and social class in the general 
population of the UK (35, 55), and it is recognised that deprived communities 
have a higher proportion of obesity than less deprived communities. In a study 
of antenatal women booking in Glasgow, those from the most deprived quintiles 
were almost 4 times more likely to be obese than those from the least deprived 
quintiles based on the Carstairs index (40). Another cross-sectional study of 
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women from Middlesbrough attending for antenatal booking showed a similar 
association (41). 
 
Diet and lifestyle 
 
Excessive weight gain results from daily increments of positive energy 
balance due to increased caloric intake and/or sedentary lifestyle leading to 
reduced activity. Recent large observational and interventional studies (56-57) 
have found that high glycaemic index diets contribute more to weight gain than 
fatty food consumption (58-60). Consumption of fruits, vegetables and whole 
grains is associated with a lower BMI (60). Excessive intake of sugar-
sweetened beverages is associated with weight gain. Data from the Nurses’ 
Health Study II in the USA showed that women between the ages of 24 and 74 
years who consumed food high in refined sugars and starch were more likely to 
have increased weight gain (61). However, those who consumed predominantly 
high fibre foods such as grains, vegetables and fruits, as well as low glycaemia 
index diets, were less likely to be overweight or obese (56, 61).   
 
Most of the data on diet and BMI comes from high income countries.  
Data from middle and low income countries, such as China and India, is now 
coming to light, alluding to the role of a Western-style diet contributing to a rapid 
rise in obesity and obesity-related diseases in these countries (34, 62).  
 
Physical activity  
 
Physical activity plays a major role in energy balance and maintaining 
weight, and many studies have assessed the link between physical activity and 
body mass index. Initial studies suggested that increasing physical activity 
restricted age-related weight gain but recent studies only demonstrated a 
moderate effect (63). The ideal physical activity necessary to prevent increased 
BMI in adults remains unknown. A recent systematic review concluded that 
increases in physical activity resulted in restricted age-related weight gain within 
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a four-year period (60). There could be multiple mechanisms to explain this but 
the most significant is likely to be increased energy expenditure. However, 
increased activity may also enhance appetite, and hence increased activity 
ought to be combined with dietary intervention to yield optimum effects on 
weight management.  
 
Other behaviours that impact on weight control include a sedentary 
lifestyle, such as TV watching (64). A study from the United States found that 
each two-hour session of TV watching was associated with a 23% increase in 
the risk of obesity in adults (64). Prolonged TV watching may be associated with 
increased food intake and hence the association may be partly mediated 
through unhealthy diet, particularly as there is greater exposure to the 
advertisement of unhealthy foods. Many women report continuing exercising 
during pregnancy (65). Increased activity in pregnancy is said to improve 
glycaemic control and may play a role in the primary prevention of gestational 
diabetes (66-67). 
 
Sleep 
 
In the past ten years, evidence has accrued about sleep deprivation as a 
risk factor for obesity (68). A recent meta-analysis showed a link between length 
of sleep and increased BMI (60, 68). This association has a characteristic U-
shaped pattern with those who sleep 6-8 hours during the night having lower 
BMI, and those who sleep less, or more, than this having higher BMI. This 
association persisted after adjusting for diet and other risk factors. Sleep 
disorder is also associated with adverse pregnancy outcome such as pre-
eclampsia and diabetes (69). Assessment of sleeping habits and behaviour 
intervention designed to improve sleeping habits may be warranted to improve 
pregnancy outcome (69). 
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Social factors 
 
There is ample evidence that changing social factors may reduce obesity 
prevalence (70). One explanation for this is that an individual’s socioeconomic 
status may have an influence on his or her access to, and choice of, healthy 
foods. It is also clear (Foresight report, 2007) that an environment that makes 
activity difficult, or impossible, contributes significantly to the prevalence of 
obesity within a particular population (37) and hence the built environment is 
very pertinent to the prevention of obesity. 
 
Psychological factors  
 
Mental and psychological stress can result in the behaviour of comfort 
eating, and particularly increased intake of sugar-containing beverages and 
food (71). Anxiety and depression, which are common in pregnancy, can also 
make an affected individual lack interest in exercise and activity, eat more, or in 
extreme cases binge eat (72). In turn, obesity can result in depression (73), 
creating a vicious circle of poor eating and activity habits. This may well be 
exacerbated in pregnancy (74). Understanding more about the inter-relationship 
between depression and obesity will aid the development of effective 
interventions.  
 
Genetic 
 
Only a small percentage of obesity can be explained by genetics (75). 
Genomic work has demonstrated that obesity gene loci can explain less than 
three percent of obesity in the population (75). Behavioural and socio-
environmental factors are the main drivers of BMI in a population and these, 
rather than genetic factors, offer opportunities for intervention. It is now thought 
that in utero, maternal over-nutrition may alter the fetal epigenetics and 
predispose the infant to become obese in adulthood (76). 
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Peripartum weight retention  
 
Peripartum weight retention (i.e. extra weight gain over and above pre-
pregnancy weight six months post-delivery) is associated with overweight and 
obesity long term (77). Peripartum weight retention is dependent on excessive 
weight gain during pregnancy. A recent systematic review alludes to 20% of 
women retaining 2.27kg of weight a year postpartum (52). Factors found to 
contribute to peripartum weight retention include maternal nutrition after 
delivery, activity and behaviour (e.g. television watching), sleep deprivation, no 
breastfeeding, and depression (78-81). Excessive weight retention at six 
months post-delivery was associated with increased weight of 10kg 15 years 
post-delivery (82).  
 
Breastfeeding  
 
Breastfeeding plays an important role in weight control post-delivery.  
Pregnancy increases fat stores, particularly visceral fat. Breastfeeding mobilises 
these fat stores after delivery and there is evidence that the longer a woman 
lactates, the more she mobilises these fat stores (83). 
 
Observational studies looking at the association between breastfeeding 
and weight retention provide conflicting findings (83-84). This may be due to 
inconsistency in agreed measurements for breastfeeding (specifically duration 
and intensity), and variation in study design and analysis, particularly with 
regards to appropriate adjustment for confounding.  Studies suggest that for the 
first three months, formula-feeding mothers consume fewer calories and hence 
lose more weight compared to breastfeeding mothers, but after that, up to a 
period of two years, breastfeeding mothers lose significantly more weight (85-
87). Evidence from interventional studies in low income settings suggests that 
greater frequency of breastfeeding up to six months postpartum resulted in 
greater weight loss in women of normal birth weight infants. Long-term studies 
beyond 24 months are currently lacking (83).  
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2.5  Obesity-related outcomes in pregnancy: consequences for mother 
and baby 
 
Obesity can seriously impact on the risk of developing a number of adult 
diseases such as type 2 diabetes, cardiovascular disease and respiratory 
problems, and can have an adverse effect on psychological health and 
wellbeing (29). The effect of obesity on pregnancy is similarly wide-ranging with 
a potentially serious impact on both the mother and the child. In the following 
sections I will provide a personal critical overview of the impact of obesity on the 
mother (Section 2.6), on the labour, delivery and postpartum period (Section 
2.7) and on the fetus and newborn (Section 2.8) (Tables 2 and 3).   
 
Table 2 summarises the maternal, labour and fetal complications associated 
with obesity during pregnancy. 
 
Table 3 summarises the published evidence from large studies and reviews for 
the effect of maternal obesity on maternal, obstetric and neonatal outcome. The 
findings are discussed further on in this chapter. 
 
Table 2: Maternal obesity and adverse pregnancy and fetal outcomes 
Maternal complications associated 
with obesity during pregnancy 
 
 
Maternal mortality 
Gestational diabetes 
Hypertensive disease, chronic 
hypertension and pre-eclampsia 
Thromboembolic disease 
Infection: wound infections, urinary tract 
infections and endometritis 
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Adverse  outcomes in labour and 
delivery associated with obesity in 
pregnancy 
 
 
Induction of labour 
Caesarean section 
Shoulder dystocia 
Anaesthetic complication 
Postpartum complications such as the 
association with postpartum 
haemorrhage and lactational dysfunction 
Major fetal and neonatal 
complications associated with 
maternal obesity  
Congenital defects 
Small for gestational age 
Intrauterine death 
Pre-term births 
Macrosomia 
 
2.6 Maternal outcomes in obese pregnancies 
 
2.6.1 Maternal mortality 
 
Maternal obesity is over-represented in maternal deaths in developed 
countries (88-89). In the most recent confidential enquiry into maternal deaths in 
the United Kingdom, 27% of the 261 deaths occurring between 2006 and 2008 
were in obese pregnant women (88). This compares to an estimated 
background obesity prevalence of 15% in pregnant women in the UK at that 
time (3, 90). Similarly, a maternal death review from California reported that 
30% of the 386 women who died in pregnancy during 2002 and 2003 were 
obese, compared to 16% of women having live births in California in the same 
time period (90-91). These findings reflect the fact that the leading direct and 
indirect causes of mortality such as thromboembolism, pre-eclampsia and 
cardiovascular diseases have a higher prevalence in the obese, compared to 
the lean population. The UK maternal death enquiry reported that three-quarters 
of mothers who died from thromboembolism were overweight or obese, as were 
61% of mothers dying from cardiac disease. For other causes, the percentage 
of women dying who were overweight or obese was around 40%, except for 
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those from suicide, haemorrhage and sepsis where the rates were lower at 20–
25% (5). The importance of these findings has led to recommendations that 
obesity be recognised as a pre-existing medical condition requiring specific 
counselling and careful management from early pregnancy (46, 88).   
 
In some parts of the developing world too, there is growing concern 
about rising BMI in women of childbearing age. Obesity is already a serious 
problem in Latin America, the Caribbean, the Middle East and North Africa (92).  
Rising national incomes in developing countries and increased 'Westernisation' 
will most likely lead to increased levels of obesity in the future with associated 
consequences for maternal mortality (93).   
   
2.6.2 Gestational diabetes mellitus 
 
Endocrine changes in pregnancy make the body more resistant to 
naturally produced insulin (94). These changes confer some physiological 
advantage to the fetus but some pregnancies – particularly in obese women 
who demonstrate enhanced insulin resistance – also increase the risk of 
hyperglycaemia and frank gestational diabetes. There is a strong correlation 
between obesity and gestational diabetes (6, 11, 95). A systematic review by 
Torloni et al. (95), estimates that moderate obesity (BMI above 30 and less than 
40kg/m2) in pregnancy results in a threefold (OR=3.01;CI=2.34-3.87) increase 
in the risk of gestational diabetes compared to women with healthy BMI. Morbid 
obesity (BMI≥ 40kg/m2) is associated with over five times the increased risk of 
gestational diabetes (OR=5.55; 95% CI=4.27-7.21). Based on the definitions of 
diabetes which, until recently, were widely used (see below), about 3% to 7% of 
women develop diabetes in pregnancy overall, ranging from 1% to 3% of 
women of normal weight compared to 14% to 17% of obese women (11, 96).  
Other than pre-pregnancy weight, risk factors related to the development of 
gestational diabetes include ethnicity, previous history of gestational diabetes, 
age, parity and family history of diabetes (97). 
 
38 
 
 
Diabetes mellitus is a metabolic disorder characterised by persistent 
hyperglycaemia, with disturbance of carbohydrate metabolism resulting from a 
defect in insulin secretion, insulin action or both (98). The early definitions of 
gestational diabetes mellitus (GDM) were based on results from oral glucose 
tolerance tests (OGTT) which predicted later diabetes in the mother, a definition 
endorsed by WHO (98). More recently, it has become apparent that a definition 
of GDM would be more clinically relevant if it more precisely defined the degree 
of glycaemia at which outcomes of pregnancy such as neonatal health and 
Caesarean section worsen. Two recently published studies, the 
Hyperglycaemia and Pregnancy Outcome observational study (HAPO) (99) and 
the Australian Carbohydrate Intolerance Study (ACHOIS) have addressed this 
problem (100). The HAPO study showed that with increasing hyperglycaemia, 
there were increases in adverse outcomes in a continuous fashion. It also 
highlighted adverse outcome over a broader range of glycaemia. However the 
HAPO study did not investigate long-term outcomes. The ACHOIS, a 
randomised trial of standard antenatal care versus a more rigorous regime of 
control of glycaemia in women with GDM, showed that the rigorous protocol 
was associated with improved pregnancy outcomes. In a subset of the ACHOIS 
population, however, the intervention did not reduce offspring BMI at the age of 
4 to 5 years (101).  
 
Following HAPO and ACHOIS, the International Association of Diabetes 
in Pregnancy Study Group redefined gestational diabetes mellitus as fasting 
plasma glucose concentration greater than 5.1 mM, 1-hour greater than 10.0 
mM, or 2-hour plasma glucose concentration greater than or equal to 8.5 mM 
following 75 g oral glucose challenge after fasting from midnight (53, 99). With 
the new HAPO definition about 30% of obese women will be classified as 
having GDM. 
 
Women diagnosed with gestational diabetes have a higher risk of 
developing type 2 diabetes mellitus in later life. In a recent systematic review, 
Bellamy et al. (102) identified twenty studies that included over 675,000 women 
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and 10,800 cases of type 2 diabetes. They found that women with gestational 
diabetes had more than seven times the risk of developing type 2 diabetes 
compared to those who had normoglycaemic pregnancies (RR=7.43; CI=4.79-
11.51).       
 
Also of importance here is the recent hypothesis of the link between 
maternal obesity, plus macrosomia, and the child’s risk of developing obesity in 
later life (17, 103). Thus, obesity in pregnancy is not only a modifiable risk factor 
for gestational diabetes but may also play a role in childhood obesity (see 
Section 2.8.4).  
 
2.6.3 Hypertensive disease in pregnancy 
 
Hypertensive disease in pregnancy, or gestational hypertension, is 
defined as new onset hypertension (systolic blood pressure greater than 140 
mmHg and/or diastolic blood pressure greater than 90 mmHg) after 20 weeks 
gestation (104-105). If gestational hypertension is associated with proteinuria as 
shown by one (measurement of 0.3 g/l) or more on proteinuria dipstick testing, 
or 300 mg or more per 24-hour urine collection, then the diagnosis is pre-
eclampsia (11). Many studies show that maternal obesity is associated with 
increased risk of gestational hypertension (7, 12, 106-107). Two large 
population-based studies and a systematic review (see summary in Table 3) 
demonstrated clear and consistent strong positive associations between 
maternal pre-pregnancy BMI and the risk of pre-eclampsia (7, 11, 45). The 
systematic review concluded that the risk of pre-eclampsia typically doubled 
with each 5-7 kg/m2 increase in pre-pregnancy BMI (7). Another recent study 
also addressed the dose-response effect of increasing body mass index and the 
rise in the prevalence of pre-eclampsia (108). With obesity prevalence rising 
throughout most countries (1), the role of pre-pregnancy body mass index as an 
independent risk factor for pre-eclampsia, and a target for pre-conceptual care, 
is a pertinent subject for research. Interestingly, a systematic review concluded 
that mothers who develop pre-eclampsia are more likely to develop 
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cardiovascular disease later on in life (109), raising the possibility that any 
preventive measure is likely to benefit health later in life as well as the more 
immediate adverse maternal and neonatal outcomes.   
 
Mechanistically, the association between the rise in BMI and increasing 
pre-eclampsia prevalence may be explained by heightened inflammation in 
obese women, oxidative stress enhancement in the obese, or increased insulin 
resistance in the obese (103, 108, 110-111).  
 
 2.6.4 Thromboembolic complications  
 
Venous thromboembolic (VTE) complications are a leading direct cause 
of maternal mortality in the United Kingdom and other developed countries (5, 
112). Pregnancy-associated death from thromboembolism occurs once in 
around 7,000 pregnancies, a 12-fold increase compared to the non-pregnant 
state where the risk is around one in a million for women of reproductive age 
(113). A small case-controlled study in Denmark showed a significant 
association between venous thromboembolism in pregnancy and obesity, 
reporting an almost ten-fold increased risk for obese pregnant women 
compared to non-obese (114). A recent study from the UK Obstetric 
Surveillance System (UKOSS) found a more moderate effect; obese women 
were approximately two-and-a-half times more likely to develop 
thromboembolism compared to lean pregnant women (8). The possible 
mechanism underlying these observations may relate to elevated 
concentrations in the blood of pro-coagulant factors found in some studies 
(115). Contributing to this may be heightened inflammatory damage to the 
venous endothelium and sedentary lifestyle in the obese.  
  
2.6.5 Infection 
 
Infection accounts for substantial morbidity during pregnancy. There is 
strong evidence of an association between maternal obesity and wound 
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infection (99), genital tract infection and urinary tract infections (11, 44-45).  The 
risk of an obese woman having an infection during pregnancy is three-and-a-
half times higher than that for pregnant women with a normal body mass index 
(RR=3.34; CI=2.74-4.06). This finding is consistent with most studies (11, 44-
45). 
 
Even though influenza and the common cold are self-limiting conditions, 
pregnant women who develop complications are at increased risk of 
hospitalisation, intensive care unit admission and death compared to non-
pregnant women (116-117). The recent pandemic spread of H1N1, 
demonstrated that pregnant women were at high risk of severe influenza-related 
complications and hence are a priority group for vaccination. Obesity, and in 
particular morbid obesity, has been shown to be a significant risk factor for 
severe disease in pregnancy in the 2009 influenza pandemic. A study by Yates 
et al. showed the odds of obese pregnant woman being hospitalised for H1N1 
compared to non-obese pregnant woman are 2 (OR=2; CI=1.3-3). The study 
also showed that earlier treatment is associated with improved outcomes and 
hence identification of obesity as a risk factor for severe complication of H1N1 
may necessitate earlier treatment for this group (118).  
 
2.6.6 Anaesthetic complications 
 
Obesity is a major risk factor for anaesthetic-related maternal mortality 
(5). In the 2002-2005 confidential enquiry into maternal death, 80% of the 
anaesthetic-related maternal deaths occurred in women who were obese. With 
obese pregnant women having increased risk of cardiac problems, 
thromboembolism, pre-eclampsia, diabetes and Caesarean section, it is not 
surprising that there is over-representation of obese pregnant women in 
anaesthetic-related maternal deaths. Secondly, the risk of failed epidural 
analgesia increases with increasing BMI. The risk of failed intubation is 1 in 280 
in the obstetric population as a whole compared to 1 in 2230 in the general 
population (119-121). In contrast, the risk of difficult intubation in the obese 
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population is estimated to be 15.5% (122). This is attributed to soft tissue 
changes, oedema and fat deposition in the obese. It is important, therefore, for 
severely obese pregnant women to be referred to the obstetric anaesthetist for 
a clear plan for pain relief in labour and prior assessment with regard to how 
best to minimise the chances of failed regional analgesia and difficult 
intubations.  
 
2.6.7 Intensive care unit admission and maternal obesity 
 
Reasons for intensive care admission for pregnant women are varied. 
The common justifications are similar to indications for maternal mortality such 
as cardiac conditions (123), thromboembolism, postpartum haemorrhage (124) 
and, very recently, H1N1 infection (125). There is a greater preponderance of 
these conditions in obese pregnant women and in the case of H1N1 it has been 
shown that obesity confers increased severity of disease and hence increased 
likelihood of admission to an adult intensive care unit (117). Very few studies 
have looked directly at obesity and intensive care admission; however, of those 
that have looked at specific conditions such as H1N1 and cardiac conditions, 
there appears to be over-representation of obesity in these groups, highlighting 
that near-miss events are more likely to be common in the obese than the lean 
(123, 126). 
 
2.7  Obesity-related adverse outcomes in labour and delivery 
 
2.7.1 Induction of labour 
 
Obese pregnant women have an increased incidence of labour induction.  
The estimated increase is between 1.7-fold and 2.2-fold, even after adjusting for 
associated antepartum complications (127). The evidence regarding labour 
duration is conflicting. Some investigators report higher incidences of prolonged 
labour and failure to progress but others do not (128). A better understanding of 
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the relationship between obesity and the labour mechanism is needed to 
prevent high rates of intervention during labour (129).  
 
2.7.2  Caesarean section  
 
Maternal obesity is an independent risk factor for Caesarean section 
(CS).  Sheiner et al. (2004) investigated the pregnancy outcome of obese 
patients not suffering from hypertensive disorders or diabetes mellitus in women 
who delivered at Soroka Medical Centre in Israel between 1988 and 2002 (130).  
They found that the association between obesity and CS remained significant 
after controlling for variables recognised to coexist with obesity. It was 
suggested that this might be because of caregiver bias. Similarly, Sebire et al. 
(2001) showed that the CS rate for obese women was over 20% compared to 
the CS rate for normal weight women in London in the 1990s, which was nearer 
to 10% (11). Usha et al. reported the effect of maternal obesity on pregnancy 
complications with good control of confounding factors (127). The study 
supported previous evidence that obese women had double the risk of 
undergoing a Caesarean section compared with non-obese women. The 
researchers suggested that this may be an effect of the increased rate of large 
for gestational age infants leading to disproportion during labour, suboptimal 
uterine contractility, or that there may be increased fat deposition in the soft 
tissues of the pelvis. A recent systematic review by Poobalan et al. confirmed 
the consistency of this association and further showed that increasing BMI is 
associated with increasing likelihood of needing a Caesarean section (9). A 
study published by Hollowell et al in 2014 demonstrated a similar association in 
healthy women in England and went on to highlight the need to consider BMI 
with parity when assessing risks associated with birth (131).  
 
2.7.3 Shoulder dystocia 
 
Shoulder dystocia is defined as a delivery in which additional 
manoeuvres are required to deliver the fetus after normal gentle downward 
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traction has failed (132). It occurs when the fetal anterior shoulder impacts 
against the maternal symphysis pubis following delivery of the vertex (133).  
Shoulder dystocia complicates 0.13%–2.1% of all deliveries and is associated 
with adverse pregnancy outcome. The case-control study of Robinson et al. 
(2003) showed that the strongest predictors of shoulder dystocia are related to 
fetal macrosomia (134). Furthermore, they found that for obese non-diabetic 
women carrying fetuses whose weights are estimated to be within normal limits, 
there is no increased risk of shoulder dystocia. Therefore, for obese women, the 
predictors of shoulder dystocia are similar to those of non-obese women, i.e. 
macrosomia. Studies from Sweden (12) and Northwest Thames (11), London, 
showed the risk of macrosomia in obese pregnant women was two to three 
times higher than that for non-obese pregnant women (see Section 2.8.4). 
 
2.7.4 Postpartum complications  
 
Overall, the evidence indicates that obese women tend to have between 
20% and 50% higher rates of postpartum haemorrhage (PPH) than non-obese 
women (53, 127, 130). The increased incidence of Caesarean section amongst 
obese women has been implicated as a causal factor. However, Usha et al. 
showed the increased rate of Caesarean section might not be the only factor 
influencing blood loss in this group; more obese women who had a vaginal 
delivery had a greater than 500 ml blood loss compared to those with a BMI of 
20-30 (130). They suggested that this might be explained by excess bleeding 
from the relatively larger area of implantation of the placenta usually associated 
with a macrosomic fetus (135). Nuthalapaty and Rouse considered the 
possibility that the relatively large volume of blood related to obesity, and the 
resultant decreased bioavailability of uterotonic agents, could be an additional 
factor related to the increased risk of PPH (129). 
 
2.7.5 Other postpartum complications 
There is conflicting evidence regarding the relationship between obesity 
and failure to initiate breastfeeding, and/or a decreased duration of 
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breastfeeding. Maternal obesity is implicated in alteration of the hypothalamic-
pituitary-gonadal axis and fat metabolism, resulting in lactational dysfunction; 
however, the exact mechanism remains to be determined (129). 
   
In the postpartum period obese women have a significantly higher 
incidence of hospitalisation (more than 4 days) compared to non-obese women 
(127, 132). This has significant health resource implications and studies are 
needed to understand and prevent the high hospitalisation rate among obese 
women postpartum (133).   
 
2.8  Obesity-related adverse outcomes on the fetus and newborn 
 
2.8.1 Congenital defects 
 
A congenital defect is defined as an abnormality in the development of 
the fetus resulting in structural, chromosomal and/or gene abnormality present 
at birth. The prevalence of major defects is around two percent of all deliveries 
and accounts for a more significant proportion of stillbirths in obese than non-
obese women (136). Obese women are at a higher risk of delivering a baby with 
a congenital defect (137). Particular defects with increased prevalence in obese 
mothers are risk of neural tube defects (138), congenital heart defects and oro-
facial defects such as cleft palate and/or lip (12, 137) (136, 139). 
 
The mechanism for the observed association between obesity and NTD 
and congenital heart disease is likely to be that obesity can be defined as a pre-
diabetic state, and diabetes has a strong association with neural tube defect 
and congenital heart disease (140-141). Hendricks et al. (2001) showed that 
hyperglycaemia and hyperinsulinaemia are a strong risk factor for neural tube 
defects and may be the driving force for the observed risk in obese women 
(142). Evidence from in vitro and in vivo studies shows that hyperglycaemia 
induces oxidative stress which alters gene expressions responsible for 
embryogenesis (143). There may be other mechanisms at play as some 
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observational studies suggest that when diabetic women are excluded from the 
data, the association between obesity and congenital defects remains (136-
137).  
 
Other mechanisms to explain the association may be deficiency in 
micronutrients such as folic acid at the periconceptional period (141). Folic acid 
provides a protective effect for the development of the neural tube as well as 
other major structures such as the heart (141). It is well recognised that obese 
women have lower folic acid levels in the blood (144-145). It may also be that 
folic acid metabolism is altered in the obese, compared to the lean. Obesity is 
associated with deficiencies in other micronutrients such as carotenoids, vitamin 
D and zinc (146). All of the above evidence emphasises the importance of 
preconceptional and early pregnancy nutrition and weight control (147).   
 
2.8.2 Intrauterine death, neonatal and small for gestational age (SGA) 
 
Miscarriage 
 
Studies looking at the association of maternal obesity and first trimester 
fetal loss tend to be focused on women undergoing fertility treatment (148-149) 
where obesity has been found to be associated with increased risk of 
miscarriage (148, 150). These cannot be generalised to the general population 
as there may be confounding factors related to subfertility. In women who do 
not have fertility problems, the evidence of association between obesity and first 
trimester loss remains conflicting (151). 
  
Stillbirth 
 
Stillbirth is defined as death of the fetus after the accepted threshold of 
viability (24 completed weeks of pregnancy in the United Kingdom and 20 
completed weeks in the United States) (152).  Sebire et al. (2001) reported that 
obese pregnant women in London had a significantly increased risk of stillbirth 
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relative to women of normal weight (BMI 20–25) after adjustment for obesity-
related diseases in pregnancy (11). Also, Cedergren (2004) found that morbidly 
obese women with a BMI >40 had an almost 3-fold increased risk of antepartum 
stillbirth (12). The study by Nohr et al. (2005) based in Denmark suggests that 
the increased risk of stillbirth could be related to rapid fetal growth due to fetal 
hyperglycaemia, which may place the fetus at risk of death by hypoxia if the 
placenta cannot transfer sufficient oxygen for metabolic requirements (153).  A 
recent meta-analysis of epidemiological studies (observational studies) by Chu 
et al. showed the odds of stillbirth were doubled in obese women compared with 
normal BMI (OR=2.1; CI=1.59-2.74) (154). The risk was also high for 
overweight women but not as high as in the obese (154). A recent systematic 
review in the Lancet on modifiable risk factors for stillbirth worldwide highlighted 
overweight and obesity as the highest major modifiable risk factor contributing 
to 23%-40% of stillbirth in developed countries (152). An observational study on 
severe obesity by the Centre for Maternal and Child enquiry in the UK showed 
that mothers who were severely obese had double the risk of stillbirth compared 
to the general population (8.6/1000 compared to 3.9/1000) (42), a similar finding 
to that of the meta-analysis by Chu et al. (154). In summary, there is evidence 
of a doubling in the risk of stillbirth in the obese compared to lean pregnant 
women, and there appears to be increasing stillbirth with increasing BMI.  
 
Neonatal Death 
 
This is defined as the death of an infant in the first 28 days of life. Up 
until recently, all the studies on the association between obesity and neonatal 
death have been based on data from developed countries (155-156). A recent 
study focusing on cross-sectional demographic and health surveys (DHS) from 
27 sub-Saharan African countries showed that obese women from sub-Saharan 
Africa were one-and-a-half times more likely to have a neonatal death 
compared to lean women (OR=1.46; 95% CI=1.11-1.91) (156). Studies have 
looked at the association between maternal obesity and neonatal death in 
developed countries and they report 1.5 to 2.6 increased odds of neonatal 
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mortality in obese mothers compared to women of normal BMI, similar to the 
findings from developing countries (12, 14, 153, 157-158). This association is 
more pronounced in the early neonatal period, suggesting the possible 
mechanism being related to medical conditions in pregnancy such as pre-
eclampsia, diabetes in pregnancy, infection in pregnancy and congenital 
abnormality and premature delivery (156, 159-161). 
 
Small for gestational age (SGA) 
 
Cnattinguis et al. (1998) examined a large-population based cohort of 
Swedish pregnancies and found that the risk of delivering an SGA baby 
increased with increasing BMI (162). Cedergren (2004) also reported a similar 
finding from Sweden, although after excluding women with pre-eclampsia this 
increased risk was no longer statistically significant (adjusted OR 1.23; 95% 
CI=0.94, 1.60) (12). Rajasingham et al. (2009) also found a similar finding 
having used the customised growth charts (108). A study from the United 
Kingdom Obstetric Surveillance System (UKOSS) looking at super-morbidly 
obese pregnant women failed to find an association between body mass index 
of over 50kg/m2 and SGA.   
 
2.8.3 Preterm birth 
 
A  prospective study by Hendler et al. (2005), the Maternal Fetal 
Medicine Units Network Preterm Prediction study, found that pre-pregnancy 
obesity was associated with fewer spontaneous preterm births (SPBs) than 
normal maternal weight (163). Conversely, a higher percentage of preterm 
births in obese women have been found because planned preterm births in 
association with early on-set pre-eclampsia are more predominant in obese, 
compared to lean women (13). Overall it seems that in obese pregnant women 
the increased risk of preterm birth is associated with obesity-related medical 
and antenatal complications and not some intrinsic predisposition to SPB (129).   
 
49 
 
 
 
 
2.8.4 Macrosomia  
 
Increased maternal pre-pregnancy weight and increased pre-pregnancy 
insulin resistance are strongly correlated with increased fetal growth, in 
particular fat mass and weight at birth (99-100). It is thought that in early 
pregnancy increased maternal insulin resistance may be related to altered 
placental function, in addition to increased fetoplacental availability of glucose, 
free fatty acid, and amino acids, but the mechanism behind this is unknown 
(164).  
 
Catalano et al. (2003) reported a significant increase in neonatal fat mass 
at birth in infants born to women with GDM (164). The strongest predictor of fat 
mass in infants of women with GDM was found to be maternal fasting glucose 
levels (99-100). This neonatal obesity is proposed to be a significant risk factor 
for adolescent/adult obesity (164). More importantly, obese female neonates 
have been shown to have higher rates of GDM in their own pregnancies (165); 
thus, a vicious cycle is created. Figure 4 shows the potential long-term effects of 
fetal overgrowth. 
 
Figure 4: Potential long-term implications of fetal overgrowth 
 
 
Adapted from Catalano (2003). 
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In light of evidence showing an abnormal metabolic state in utero in 
obese women, there seems a potential for in utero therapy/intervention to 
prevent the effects of maternal obesity on subsequent generations (103, 164).  
A recent study describes an association between maternal obesity and risk of 
adult offspring cardiovascular disease and mortality in mid-life. These 
observations make the development of an intervention to mitigate the effect of 
obesity in utero or pre-pregnancy highly pertinent (15). 
 
2.9  The population impact of obese pregnancies on maternal, fetal and 
neonatal outcomes 
 
The evidence presented thus far shows a markedly increased risk of 
adverse obstetric events in obese pregnancies, including gestational diabetes, 
hypertensive diseases, thromboembolism, infection, Caesarean section and 
postpartum haemorrhage. There are also clear indications that risks increase as 
BMI or the level of obesity increases. This is vitally important information for 
overweight or obese women considering pregnancy or in the early stages of 
pregnancy, and for the clinician managing her pregnancy. The evidence is 
sufficiently robust to consider an obese pregnancy as an at-risk pregnancy as 
reflected in the recent UK guidelines for the clinical management of women with 
obesity in pregnancy (42). 
 
An important question to ask is: What proportion of the adverse obstetric 
events seen in the population, rather than the individual, can be attributed to 
obesity? A useful measure is the population attributable fraction (PAF). This can 
be thought of as the proportion of obstetric morbidity attributable to maternal 
obesity in the population, and also as the proportion of ‘potentially avoidable’ 
adverse outcomes if obesity was eliminated in the population; that is, avoidable 
if all pregnant women were of healthy BMI. 
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The proportion of potentially avoidable adverse outcomes increases with 
both the strength of association between obesity and the outcome, and the 
prevalence of maternal obesity in the population. For example, if maternal 
obesity is associated with an increased risk of 50% (relative risk 1.5) and the 
prevalence of maternal obesity in the population is low at 5%, the proportion of 
adverse obstetric events that could be avoided if obesity was eliminated is only 
2%. However, if obesity is linked to a five-fold increased risk (relative risk of 5) 
of a particular outcome, and the prevalence of obesity in pregnancy is 50%, the 
proportion of potentially avoidable adverse outcome if obesity were eliminated is 
very high at 67%. 
 
In most developed countries obesity is associated with two to three times 
increased risk of adverse outcome and the prevalence of obesity is around 
20%. The best available estimates of relative risk measures from the literature, 
after adjustment for potential confounding factors such as age and parity, are 
used here. Using standard equations (PAF = P1 (AOR-1)/AOR see page 81 for 
details of equations used) PAFs for obesity-related pregnancy outcomes were 
calculated and are depicted below in Figures 5 and 6. The calculations 
demonstrate that the contribution of maternal obesity to gestational diabetes 
and hypertension in pregnancy is around 30%, meaning that almost one-third of 
these outcomes could be prevented in the population if maternal obesity could 
be prevented.  For CS, the figure is around one-fifth, and for postpartum 
haemorrhage, around 9%. If the prevalence of obesity were to increase to 50% 
in the future, the analogous PAF would be higher (Figure 6).  
  
These are worrying estimates. They demonstrate the substantial impact 
of maternal obesity on obstetric health that currently exists in the population, 
and which is likely to increase further if there is no reversal in the trend of 
increasing maternal obesity. The figures also point to potentially huge savings in 
health service expenditure if maternal obesity could be eliminated, or at least 
reduced, in the population. 
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Figure 5: Proportion of potentially avoidable adverse obstetric events (in 
grey) if all mothers were normal weight in early pregnancy 
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(a) 20% pregnant mothers obese
 
 
Figure 6: Proportion of potentially avoidable adverse obstetric events (in 
grey) if all mothers were normal weight in early pregnancy 
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Table 3: Summary of evidence from systematic reviews and large-scale 
epidemiological studies on risk of maternal and fetal outcomes in obese 
pregnant women 
 
 
 
Outcome 
 
 
Reference 
 
 
Setting 
 
 
Study Design 
 
 
Numbers in study 
Estimated measure of effect  
(relative risk) (95% Confidence 
Interval) of obesity on outcome 
of interest 
Gestational 
diabetes 
Torloni et al., 
2009 (95) 
Worldwide Systematic review 
of 59 cohorts and 
11 case-control 
studies 1977 to 
2007 
70 studies   
involving 671945 
women  
Overweight: 1.97(1.77-2.19).  
Mild and moderate obesity: 
3.01(2.34-3.87) 
Morbid obesity: 5.55 (4.27-7.21) 
  
 
 
 
 
 
Hypertensive 
disorders in 
pregnancy 
  
  
Obrien et al., 
2003 (7) 
  
 Canada Systematic review 
of cohort studies 
13 cohort studies 
comprising 1.4 
million pregnant 
women 
The risk of pre-eclampsia 
doubled with each 5 to 7kg/m2 
increase in pre-pregnancy BMI  
Sebire et al., 
2001 (11) 
 UK Cross-sectional 
analysis of North 
West Thames 
maternity 
database 
287213 women with 
singleton 
pregnancies 
delivering 1989 to 
1997 
Overweight: 1.44 (1.28-1.62)  
Obese:  2.14 (1.85-2.47) 
Bhattacharya
, 2007 (107) 
UK Cohort study 24241 nulliparous 
women with 
singleton 
pregnancies 
delivering 1976-
2005 
Overweight:1.6(1.2-1.8)  
Obese: 3.1 (2.8-3.5) 
Morbidly obese: 7.2(4.7-11.2) 
 
 
 
 
Thrombo-
embolism  
  
Larsen et al., 
2007 (114) 
Denmark Case control 
study nested in a 
cohort  
129 cases with VTE 
in pregnancy and 
258 controls who 
are pregnant 
without VTE 
Obese: 9.7 (3.1-30.8) 
Knight et al., 
2009 (8) 
 UK Case control 
study 
143 women who 
had 
thromboembolism 
antenatally between 
2005-2006 
Obese: 2.65 (0.9-6.45) 
Induction of 
Labour 
Sebire et al., 
2001 (11) 
UK Cross-sectional 
study of deliveries 
in Liverpool 
Women’s Hospital 
 287213 women 
with singleton 
pregnancies 
delivering 1989 to 
1997 
Overweight: 2.14(1.85-2.47) 
Obese: 1.70(1.64-1.76) 
Zhang et al., 
2007 (128) 
 UK  Cross-sectional 
study 
3913 completed 
singleton 
pregnancies who 
delivered in 2002 
Overweight: 1.41 (1.21-1.66) 
 
Obese: 2.10 (1.73-2.55) 
Caesarean 
section 
Poobalan et 
al., 2009 
(135)  
UK  Systematic review 
and meta-analysis 
of publications 
1996 to 2007 
11 studies involving 
166168 pregnant 
women 
Combined: 2.1 (1.9-2.3) 
Overweight:1.53 (1.48-1.58) 
Mild and moderate obesity: 2.26 
(2.04-2.51) 
Morbid obesity: 3.38 (2.49-4.57) 
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Outcome 
 
 
Reference 
 
 
Setting 
 
 
Study Design 
 
 
Numbers in study 
Estimated measure of effect  
(relative risk) (95% Confidence 
Interval) of obesity on outcome 
of interest 
 
 
 
 
Postpartum 
haemorrhage 
  
Sebire et al., 
2001 (11) 
UK Cross-sectional 
analysis of North 
West Thames 
maternity 
database 
287213 women with 
singleton 
pregnancies 
delivering 1989 to 
1997 
Obesity:  1.4  (1.2-1.6) 
Usha et al., 
2005 (127) 
UK A population-
based birth survey 
between 1990-
1999 
60167 women who 
delivered between 
1990-1999 
Obesity:  1.5 (1.2-18) 
Heslehurst et 
al., 2008 (44) 
Europe and 
USA 
Systematic review 
of publications 
1990 to 2007 on 
BMI in pregnancy 
and pregnancy 
outcomes 
6 studies included 
in meta-analysis 
Obesity: 3.34 (2.74-4.06) 
Maternal 
Infection 
Heslehurst et 
al., 2008 (44) 
Europe and 
USA 
Systematic review 
of publications 
1990 to 2007 on 
BMI in pregnancy 
and pregnancy 
outcomes 
6 studies included 
in meta-analysis 
Obesity: 3.34 (2.74-4.06) 
Wound 
infection 
Sebire et al., 
2001 (11) 
 UK  Cross-sectional 
analysis of North 
West Thames 
maternity 
database 
287213 women with 
singleton 
pregnancies 
delivering 1989 to 
1997 
Obesity: 2.24 (1.9-2.64) 
Respiratory 
tract infection 
specifically 
H1N1 
Yates et al., 
2010 (117) 
UK National cohort 
study 
1453 pregnant 
women of whom 
241 admitted with 
H1N1 
Obesity 1.5 (1.3-1.7) 
Admission to 
ITU 
Zwart et al., 
2008 (126) 
Netherlands Cohort study 
371,021 pregnant 
women with 2552 
near misses 
Obesity 1.5 (1.3-1.7) 
Length of 
hospital stay 
Heslehurst et 
al., 2008 (44) 
Worldwide Systematic review 
of publications 
1990 to 2007 on 
BMI in pregnancy 
and pregnancy 
outcomes 
 4 studies included 
in meta-analysis 
Healthy BMI: 2.4 days 
Mild and moderate obesity: 
2.71days 
Morbid obesity: 3.28 days 
Birth defects 
e.g. Neural 
tube defect 
Stothard et 
al., 2009 
(137) 
  
 UK  
 
Systematic 
Review 
 
 
39 studies were 
included in 
systematic review 
and 18 in meta-
analysis 
Overweight and obesity:1.8 (1.62-
2.5) 
Birth defects 
e.g. Cardio-
vascular 
abnormality 
Stothard et 
al., 2009 
(137) 
 UK Systematic 
Review 
39 studies were 
included in 
systematic review 
and 18 in meta-
analysis 
 Overweight and obesity:1.30 
(1.12-1.51) 
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Outcome 
 
 
Reference 
 
 
Setting 
 
 
Study Design 
 
 
Numbers in study 
Estimated measure of effect  
(relative risk) (95% Confidence 
Interval) of obesity on outcome 
of interest 
 
 
 
 
Elective 
Prematurity 
Smith et al., 
2007 (13) 
 
 
 
Scotland, 
UK 
 
 
 
Cross-sectional 
study 
 
 
187290 of women 
who delivered their 
babies in Scotland; 
the data were 
collected when they 
were discharged 
Obesity: 1.6 (1.2-1.8) 
 
 
 
McDonald et 
al., 2010 
(166) 
Canada Systematic review 84 observational 
studies 1095834 
women 
Obesity:1.56 (1.42-1.71) 
 
 
 
 
Spontaneous 
prematurity 
Smith et al., 
2007 (13)  
 
 
 
 
 UK 
 
 
 
 
 
Cross-sectional 
study 
 
 
 
 
187290 of women 
who delivered their 
babies in Scotland 
and the data were 
collected when they 
were discharged  
Obesity:0.95 (.095-0.96) 
 
 
 
 
McDonald et 
al., 2010 
(166) 
Canada Systematic review 84 observational 
studies 1095834 
women 
Obesity: 0.93 (0.85-1.01) 
  
 
 
 
Macrosomia 
  
Sebire et al. 
2001 (11) 
Lon UK Cross-sectional 
analysis of North 
West Thames 
maternity 
database 
287213 Obesity: 2.4 (2.2-2.5) 
Cedergren et 
al., 2004 (12) 
 USA  Cohort 805275 Morbid obesity: 3.82 (3.5-4.2) 
Shoulder 
dystocia 
Sebire et al., 
2001 (11) 
 UK Cross-sectional 
analysis of North 
West Thames 
maternity 
database 
287213 Obesity: 3.14 (1.86-5.31) 
Stillbirth 
 
 
Chu et al., 
2007 (154) 
 USA 
 
Systematic review 
 
Meta-analysis of 9 
studies 
Overweight and obesity: 2.1 (1.5-
2.7) 
Flenady et 
al., 
2011(152) 
Australia Systematic review Meta-analysis of 4 
studies 
Overweight and obesity:1.63 
(1.35-1.95) 
Neonatal 
death 
Kristensen et 
al., 2005 (14)  
Denmark Cohort study 24505 women 
receiving antenatal 
care in Aarhus 
University Hospital 
from 1989-1996 
Overweight and obesity: 2.6 (1.2-
5.8) 
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2.10 Interventions for maternal obesity 
 
Approaches to prevent complications of obesity in pregnancy can be 
offered either pre-pregnancy or during pregnancy. The main approaches to 
obesity interventions in the general population which could be utilised pre-
pregnancy include lifestyle changes (i.e. dietary, physical activity and 
behavioural therapy interventions), pharmacotherapy (for example, Orlistat and 
Metformin) and bariatric surgery (surgery whose sole purpose is to reduce the 
weight of the individual). During pregnancy, most of these interventions – in 
particular, bariatric surgery and some pharmacotherapies – are contra-
indicated.   
 
Interventions during pregnancy are discussed in Chapter 3 and a 
systematic review of the evidence on lifestyle interventions for obesity in 
pregnancy is presented in Chapter 5. Thus, the following sections will focus on 
pre-pregnancy interventions only. 
 
Evidence from the literature shows the correlation between obesity pre-
pregnancy and adverse outcomes, and so effective interventions pre-pregnancy 
to reduce BMI in the overweight and obese could be of enormous benefit. The 
options available pre-pregnancy are either at the population level or the 
individual level. At the population level political, economic, sociodemographic, 
technological, legislative or environmental strategies can be employed to 
reduce obesity prevalence. At the individual level, the options available are 
pharmacotherapy, bariatric surgery, lifestyle interventions, or combinations of 
these.   
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2.10.1 Pre-pregnancy interventions at the population level   
 
Political 
 
As there is now acceptance that there is a global obesity crisis, as 
alluded to in the recent United Nations high level meeting on non-communicable 
diseases, there is the political will to provide solutions and policies to support 
healthy lifestyles (improved diet and increased physical activities) (167-168).  
Political interventions such as mass media health promotion campaigns, for 
example Change for Life (169), legislating  and imposing taxes on companies 
that sell unhealthy foods containing trans-fat, sugar-sweetened beverages, and 
government policies banning trans-fat, may serve to reduce obesity in the long 
term at the population level (170). A statement by Dame Sally Davies, Chief 
Medical Officer for England, recently intimated that if food companies do not 
reduce the amount of refined sugars in their food products, she might be forced 
to recommend imposing taxes as a last resort (171). Hungary already has 
measures in place that tax foods which are high in sugar and salt and France 
has recently done the same. The recent modelling evidence by Raynor and 
Mytton (2012) provides a comprehensive summary of this (172). It suggests that 
the level of tax levied on unhealthy foods in Hungary and France may not have 
much influence but provides a step in the right direction. It proposes that to see 
a marked change in behaviour or reduction in the consumption of sugar, salt 
and saturated fat-rich diet, the tax ought to result in price increases of at least 
20%. A recent modelling study by Briggs et al. estimated a 20% tax on sugar-
sweetened drinks would reduce the number of obese adults in the United 
Kingdom by 1.3%, with the greatest impact in the 16 to 29 year age group and 
hence would be likely to have a higher impact in the pregnancy population. A 
study from Australia calculated a saving of approximately 660,000 disability-
adjusted life-years on a 10% reduction in salt, sugar and saturated fatty acid-
rich food.  Another approach is to impose tax on manufacturers who produce 
unhealthy foods in order to incentivise them to promote healthier options. This 
may provide a balance between influencing the market and maintaining 
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consumer choice (72). Legislation on food labelling, subsidies on healthy foods 
and market restriction could be important policy interventions that may reduce 
obesity prevalence (167). Political intervention that provides a clear agenda with 
the backing of national and international leaders such as WHO, World Bank and 
United Nations, with agreement from government leaders, may ensure that 
governments provide policies that align with healthy diets and improved levels 
of activity, thus contributing to reducing obesity pre-pregnancy.  
 
While these policies may change behaviour in terms of eating healthily, 
and reducing the intake of sugar-sweetened drinks (168), the direct evidence 
that this results in a reduction in obesity prevalence is currently lacking. Thus, 
the political will to do this is proving difficult to secure as governments become 
concerned about taxes and strong lobbying by big cooperate organisations as 
well as being accused of being a “nanny state”. 
  
Economic   
 
Population-level interventions require adequate funding for 
implementation and international cooperation to provide adequate sustained 
funding for programmes that address obesity reduction. These policies are likely 
to be cost-effective as reduction in obesity prevalence could reduce morbidity 
and hence health care costs (170, 173). A recent report from the Academy of 
Royal Colleges led by Stevenson et al. highlights the importance of making 
every contact count, and the need for appropriate services to refer to (174).  
The report stresses that an investment of at least 100 million pounds in each of 
the next three financial years will be needed to address the shortfall in obesity 
services throughout the country. The evidence that this amount of funding will 
reduce obesity prevalence has been extrapolated from smoking cessation 
(174).  A recent study in Science stresses that early years intervention from 0-5 
(i.e. prenatal to aged five years) is extremely cost-effective compared to beyond 
aged 5 years (175). 
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Sociodemographic 
 
In developed countries obesity is more common in the lower 
socioeconomic groups, whilst in developing countries the opposite is the case 
(176). Any population-based intervention should therefore engage and include 
targeting the sociodemographic groups most affected. In developed countries 
most published lifestyle interventions have under-representation of lower 
socioeconomic groups despite obesity being more common in these groups 
(177). This gap could be addressed by developing and trialling an intervention 
within a diverse community. A recent Marmot report, Fair Society Healthy Lives, 
alludes to the importance of early life intervention in addressing 
sociodemographic inequality (178) 
 
Technological  
 
With the advent of mass media and television there is ample opportunity 
for mass marketing and advertising unhealthy foods. Thus, banning the 
advertisement of unhealthy diets on television, particularly to children and 
adolescents, may contribute to reducing obesity pre-pregnancy (167, 173). 
However, the advertising industry employs around 300,000 people in the UK 
alone with a total expenditure of £16.1 billion. Global marketing needs to be 
regulated in order to protect children against the commercial promotion of 
unhealthy foods and beverages. Evidence that this approach may work is, 
however, lacking. 
 
Environmental 
 
  Policies that incorporate town planning, such as the development of safe 
neighbourhoods, and increasing the number of local parks, walking areas and 
cycling routes, may improve physical activities (179). Secondly, reducing the 
number of fast food stores, shops and restaurants concentrated around schools 
and small localities by borough councils may also reduce the consumption of 
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unhealthy foods (180) (181). Environmental issues were alluded to in the 
Foresight report as promoting passive obesity (37). Thus, improving the 
environment may lead to improvements in physical activity levels and reduce 
the pre-pregnancy prevalence of obesity (182). Health impact assessment 
should be mandated when planning communities, as evidence from NICE 
alludes to its potential benefits (NICE (87) (183). This has been shown to be 
effective in some regions in France, the Netherlands and Denmark (184-185), 
and may also be true in the United Kingdom (186) (187). 
 
2.10.2 Interventions for preventing obesity in children; targeting girls before 
reproductive years 
 
Prevention of obesity in girls before they reach reproductive age is likely 
to be an effective strategy for the prevention of obesity in pregnancy. Over the 
last 30 years, the increase in obesity prevalence reported in adults has also 
been shown in children in many countries (e.g. China, India, Mexico and 
Canada) with evidence of some deceleration of the rate in the UK, the USA 
(188) and Australia (189). Once obesity is established, it is difficult to reverse. 
 
A recent Cochrane systematic review meta-analysis, which assessed 
educational, health promotion and behavioural interventions in children of less 
than 18 years of age, demonstrated that childhood obesity lifestyle interventions 
may be effective in reducing adiposity (190). The results from this review should 
be interpreted with caution due to the level of heterogeneity observed between 
studies and the potential biases noted in many of the studies. Most of the 
included interventions combined dietary and activity modification strategies 
which may be limited in their approach and it is suggested that consideration 
ought to be given to other approaches such as advertising, obesogenic 
environment and school policies. Further synthesis of the included studies 
demonstrated that school curricula, including healthy eating and physical 
activity, may be effective. The review highlights that childhood obesity lifestyle 
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interventions can be both safe and effective, and from the limited data on 
indicators of equity, appear to be equitable.  
 
Of the 37 studies included, 19 analysed the effect of the outcome based 
on gender. Eight showed no gender difference in outcome, four showed more of 
an effect on males than on females and seven showed more of an effect on 
females than males. Of the 18 studies which did not analyse gender, five of the 
studies included only females. The Cochrane review did not meta-regress on 
gender. 
 
There are strengths in focusing on childhood obesity prevention. If shown 
to be cost-effective and not harmful to girls, then such interventions may reduce 
adult obesity in women and hence pre-pregnancy obesity, which may improve 
outcomes for mother and infant and minimise the intergenerational increase in 
obesity prevalence and its associated co-morbidity. The weakness of lifestyle 
interventions in children is that they may be deemed stigmatising, highlighting 
the problem to be the child’s fault. It is well recognised that most of the 
beneficial effects of childhood interventions have not been sustained (191) and 
this may be due to the general obesogenic environment in which there is 
aggressive marketing or advertising of the unhealthy lifestyle to children at 
school, in the community and at home via television or sports sponsors of 
companies that sell unhealthy foods such as Coca-Cola. Also, introducing 
interventions in childhood may be far too late. With evidence of fetal 
programming, focusing on dietary or activity changes during the intra-uterine 
environment, such as interventions during pregnancy, may be more effective 
with possibly greater uptake and sustainability (190). 
 
While it is extremely important to tackle the obesity epidemic at the 
population level by changing the environment, the fact that obesity is rising in 
most countries and most populations implies that interventions also ought to 
focus on the individual as well as the population.  
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2.10.3 Pre-pregnancy interventions focusing on the individual 
 
Bariatric surgery pre-pregnancy 
 
Surgery whose purpose is to reduce weight (bariatric surgery) may offer 
an effective treatment modality. There is an increasing trend in bariatric surgery 
being offered and performed in the UK for cases in which lifestyle interventions 
have not worked, particularly for those with morbid obesity (192). Obstetricians 
are increasingly seeing pregnant women who have had bariatric surgery (193).  
 
The operation can either be classified as restrictive or malabsorptive;  
some patients may have both. Restrictive surgery is focused on reducing the 
size of the stomach; for example, gastric banding performed through keyhole 
surgery, i.e. laparoscopically. The restrictive method is intended to reduce the 
capacity of the stomach and hence ensure reduced food intake and the feeling 
of fullness. The malabsorptive procedure involves diversion of part of the gullet; 
for example, biliopancreatic diversion or jejunoileal bypass, which then reduces 
food absorption and in so doing reduces uptake of nutrients. Most of these 
procedures are now performed through keyhole surgery as it has minimal 
complications and reduced length of hospital stay (194); nevertheless, this can 
be very expensive (194). 
 
Evidence suggests that weight loss associated with these operations is 
substantial compared to the non-intervention group (192).  A ten-year follow-up 
of such patients showed a sustained weight loss marked with improvement 
such as diabetes, hypertension, sleep apnoea and abnormal lipids (195-196).  
However, it is important to note that these operations are not free of side effects 
or indeed complications. There is about 0.1% mortality associated with these 
operations and other complications such as bowel hernia, blockage of the 
bowel, and infection (197). Additionally, patients who have had such operations 
are at risk of deficiencies in micro-nutrients such as B12, folates and zinc (198).  
The success of the operations is dependent on the surgeon’s skill level, type of 
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surgery, patient indication, psychological support and the back-up lifestyle 
intervention afterwards, emphasising the importance of follow-up. 
 
Weight loss following bariatric surgery may improve fertility, either 
because of improved confidence and sexual interest, or due to improved 
hormonal endocrine function which is favourable to fertility (199-200). There is 
little high quality evidence of the benefits of bariatric surgery on later pregnancy.  
However, some studies show that such pregnancies have a reduced prevalence 
of maternal complications such as gestational diabetes and pre-eclampsia 
compared to pregnancies of obese women without surgery (201). Currently, 
there are no data to answer the question of whether bariatric surgery prior to 
pregnancy reduces perinatal mortality in subsequent pregnancies. 
 
In view of the micro-nutrient deficiency and the concern that rapid weight 
loss following bariatric surgery may contribute to fetal growth restriction, most 
guidelines recommend that pregnancy is deferred for at least a year to 18 
months (198).  
   
Drugs: weight loss agents 
 
Weight reducing agents have been around for over twelve years but 
most have been deemed ineffective and there have been questions over their 
safety, particularly for women of reproductive age because of the concern about 
teratogenicity (202). As such, most of these drugs, such as Orlistat, are contra-
indicated in pregnancy. A newly licenced anti-obesity drug, Toperamate, has 
been associated with increasing the risk of oral cleft (cleft lip and cleft palate) 
(203). Moreover, extreme weight loss peri-conception has been associated with 
adverse outcome and a recent NICE guideline advises against this (204). 
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Drugs: Insulin sensitive agents  
 
Metformin, a drug used in the treatment of type 2 diabetes and an 
example of an insulin sensitive agent, is becoming commonly used in obese 
women pre-pregnancy, particularly in women with polycystic ovarian syndrome 
where the pathophysiology is thought to be insulin resistance. In diabetic 
patients, metformin sensitises the insulin receptors to insulin and reduces 
endogenous insulin production. Its use in obese non-diabetic and non-PCOS 
women for weight loss has not yet been investigated. (205). 
 
2.10.4 Lifestyle interventions focusing on the individual 
 
Preventive medicine aims to undertake measures to prevent disease.  
The National Institute for Clinical Excellence (NICE), the RCOG study group on 
Obesity and Reproductive Health, the American Dietetic Association, and the 
American Society of Nutrition (2009) advocate weight loss pre-pregnancy for 
obese women and recommend randomised trials to evaluate pre-pregnancy 
interventions (206-209). Weight loss can be achieved by lifestyle interventions 
incorporating the combination of a healthy low caloric intake, low glycaemic 
index diet, increased physical activity and behavioural modification (210).  
 
Few studies have evaluated weight changes pre-pregnancy. One study 
reported that women with BMI increase between pregnancies from normal 
weight to obese, and normal weight to overweight, were at increased risk of 
medically indicated preterm birth (211). Inter-pregnancy weight gain was 
associated with a dose-response increase in the risk of gestational and type 2 
diabetes (212). A nationwide Swedish study of 151,025 women evaluating inter-
pregnancy BMI change and adverse outcome reported that compared to 
women whose BMI changed between -1.0 and 0.9kg/m2, the odds for adverse 
outcomes for those who gained 3kg/m2 or more over two years were 
approximately doubled for pre-eclampsia, gestational hypertension, gestational 
diabetes, large for gestational age babies and stillbirth (213).  
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There is an urgent need for studies in both the UK and internationally to 
evaluate interventions that address obesity pre-pregnancy and during 
pregnancy. These periods have been deemed the critical and sensitive periods 
for the primary prevention of obesity (214). This thesis will focus on lifestyle 
intervention during pregnancy. A summary of interventional approaches during 
pregnancies is presented in Chapter 3. A systematic review and meta-analysis 
of lifestyle interventions during pregnancy is presented in Chapter 5. 
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CHAPTER 3: Rationale, aims and objectives of proposed research 
 
3.1 Introduction  
 
Prior to pregnancy, interventions described in Section 2.10.2 above, 
including pharmacotherapy and bariatric surgery, could be considered as part of 
planning for pregnancy. However, around half of pregnancies in the United 
Kingdom are unplanned (215) and only a small proportion of women planning 
pregnancy follow the recommendations for nutrition and lifestyle (215). Thus, an 
intervention which is developed pre-pregnancy may only reach a small 
proportion of women who could benefit from it. This may be due to difficulty in 
identifying a pre-pregnancy point of care in that there is no obvious contact 
point for most women planning pregnancy. 
 
 In contrast, during pregnancy, there is sufficient evidence to suggest that 
mothers are more motivated to adapt healthy lifestyle changes - for example, 
stoppage of alcohol and smoking (216) - and this could also be true for lifestyle 
behaviour change during pregnancy (217). Current government policy and the 
Royal College of Obstetricians and Gynaecologists support a life-course 
approach to tackling the obesity epidemic and a safe effective intervention 
during pregnancy may provide benefit for mother and baby as well as 
generations to come (218-219). However, recent systematic reviews concluded 
that interventions for obese pregnant women to improve maternal and perinatal 
health outcomes remain unclear and equivocal (177, 220). A recent National 
Institute of Health and Clinical Excellence guideline on weight management 
before, during and after pregnancy recommended the need for randomised 
controlled trials (RCTs) on lifestyle interventions in pregnancy in the United 
Kingdom to inform safe and effective means of improving outcomes and to 
define optimal gestational weight gain for pregnant women (221). 
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3.2 Outcome measures used in maternal obesity interventions   
 
  A recent study by Thangaratinam which analysed lifestyle interventions 
for restricting weight gain in pregnancy asked clinicians what they would deem 
appropriate as a primary outcome for lifestyle interventions in pregnancy. They 
recommended focussing on gestational diabetes, pre-eclampsia, Caesarean 
section, preterm delivery and birth weight, as well as gestational weight gain 
based on BMI of the mother pre-pregnancy (222). The Institute of Medicine 
(IOM) in the United States of America (USA) has recommended gestational 
weight gain relative to each BMI category, as shown in Table 4 below, and this 
is used as a reference range. This advice has been based on observational 
studies. Data from interventional studies may confirm or refute these 
recommendations being used as optimum weight gain in pregnancy for each 
BMI category (223).  
 
Table 4: 2009 IOM gestational weight gain recommendations USA 
 
3.3 Behavioural interventions in obese pregnant women  
 
There are two approaches commonly adopted to improve pregnancy 
outcome. One focuses on restriction of gestational weight gain and the other on 
improvement of insulin sensitivity. Both interventions focus on behavioural 
change but with different emphases and different dietary recommendations.  
Pre-pregnancy BMI category Total weight 
gain range(kg) 
Rate of weight gain 2nd 
and 3rd trimester mean 
range in kg/week 
Underweight (<18.5kg/m2) 12.5-18 0.51 (0.44-0.58) 
Normal weight (18.5-24.9kg/m2)  11.5-16 0.42(0.35-0.50) 
Overweight (25.0-29.9kg/m2) 7-11.5 0.28(0.23-0.33) 
Obese (≥30.0kg/m2) 5-9 0.22 (0.17-0.27) 
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The rationale underpinning the focus on insulin sensitivity is that pre-pregnancy 
obesity and excessive weight gain in pregnancy are associated with 
exaggeration of the physiological state of insulin resistance in pregnancy, 
leading to associated postprandial hyperglycaemia and other related metabolic 
sequelae (103, 224). Obese women gain less weight during pregnancy 
compared to the lean, but they also have a lower recommended weight gain 
during pregnancy and hence a greater proportion do not meet the USA Institute 
of Medicine recommended weight gain compared to the normal or overweight 
women (Table 4) (223). While a significant number of observational studies 
conclude that there is an association between adverse pregnancy outcome and 
excessive weight gain (223, 225), because of the lack of appropriately powered 
interventional studies, the National Institute of Health and Clinical Excellence 
guideline ‘dietary intervention and physical activity intervention for weight 
management before, during and after pregnancy’ recommended that more 
robust and appropriately powered interventional studies are required which 
focus on improved clinical outcomes and not only gestational weight (204). A 
recent meta-analysis which undertook a systematic review of all the studies 
which have attempted to restrict weight gain showed that although a modest 
restricted weight gain can be achieved (1.42kg less in weight gain compared to 
control) (CI=0.95-1.89kg) (222), there is no good quality evidence yet for a clear 
beneficial effect on clinical outcomes. This might suggest that the focus on 
gestational weight gain is inappropriate. However, most of the studies reviewed 
were of a small size and underpowered to assess clinical outcomes and larger, 
better designed studies are required.  
 
 The strategies employed to date to restrict gestational weight gain are 
varied and include either diet alone or diet and physical activity. Thangaratinam 
et al.’s review suggests that diet is more effective (222). Dietary advice varied 
between calorific restriction and portion control. The frequency and mode of 
delivery of the intervention varied widely from study to study and at present 
there seems to be no pattern of relationship between intensity and outcome 
(226). 
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 There are several relevant and large ongoing trials undertaking 
behavioural interventions in overweight and obese women during pregnancy 
which are adequately powered to assess clinical outcomes and their findings 
are awaited with interest. These include a study from Australia, the LIMIT 
randomised controlled trial (limiting gestational weight gain for overweight and 
obese women to improve health outcomes) study (Clinical trial register ACTRN 
12607000161426), the HELP study (UK), and the United Kingdom pregnancy 
better eating and activity trial (UPBEAT study). Although gestational weight gain 
(GWG) is not the primary outcome in these studies, it is assessed in all and will 
provide important information on the relationship between restriction of weight 
gain and pregnancy outcome (227). The recently published LIMIT study did not 
show improvement in primary clinical outcome such as gestational diabetes and 
large for gestational age infant (67); however, as a secondary outcome 
measure, it showed reduction in the proportion of infants who were macrosomic. 
3.3.1 Prevention of GDM and macrosomia  
 
Other studies have focused on the role of abnormal glucose tolerance in 
adverse outcomes in obese pregnancies. Recent evidence from the HAPO 
study shows that there is a dose-response association between maternal 
hyperglycaemia and perinatal morbidity (228). As mentioned above, the 
predominant metabolic change associated with obesity and pregnancy is 
heightened insulin resistance, which predisposes women to GDM (224). Thus, 
lifestyle interventions currently used in managing diabetes, whether type 2 
diabetes or indeed gestational diabetes, are likely to be effective in obese 
pregnant women without co-morbidities in preventing diabetes and other 
associated adverse outcomes (97, 229). The lifestyle intervention used focuses 
on the individual changing their diet to a low glycaemic index diet with a 
reduced glycaemic load, combined with improved physical activity (229). A low 
glycaemic index diet results in diminished glycaemic response after oral intake 
relative to the same amount of carbohydrate from a reference food (230-231). 
Glycaemic load includes the total amount of carbohydrate within food consumed 
and the glycaemic index of the food, thus measuring both the quantity and 
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quality of the carbohydrate ingested and an indicator of total glycaemic 
response. There is strong evidence that maternal dietary glycaemic load has an 
inverse relationship with pregnancy outcome even in non-diabetics (231). This 
association may be more pronounced in the overweight and obese (231). Also, 
interventional studies which utilise low glycaemic index diets have resulted in 
improved pregnancy outcome in non-diabetics irrespective of body mass index 
(232), (233-235).  
 
3.3.2 Physical activity 
 
An increase in physical activity has been employed as an intervention in 
both GWG restriction studies and in current trials focusing on improvement of 
insulin sensitivity. Some concerns may arise about the safety of the fetus during 
physical activity in pregnancy, but there is ample evidence which suggests that 
low impact exercises and activities such as walking, swimming and cycling are 
safe in pregnancy (65, 236). High impact activities during the first trimester may 
be associated with early miscarriage but from mid-pregnancy onwards there is 
no data to suggest that exercise is associated with a deleterious pregnancy 
outcome. If anything, it may well be protective (81-84). 
 
 Several studies have demonstrated that physical activity in pregnancy is 
not associated with reduced birth weight except in association with high impact 
intensive exercises where growth restriction may occur (237-239) (240-241).  
However, a lower birth weight in those at risk of large for gestational age 
delivery could potentially be positive for the baby and reduce the incidence of 
birth trauma. Several studies have reported that physical activity during 
pregnancy may prevent adverse outcomes, particularly in women who have 
gestational diabetes (100, 242). A study which looked at moderate physical 
activity for a period of two hours per week showed a reduced chance of large 
for gestational age delivery and reduced birth weight in gestational diabetics, 
which was associated with improved neonatal outcome (243). Yet currently 
there are very few robust studies evaluating the role of physical activity 
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intervention in the prevention of gestational diabetes. Physical activity may 
improve insulin sensitivity and increased skeletal muscle glucose uptake (63).  
 
3.3.3 Theoretical approach to intervention delivery 
  
 Whatever the intervention, it is important to evaluate the impact of 
lifestyle intervention on maternal behaviours (diet and physical activity) and to 
show that these are modified. Development of the intervention and potential 
success in achieving behavioural change depends on a detailed understanding 
of barriers to behavioural change. Addressing these barriers within interventions 
could contribute to the success of that intervention. Most studies fail to 
incorporate the theory of behaviour change within the design of their 
intervention and this may explain the difference between a successful or failed 
intervention (226). 
 
The distinctive factors that obese pregnant women may not be motivated 
and may have low self-esteem could explain why they may not comply with a 
lifestyle intervention (244). They may come from a cultural background which 
views obesity as a form of affluence and may not accept the association of 
obesity with adverse health outcomes. They may have a partner or other 
important persons in their life who may restrict their motivation for behaviour 
change. They may also be stigmatised by their weight which may compromise 
changes in behaviour, or indeed they may have limited education and hence 
understanding the implications may be a challenge. A feasibility study which 
addresses these barriers, and assesses the glycaemic load as well as the 
physical activity, before embarking on a bigger main randomised trial will be an 
important pre-requisite to a successful intervention.  
  
 Obese women can be identified and are being identified at booking, as 
all women who book during pregnancy in the United Kingdom are 
recommended to be weighed and  have their BMI calculated and documented 
(46, 204). Interventions that could help improve the outcome in this group of 
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patients are urgently needed. Whilst it is ideal for interventions to be offered 
pre-pregnancy or even in childhood or adolescence, the fact that adolescent 
obesity, childhood obesity and maternal obesity are all increasing alludes to the 
fact that this is not easily achieved (218). 
 
 In conclusion, the global obesity epidemic in adults, in childhood and in 
pregnancy highlights the importance of developing interventions that will be 
effective in reducing obesity. Evaluating these lifestyle interventions should be 
based on a robust framework such as the MRC framework for evaluating 
complex interventions (245).  Any new interventions should incorporate detailed 
understanding of the metabolic milieu in pregnancy and evaluate possible 
implications for the wellbeing of the mother and baby. 
 
 3.4 Aim and objectives of PhD 
 
The aim of this work was to assess the extent and the potential for the 
prevention of adverse impacts of obesity in pregnancy.  
 
Specific objectives were:  
 
(i) To summarise the literature on adverse effects of obesity on maternal 
and child health outcomes in the UK and elsewhere and to estimate the 
population attributable fraction (Chapter Two). This is a personal critical 
review. 
(ii) To examine the determinants of maternal obesity and its effect and 
impact on different ethnic groups attending Guy’s and St Thomas’ NHS 
Foundation in South London (Chapter Four).  
(iii) To conduct a systematic review and meta-analysis of lifestyle 
interventions for overweight and obese pregnant women to improve 
pregnancy outcomes (Chapter Five). 
(iv) To use the results of the systematic review as a platform to develop a 
multi-component lifestyle change (Community-based Activity and 
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Nutrition, CAN) intervention for maternal obesity to be piloted in the 
South London boroughs of Lambeth and Southwark (Chapters Six, 
Seven and Eight). 
(v) To evaluate the feasibility of the CAN intervention in South London 
(Chapter Nine). 
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CHAPTER 4: The determinants and effect of maternal obesity in a South 
London population  
 
 
 
 
 
  
 
The above publication included births from 2004-2008. The study described 
below relates to a complete re-analysis of data on births from 1st January 2004 
to 31st May 2012 performed in late 2013 and early 2014. 
 
4.1 Introduction  
 
Before developing and evaluating a lifestyle intervention for obese 
pregnant women in South London, it is important to establish the public health 
need for it. The prevalence of maternal obesity, as well as adverse associations 
and impact of maternal obesity on obstetric and neonatal outcome, in South 
London is undocumented.  
 
Whilst the literature described in Chapter One alludes to adverse 
outcomes associated with obesity in pregnancy generally, this may not 
necessarily be the case in South London (a multi-ethnic deprived Inner London 
community) where I work and where the developed intervention is being trialled.     
 
Over half of the women of childbearing age in most developed countries 
are either overweight (BMI 25-29.9kg/m2) or obese (≥30kg/m2) (1). It has been 
estimated that at the start of pregnancy around one in six women in England is 
obese (3). Women who are obese pre-pregnancy face an increased risk of 
adverse obstetric outcomes (12, 44). These risks include gestational diabetes 
(95), pre-eclampsia (7), thromboembolism (8), increased likelihood of 
 
Publication based on part of this work: 
Oteng-Ntim E, Kopeika J, Seed P, Wandiembe S, Doyle P. Impact of 
obesity on pregnancy outcome in different ethnic groups: Calculating 
population attributable fractions. Plos One; 2013: 8(1):e53749 
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Caesarean section (135) and perinatal morbidity and mortality (11, 162).  
However, most of the published research has been conducted in predominantly 
White populations with less than 10% Black and ethnic minorities (44). Some 
studies conclude that obesity is more common in Blacks (3), while others 
conclude it is less prevalent (46), and ethnic susceptibility to obesity is not fully 
documented in the United Kingdom. An understanding of the independent  
impact of obesity in pregnant women in general, and in Blacks or ethnic 
minorities in particular, is important in identifying relevant interventions (246).  
Some recent evidence suggested that there might be a substantial difference 
between ethnic groups in the association of obesity with adverse outcomes 
(247).  
 
 Population attributable fractions (PAFs) are useful in assessing the 
impact of disease risk factors in populations. They take into account both the 
strength of the association between a risk factor and an outcome, and the 
prevalence of the risk factor in the population. There have been only a limited 
number of studies looking at PAFs for maternal obesity; two in the United States 
population (248) (249) and one in Western Europe (250). The latter has 
examined PAFs for the effect of obesity in a cohort of women living in the 
Netherlands on perinatal outcome, the majority of the population being white.  
No comparable studies have been published in the UK. The importance of 
PAFs in obstetrics was made poignant in a recent publication in the Lancet 
which concluded that overweight and obesity may contribute to 40% of stillbirths 
in developed countries (152). 
  
The overall aim of this study is to examine the determinants of maternal 
obesity and its effect and impact on adverse pregnancy and neonatal outcomes 
in a large, ethnically diverse Inner London obstetric population. 
 
The specific objectives of this work were:   
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a. To measure the prevalence of maternal obesity in a multi-ethnic 
community in South London over the period from 1st January 2004 to 31st 
May 2012, using deliveries at hospitals within Guy's and St Thomas' 
NHS Foundation Trust, part of King’s Health partners.  
b. To examine the determinants of obesity in women delivering at this group 
of hospitals. 
c. To investigate the association between maternal obesity and obstetric 
and neonatal outcome in these data. 
d. To measure the impact of maternal obesity on obstetric and neonatal 
outcome in this data by calculating population attributable fractions. 
 
4.2 Methods 
 
4.2.1 Study design and setting     
 
     This was a cross-sectional analysis of a routine clinical dataset. Data 
were obtained from all singleton deliveries at Guy’s and St Thomas’ NHS 
Foundation Trust between 1st January 2004 and 31st May 2012. 
 
4.2.2 Data source and extraction  
 
Data on all deliveries between January 1st 2004 and May 31st 2012 were 
identified and extracted from the maternity information system database 
(Terranova Pacific Services (UK) Ltd, Healthware system). Information is 
routinely entered by midwives in charge of each case. The software has some 
prompts, standardised clinical definitions and mandatory fields. In 2008 the BMI 
field was made mandatory to minimise missing BMI data as identified in a 
previous analysis. All midwives were given formal training before they were 
issued with login access to the database. To ensure the accuracy of the entries, 
two dedicated information technology midwives performed daily data quality 
checks, and cross-checks with clinical notes in some cases. The daily electronic 
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Birth and Discharge Notifications sent to South East London Shared Services 
Partnership also acted as a further data quality check. 
Data items extracted for this research study included the patient 
identification number and date of birth, postcode of residence, maternal age at 
delivery, height, weight, BMI, parity, ethnicity, estimated date of delivery based 
on last menstrual period and/or ultrasound dating, smoking at booking, medical 
conditions at booking and during pregnancy, mode of delivery, liquor grading, 
estimated blood loss and infant’s gestation at delivery, outcome of the infant at 
delivery, gender and birth weight, Apgar scores, cord pH and admission to 
special care baby unit (SCBU) or neonatal intensive care unit. 
 
4.2.3 Data cleaning  
 
The data were extracted from the maternity information system and 
imported into STATA 13. The following steps were taken in order to clean the 
data: 
 
a. The data were sorted by patient identification number and date and time 
of delivery. Duplicate records were removed. 
b. The number of individuals with a record for each variable in the dataset 
was checked.  
c. Suspected recording errors for each variable were changed to missing 
value codes. For example, adjustments were made with regard to birth 
weight, such that birth weight greater than 15kg was thought to be 
unrealistic and hence was removed. 
d. Consistency between pairs of variables was checked to identify extreme 
and unreasonable values. The pairs of variables examined included 
gestational age at delivery and birth weight.   
e. Each variable was explored in depth to assess the extent of missing 
data. Methods for addressing missing data for BMI are described in 
Section 4.2.6. 
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4.2.4 Data management 
 
Inclusion criteria 
 
All singleton deliveries after 24 completed weeks of gestation born 
between January 2004 and May 2012 were included in the study dataset.  
 
Exclusion criteria 
 
Deliveries which ended in miscarriage, or termination, and multiple 
pregnancies were excluded from the study database. 
 
Defining and recoding variables 
 
BMI was calculated as weight (kg) at first antenatal visit (booking), 
divided by height (m) squared. In cases where information on weight and height 
were missing, the original notes were retrieved. BMI was recorded as missing 
when information on height and weight was missing from the original notes or 
the booking BMI was unrealistic (<13 kg/m2). The subjects were categorised 
into the following groups of BMI: underweight <18.5 kg/m2; normal 18.5 to 24.9 
kg/m2; overweight 25 to 29.9 kg m2; and obese ≥ 30 kg/m2. Obese mothers 
were further categorised into mildly obese (30-34.9kg/m2); moderately obese 
(35-39.9kg/m2); and morbidly obese (≥40kg/m2). 
 
All postcodes obtained from the electronic database were converted into 
Indices of Multiple Deprivation (251) using the Department of communities and 
Local Government data base and Centre for Maternal and online electronic 
converting system. The Index of Multiple Deprivation (IMD) brings together 7 
different indicators which cover specific aspects or dimensions of deprivation: 
Income, Employment, Health and Disability, Education, Skills and Training, 
Barriers to Housing and Services, Living Environment and Crime. These are 
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weighted and combined to create the overall IMD 2010 (251). Obtained indices 
were then categorised into quintile groups for the United Kingdom with 1 being 
the least and 5 being the most deprived groups.  
 
Information on ethnic group was classified as White (White British, White 
Irish and Other White), Asian (Bangladeshi, Indian, Pakistani, other Asian and 
Asian British), Black (Black Caribbean, Black African, other Black and Black 
British), Oriental (Chinese, Japanese, Korean and Vietnamese), Others and 
Missing (no information recorded).   
 
Parity, defined as the number of deliveries beyond 24 weeks of 
gestation, was categorised into 0 (nulliparous), 1-3 (one to three previous 
deliveries) and ≥4 (four or more previous deliveries).    
 
Maternal age was calculated as exact age in years on the day of delivery 
and then categorised into the following groups: <20 years; 20-24 years; 25-29 
years; 30-34 years; 35-39 years; 40+ years. Smoking status at booking was 
documented and taken to represent the smoking status of the mother 
throughout pregnancy. Binary variables for hypertension and diabetes were 
generated using data from the following categorical variables: antenatal 
conditions; pregnancy complication; and problems at delivery. Women were 
considered to be a diabetes case when pre-existing type 1 or 2, or gestational 
diabetes, was recorded in any of the above variables at any level of gestation. 
 
Data were also collected for other obstetric parameters, including 
Caesarean section, gestation at delivery, postpartum haemorrhage (blood loss 
after delivery greater than or equal to 500mls) and for neonatal parameters 
including birth weight, admission to neonatal intensive care and special care 
baby unit (NICU & SCBU). 
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4.2.5 Outcome variables 
 
 For objective (a), the primary outcome variable was the prevalence of 
maternal obesity in this population. For objective (b) the primary outcome 
variable was obesity, with the exposure variables being ethnicity, age, parity, 
smoking and deprivation.  
 
  For objectives (c) and (d), the primary outcome variables were diabetes 
in pregnancy (which includes pre-existing diabetes and gestational diabetes 
(defined by WHO) (252), Caesarean section (elective and emergency), 
instrumental delivery,  postpartum haemorrhage status (greater than or equal to 
500mls), preterm delivery (delivery less than 37 completed weeks); and for 
neonatal parameters low birth weight (<2.5kg), macrosomia (>4kg), admission 
to neonatal intensive care unit (NICU) or special care baby unit (SCBU), and 
perinatal death.  
 
4.2.6 Statistical analysis 
 
 Stata 13 software was used for all analyses. Unless specified otherwise, 
a probability of 0.05 was used as the limit of statistical significance for all tests. 
All reported p-values are two-sided. 
 
The prevalence of obesity was derived from the number of deliveries to 
obese pregnant women as a proportion of the total number of deliveries (with 
complete BMI data).   
 
Data were summarised and displayed in cross-tabulations. The 
proportions of missing data for each variable were examined. Since BMI had a 
high proportion of missing data, the issue of potential selection bias was further 
investigated by cross-tabulating BMI with other variables and compared using 
the chi-squared test.  
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 Associations between exposures and outcome were assessed using 
univariate and multivariate logistic regression. Potential confounders were 
identified by a statistically significant (p<0.05) association with the outcome in 
univariate analysis. For multivariate models, each potential confounder was 
added to the logistic regression model in turn. Confounding was assumed if 
adjusting for each potential confounder changed the odds ratio by 10% or more. 
 
Imputation for missing BMI was not used in the multivariate models 
because there was evidence that missing data were not missing at random (see 
Section 4.3.2). To further investigate the possible bias resulting from missing 
data for BMI, two sensitivity tests were performed. Firstly, “BMI missing” was 
used as a dummy category in the multivariate logistic regression analysis and 
the results were compared with those obtained when women with missing BMI 
data were omitted (the standard approach). Secondly, since there was a 
reduction in the proportion of missing data in more recent years, models were 
re-run for births in more recent years (2008 onwards) and compared to the 
results for the whole dataset (January 2004 to May 2012).  
 
It was anticipated before the analysis that there may be statistical 
interaction (effect modification) between factors, such as ethnicity and BMI, in 
their effects on obstetric and neonatal outcomes based on evidence outside 
pregnancy (27). To test for potential ethnic variation in the association between 
obesity and adverse obstetric outcomes, the analyses were stratified by 
ethnicity and formally tested for interaction by adding an ethnicity-obesity 
interaction term to the logistic regression model. Effect modification was 
confirmed by a p-value of <0.05 in a likelihood ratio test. 
 
Adjusted population attributable fractions (PAFs) for the impact of obesity 
on different obstetric outcomes were also computed for the whole group and 
separately for each ethnic group. The formula used for calculating the PAF was: 
 
PAF = P1 (AOR-1)/AOR 
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55,609 deliveries at 
GSTFT 
53,917 Singleton 
deliveries included 
in analysis 
Termination = 218 
Excluded 
Miscarriage = 360 
Excluded 
Twins = 1,114 
Excluded 
where:  
P1 = proportion of women with the outcome of interest who are obese 
AOR = Adjusted odds ratio for the association between obesity and the 
outcome of interest. 
  
The study was approved by Guy’s and St Thomas’ ethics committee and 
it did not require consent. 
 
4.3 Results 
 
4.3.1 Description of study population 
 
53,917 singleton deliveries between the 1st of January 2004 and the 31st 
of May 2012 were included in this analysis. Figure 8 describes the number and 
type of exclusions. 
 
Figure 8: Figure illustrating the number of deliveries included in the 
analysis and the number of excluded deliveries by category 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
84 
 
 
There was an average of 6,304 singleton deliveries per year to 2011 (see 
Table 5). Complete data on BMI was available for 43,249 women (80.2%) and 
of these 25% were classified as overweight and 15% were classified as obese. 
Fifty-five percent of mothers were aged between 25 and 34 years (mean age 31 
years) and almost two-thirds (58%) were nulliparous. Seventy-eight percent of 
the population lived in deprived communities (4th or 5th quintiles IMD) and 46% 
were from ethnic minority groups: 35% Black; 6% Asian; 4% Oriental; and 0.5% 
Other (Table 5). For all variables other than BMI, smoking and gestation at 
delivery, the proportion of missing data was below 2% (Table 5). Missing data 
for BMI was examined in more detail below (Section 4.3.2).  
 
With regard to the obstetric outcomes, 2.3% of the population had 
diabetes, 8.7% and 19.7% had elective and emergency Caesarean section 
respectively, 13.6% had instrumental delivery and 32.3% had postpartum 
haemorrhage (Table 6). In relation to neonatal outcomes, 6.5% of the infants 
were delivered preterm, 10.1% were macrosomic, 6.7% had low birth weight, 
5.7% were admitted to either special care or neonatal intensive care unit and 
the proportion that resulted in perinatal death was 0.8% (Table 6). 
 
4.3.2 Missing data for BMI   
 
 The proportions of individuals with missing BMI data by year of delivery, 
maternal characteristics and outcome categories were compared (Tables 7 and 
8). Most of the variables showed little difference in the group with missing BMI 
data compared to the group with recorded BMI data. However, despite these 
small differences, in light of the large sample size, low P-values were obtained. 
Individuals with missing data for BMI were more likely to be delivered before 
2008, were more likely to be nulliparous, slightly older, less deprived and much 
less likely to have diabetes (Tables 7 and 8). These maternal characteristics are 
associated with a lower prevalence of obesity (see Section 4.3.3). This provided 
evidence that BMI data were more likely to be missing for non-obese, rather 
than obese women, and was thus not missing at random.  
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4.3.3 Determinants of obesity 
 
 There was evidence of a weak trend of increasing obesity prevalence 
with calendar year, although the effect was not marked until 2012 when the 
odds of obesity were 20% higher than in 2004 (Table 9). The prevalence of 
obesity was 10% in Whites, 24% in Blacks, 10% in Asians and 5% in Chinese 
(Table 9). After adjusting for confounding factors, the odds of maternal obesity 
were found to be 2.4 times higher in Blacks compared to Whites (AOR=2.37; 
CI=2.27-2.52) and less than half in Chinese compared to Whites (AOR=0.44; 
CI=0.35-0.56) (Table 9). The odds of obesity increased steadily with increasing 
age and parity. An association between deprivation and obesity was present at 
the highest two quintiles of deprivation (AOR=1.56; CI=1.39-1.75 for level 4 and 
AOR=1.89; CI=1.68-2.13 for level 5, the most deprived group) (Table 9). 
  
4.3.4 Association between BMI and pregnancy outcome 
 
 Increasing maternal BMI was strongly associated with increasing risk of 
adverse pregnancy outcome including diabetes, Caesarean section (elective 
and emergency) and postpartum haemorrhage (Table 10). The trend was 
strongest for diabetes with odds ratios increasing from 2.32 (95% CI=1.96-2.72) 
for overweight women to 8.74 (95% CI=6.62-11.55) for morbidly obese women 
compared to women with normal BMI. For emergency Caesarean section, odds 
ratios increased from 1.37 (95% CI=1.29-1.45) for overweight women to 1.96 
(95% CI=1.64-2.34) for morbidly obese women compared to women of normal 
BMI. Postpartum haemorrhage showed a similar pattern and magnitude of 
effect. In these examples risks were lowest for underweight women compared 
to women of normal weight (Table 10). A weaker association was seen for 
preterm delivery, reaching statistical significance in the morbidly obese group 
(OR=1.66; CI=1.271-2.16). For neonatal outcomes, there was a clear 
association between maternal BMI and macrosomia, with odds ratios increasing 
from 1.53 (95% CI=1.41-1.65) for overweight women to 2.33 (95% CI=1.89-
2.88) for morbidly obese women, compared to women with normal BMI. 
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Increasing maternal BMI was associated with increasing odds of admission of 
the baby to a neonatal intensive care or special care baby unit: odds ratios of 
1.41 (95% CI=1.23-1.62) for obese women and 1.63 (95% CI=1.22-2.17) for 
morbidly obese women compared to women with normal BMI. 
 
There were relatively few perinatal deaths (347), making the numbers in 
each BMI category small. Categorising obesity as BMI≥30kg/m2, obese women 
were 57% more likely to lose their babies through stillbirth or early neonatal 
death (OR=1.57; CI=1.21-2.04) than women with BMI less than 30kg/m2 (Table 
11, sixth column); this finding reached statistical significance. The influence of 
obesity as a categorical variable is summarised in Table 11 (third column). 
 
4.3.5 Association between obesity and pregnancy outcome within ethnic groups 
 
 Table 11 shows the effect of obesity on obstetric outcomes within each 
ethnic group. Obesity was associated with diabetes in all four ethnic groups, 
and there was evidence of statistical interaction (P=0.004). Odds ratios were 
highest for the Asian group (OR=5.82; CI=3.90-8.70) and the Chinese group 
(OR=4.51; CI=2.28-8.93), and lowest for the Black group (OR=3.12; CI=2.61-
3.73). There was evidence of interaction between obesity and ethnicity in the 
likelihood of both elective (p=0.02) and emergency (p<0.001) Caesarean 
section, odds ratios being highest for the Chinese population (AOR=3.38; 
CI=1.81-6.31 for elective CS and AOR=2.01; CI=1.19-3.44 for emergency CS).  
The odds ratios for admission of the neonate to a neonatal unit also showed 
significant variation according to ethnic group (p=0.004): odds ratios were 
highest for the White group (OR=1.75; CI=1.49-2.06) and lowest for the 
Chinese group (OR=0.98; CI=0.30-3.22). The effect of maternal obesity on 
other outcomes showed variability across the ethnic groups, but this variation 
did not reach statistical significance.    
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4.3.6 Sensitivity analyses 
 
Two sensitivity analyses were performed to investigate the impact of 
missing BMI data. Firstly, logistic regression analyses were repeated using “BMI 
missing” as a category in the logistic regression model. The results are 
presented in Table 12. The findings are very similar to the findings presented in 
Table 11 (using the standard analysis method). A second sensitivity analysis 
was conducted repeating the analysis using more recent births, from 2009 to 
2012, for which the proportion of missing BMI data was around 15%. The 
findings are presented in Table 13.  Again, the findings are similar to those in 
Table 11.  
 
4.3.7 Population attributable risk fractions 
 
 Adjusted odds ratios and proportions of obesity were used to calculate 
population attributable risk fractions (PAFs) for obesity in the total population 
and in each ethnic group. In order of magnitude, PAFs for the total study 
population were 30% for diabetes, 12% for Caesarean section (elective and 
emergency combined), 9.3% for perinatal death, 8.1% for macrosomia, 5% for 
admission to a neonatal unit, 4.2% for postpartum haemorrhage, and 3.7% for 
preterm delivery (Table 14). 
  
 There were substantial differences in PAFs between different ethnic 
groups, reflecting both differences in the strength of associations between 
obesity and the outcome, and the prevalence of obesity in the different ethnic 
groups. The contribution of excessive weight to diabetes in the population was 
highest in the Black group (35.3%), followed by that in the White group (26%), 
the Asian group (26.3%), and the Chinese group (13.6%) (Table 14). For 
elective Caesarean section the PAF was highest in the Black group (13.3%), 
followed by 9.6% for the Chinese, 3.4% for the White, and no impact for the 
Asian group. For emergency Caesarean section, PAFs were lower for Asian 
women (2%) and Chinese women (2.8%) compared to Black (4.8%) and White 
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(5.6%) women. A similar pattern was seen for postpartum haemorrhage (PAFs 
in order of magnitude 6% for the Black group, 3% for the White, 1.6% for the 
Asian group, and 1.9% for the Chinese group), and preterm delivery (PAFs in 
order of magnitude 3.6% for the Black group, 3.1% for the White, 3% for the 
Asian group, and 1% for the Chinese group). 
 
 For the neonates, PAFs for macrosomia are 14.2% for the babies of 
Black mothers, 12.1% for the babies of Asian mothers, 6.2% for babies of 
Chinese mothers and 6.1% for babies of White mothers (Table 14). For 
admission to a neonatal care unit PAFs are, in order of magnitude, 6% for the 
babies of  White mothers, 3.5% for the babies of Black mothers, 0.5% for Asian 
mothers and no impact for the babies of Oriental mothers (Table 14). 
 
4.4 Discussion 
 
4.4.1 Summary of findings 
 
 This research estimates the prevalence of obesity in pregnancy in a 
South London population (deliveries between 2004 and 2012) to be 15%. This 
shows that Black people, are 2.4 times more likely to be obese compared to 
Whites (OR=2.37; CI=2.27-2.52) and that Chinese people are less than half as 
likely to be obese as Black people (OR=0.44; CI=0.35-0.56). Maternal body 
mass index increased with increasing age and parity. There was a weak 
association between deprivation and obesity except at the two most deprived 
quintiles of deprivation where the association was strong (for fifth quintile 
OR=1.89; CI=1.68-2.13 and fourth OR=1.56 (1.39-1.75).  
 
 The findings presented here show a strong association between 
maternal obesity and adverse obstetric and neonatal events, including diabetes, 
Caesarean section, preterm birth, postpartum haemorrhage, macrosomia and 
admission to neonatal intensive care unit or special care baby unit. This work 
confirms previous findings on the adverse effects of maternal obesity (44).  
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Interestingly, the association between obesity and diabetes showed significant 
variation according to the ethnicity of the mother, being strongest for Asian 
women and lowest for Black women. This observation has been reported only 
once previously in the United Kingdom (247), when it was concluded that body 
mass index interacts with racial group with regard to the prevalence of 
gestational diabetes, particularly in South Asian women (247). 
 
 A relevant question to ask is: How much of the burden of adverse 
obstetric and neonatal events could be avoided if obesity was eliminated, or at 
least reduced, in the population? In this study, it was shown that 30% of 
diabetes in pregnancy, 12% of Caesarean section, 4.2% of postpartum 
haemorrhage, 3.7% of preterm delivery, 8% of macrosomia, 5% of admissions 
to a neonatal intensive care unit or special care baby unit, and 9.3% of perinatal 
deaths could potentially be avoided if there was no maternal obesity in the 
population. These are, of course, theoretical calculations, but they illustrate the 
important role obesity plays in determining obstetric morbidity in this population.  
They also demonstrate the opportunity for substantial cost savings in obstetric 
health services in this area of South London. 
 
 The impact of obesity varied by ethnic groups and reflected differences in 
the prevalence of obesity, and the strength of the association between obesity 
and the outcomes. This variation was most marked for diabetes, as it was 
estimated that 35.3% of diabetes could be attributed to obesity in the Black 
population compared to only 13.6% in the Chinese population. In fact, most 
outcomes examined showed higher population attributable risk fractions for 
obesity in Black women, driven by the very high prevalence of maternal obesity 
in this group (24.4%). Although at the individual level obesity had a greater 
effect for some outcomes in Asian or Chinese women than in Black women, 
attributable risk fractions were lower for these groups because of the lower 
prevalence of obesity in these groups (4.7% Chinese and 9.7% Asian). 
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4.4.2 Interpretation of findings  
 
 The magnitude of the impact of obesity on diabetes (30%) and 
Caesarean section (12%) found in this study was similar to findings reported for 
the US population of pregnant women (248), which was 30% and 15% 
respectively. However, the PAF for macrosomia is lower in the current study 
(8.1%) in comparison with others (248, 250) (19% and 15%). This difference 
could be due to differences in the definition of macrosomia as well as 
differences in the underlying characteristics of the populations. 
 
 Obesity is associated with insulin resistance (224, 253). Insulin 
resistance predisposes to diabetes, pre-eclampsia (254), and macrosomia 
(255). Macrosomia tends to make vaginal delivery very difficult because of the 
size of the fetus; it is associated with an increase in Caesarean section rate.  
Following delivery of a macrosomic infant, the uterus is more likely to be atonic 
and hence predisposed to postpartum haemorrhage. Also, with a higher 
Caesarean section rate this also predisposes to postpartum haemorrhage.  
Recent guidelines from RCOG/CMACE and NICE emphasise the importance of 
managing obesity in pregnancy (26, 204). This study provides a strong 
indication that if we are able to reduce obesity pre-pregnancy, it would have a 
significant impact on maternal and perinatal morbidity and mortality. It 
also highlights that policies should address the demographic inequality 
associated with obesity in that it is more common in women from deprived 
communities, as well as from minority ethnic groups; thus, it has a greater 
impact on the Black population compared to other ethnic groups.  
 
4.4.3 Limitations 
 
This chapter has highlighted important new findings in obstetrics but it 
has some limitations.   
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Missing BMI data 
 
Missing data is unfortunately common in studies where routine data sets 
have been used. In the dataset used for this research 19.8% of BMI data were 
missing. There could be several reasons for this. It could be because midwives 
who are meant to measure women and record height, weight and BMI in the 
healthware database were not aware that BMI was important and thus were not 
recording it as a matter of priority. This problem was recognised in 2008 and the 
BMI field on the database was made mandatory before the midwives could 
progress to the next data field. Another reason could be missing notes; 
however, this data is routinely recorded at booking directly into the healthware 
database, and hence missing notes are unlikely to be a significant reason for 
the missing BMI data, especially in more recent years.  
 
Missing data can be classified as ‘missing completely at random’, 
‘missing at random’ or ‘missing not at random’. If it is assumed that the missing 
BMI data was missing completely at random or missing at random, then 
analysing the data using multiple imputation techniques can be advantageous 
as it ensures that the data are handled in an unbiased way and improves 
statistical validity (256). In order to assess whether the population whose BMI 
data were missing were similar to those with complete BMI data, the 
demographic profiles of women with and without BMI data were compared. It 
was found that BMI was more likely to be missing for women with a lower 
likelihood of obesity e.g. low parity, low level of deprivation and no diabetes. 
Thus, it is reasonable to assume that the missing BMI data were missing not at 
random. This is a well-recognised finding for parameters such as BMI which are 
visible to the clinician and which can vary between otherwise similar patients 
(256). It is possible that BMI was more likely to be measured and recorded for 
overweight or obese women because the midwife appreciated the clinical 
importance of this, and hence the distribution of BMI is likely to be on the lower 
side in the missing BMI group and higher in the recorded group. Missing data 
for women with low BMI will tend to inflate the prevalence, but we estimate that 
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even if all the women with missing data were not obese, the prevalence would 
fall to 12% (from 14.8%). The actual prevalence is likely to be somewhere 
between 12 and 14.8%.    
 
There is a concern that missing BMI data - which is non-random - may 
bias the analyses. However, a sensitivity analysis, which used logistic 
regression analyses with a BMI missing dummy variable, and an analysis using 
data from 2008 onwards (where the proportion of missing BMI data was lower), 
showed a similar pattern of results to those obtained from the standard 
analyses. This provides evidence that any bias is likely to be minimal.  
 
Confounding factors 
 
Confounding is defined as a variable which is independently associated 
with the exposure variable and also independently associated with the outcome 
variable while at the same time the variable is not in the causal pathway. Not 
addressing confounding in studies is likely to lead to bias and every effort was 
made in this study to address important confounding factors such as the age, 
ethnicity, and parity of the patient, smoking, and deprivation quintile. This 
analysis also considered the calendar year at delivery as a confounder.   
 
 I accept that there may have been a confounding that was not 
addressed. For example, the study could not address confounding at the 
individual socioeconomic level, but it could be argued that individual 
socioeconomic level has a narrow definition limited only to the employment and 
education of the patient or partner. Hypertension may be an important 
confounding factor or effect modifier, or on the causal pathway to adverse 
outcome, and in future work I will be looking at this in more detail in prospective 
data collection in order to ensure that hypertension and other co-morbidity can 
be investigated in more detail. Finally, in this study I was unable to distinguish 
pre-existing diabetes from gestational diabetes so there was some degree of 
misclassification of outcome. Gestational diabetes accounts for 90% of all 
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diabetes in pregnancy. Of the remaining 10%, five percent is type 2 diabetes 
and the other five percent is type 1 diabetes (97). Thus, only a small proportion 
of diabetes in pregnancy existed pre-pregnancy, and while I accept that the 
data are not ideal, I would argue that it would have been unethical to wait for 
prospective longitudinal data before publishing the findings.  
 
 In conclusion, this chapter confirms that maternal obesity is linked to 
maternal and perinatal morbidity for both the individual and the population as a 
whole. Reducing the prevalence of obesity will reduce the likelihood of adverse 
events for the obese woman herself and the burden of adverse events in the 
population. The greatest population impact was seen for diabetes, where 30% 
of cases could potentially be avoided if all pregnant women were of normal BMI 
at the start of pregnancy. The impact of obesity is highest for Black women, 
reflecting the high prevalence of obesity in this group. Policies and strategies to 
address obesity in pregnancy will have the greatest impact if they target the 
whole population but with a proportionate emphasis on Black women. 
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Table 5: Summary table for background characteristics of the mothers  
 
Description Number of 
women  
Percentage 
All singleton deliveries 
 
53917 100% 
Year of delivery 
2004 
2005 
2006 
2007 
2008 
2009 
2010 
2011 
2012 
Total 
 
 
5537 
5826 
6162 
6188 
6818 
6423 
6762 
6716 
3485 
53917 
 
10.27% 
10.81% 
11.43% 
11.48% 
12.65% 
11.91% 
12.54% 
12.46% 
 6.45% 
100% 
Maternal BMI at booking 
Underweight (<18.5 kg/m2) 
Normal weight (18.5-24.9 kg/m2) 
Overweight (25.0-29.9 kg/m2) 
Class I obese (30.0-34.9 kg/m2) 
Class II obese (35.0-39.9 kg/m2) 
Class III obese(≥40.0 kg/m2) 
Total of obese ≥30 
Total (non-missing) 
Missing data 
 
  
1430 
24743 
10647 
4239 
1498 
692 
6429 
43249 
10668 
 
3.3% 
57.2% 
24.6% 
9.8% 
3.5% 
1.6% 
14.9% 
100% 
19.8% 
Mean BMI  (SD) kg/ m2 25.0 (5.3)  
Maternal age at delivery 
<20 
20-24 
25-29 
30-34 
35-40 
>40 
Total (non-missing) 
Missing data 
 
 
2042 
7260 
12250 
17695 
11590 
3080 
53917 
0 
 
3.8% 
13.5% 
22.7% 
32.8% 
21.5% 
5.7% 
100% 
- 
Mean Age at delivery (SD) years 31 (6)  
Parity 
0 
1-3 
4 plus 
Total (non-missing) 
Missing data 
 
 
31210 
21282 
1351 
53843 
74 
 
58% 
39.5% 
2.5% 
100% 
 0.1% 
Ethnicity 
White 
Asian or Asian British 
Black or Black British 
Chinese 
Other 
Total (non-missing) 
Missing data 
 
28799 
3004 
19076 
1926       
288 
53093 
824 
 
54.3% 
5.6% 
35.9% 
3.6% 
0.5% 
100% 
1.5%    
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Description Number of 
women  
Percentage 
Smoking 
Non-smoking 
Total non-missing 
Missing 
 
3357 
44753 
48110 
5807 
7.0% 
93.0% 
100% 
10.8% 
Index of Deprivation 
1 (least deprived ) 
2 
3 
4 
5  (most deprived) 
Total (non-missing) 
Missing data 
 
 
1663 
3094 
6148 
24269 
18351 
53525 
392 
 
3.2% 
5.8% 
11.4% 
45.3% 
34.3% 
100% 
0.7% 
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Table 6: Summary table of obstetric and neonatal outcomes 
 
Outcomes Number of 
women  
Percentage 
Diabetic  
Non-diabetic 
Total non-missing 
Missing 
 
1213 
52704 
53917 
0 
2.25% 
97.75% 
100% 
0% 
Elective Caesarean section 
Vaginal deliveries and non-elective 
Caesarean section 
Total non-missing 
Missing 
 
4694 
49223 
 
53917 
0 
8.71% 
91.29% 
 
100% 
0% 
Emergency Caesarean section 
Vaginal deliveries and non-emergency 
Caesarean section 
Total non-missing 
Missing 
 
10592 
43325 
 
53917 
0 
19.65% 
80.35% 
 
100% 
0% 
Instrumental delivery 
Non-instrumental delivery 
Total non-missing 
Missing 
 
7333 
46584 
53917 
0 
13.60% 
86.40% 
100% 
0% 
Postpartum haemorrhage 
Normal blood loss 
Total non-missing 
Missing 
 
17345 
36257 
53602 
315 
32.36% 
67.64% 
100% 
0.58% 
Preterm delivery 
Term delivery 
Total non-missing 
Missing 
 
3476 
47819 
51295 
2622 
6.78% 
93.22% 
100% 
4.86% 
Macrosomic 
Non-macrosomic 
Total non-missing 
Missing 
 
5444 
48473 
53917 
0 
10.10% 
89.90% 
100% 
0% 
Low birth weight 
Non-low birth weight 
Total non-missing 
Missing 
 
3605 
50312 
53917 
0 
6.69% 
93.31% 
100% 
0% 
NICU/SCBU 
No NICU/SCBU admission 
Total non-missing 
Missing 
 
3089 
50828 
53917 
0 
5.73% 
94.27% 
100% 
0% 
Perinatal death 
Live births surviving 7 days 
Total non-missing 
Missing 
438 
53479 
53917 
0 
0.81% 
99.19% 
100% 
0% 
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Table 7: Table comparing maternal characteristics for deliveries with and 
without BMI measurement   
 
Year of 
delivery 
Non-missing BMI 
n(Column%)[Row%] 
Missing BMI 
n(Column%)[Row%] 
2004 3681(8.51)[66.5] 1856 (17.40)[33.5] 
2005 4172(9.65)[71.6] 1654(15.50)[28.4] 
2006 4579(10.59)[74.3] 1583(14.84)[25.7] 
2007 4569(10.56)[73.8] 1619(15.18)[26.2] 
2008 5362(12.40)[78.6] 1456(13.65)[21.4] 
2009 5521(12.77)[86.0] 902(8.46)[14.0] 
2010 6063(14.03)[90.0] 699(6.55)[10.0] 
2011 6135(14.19)[91.3] 581(5.45)[8.7] 
2012 3137(7.30)[90.8] 318(2.97)[9.2] 
Total 43249(100)[80.2] 10668 (100)[19.8] 
  P<0.001 
Ethnicity 
ONS 
Non-missing BMI 
n(Column%)[Row%] 
Missing BMI 
n(Column%)]Row%] 
White N % 23140 (54.23)[80.4] 5659 (54.28)[19.6] 
Black  N % 15288 (35.83)[80.1] 3788 (36.34)[19.9] 
Asian  N  % 2410 (5.65)[80.2] 594 (5.70)[19.9] 
Chinese  N  % 1598  (3.75)[83.0] 328 (3.15)[17.0] 
Other  N  % 232  (0.54)[80.6] 56 (0.54)[19.4] 
Total  N  % 42668 (100)[80.2] 10425 (100)[19.8] 
  P=0.06 
Maternal 
Age 
Non-missing BMI 
n(Column%)[Row%] 
Missing BMI 
n(Column%)[Row%] 
<20  N % 1605 (3.71)[78.6] 437 (4.10)[21.4] 
20-24  N % 5911(13.67)(81.4)[18.6] 1349 [12.65] 
25-29  N % 9933 (22.97)[81.1] 2317 (21.72)[18.9] 
30-34  N % 14286 (33.03)[80.7] 3409 (31.96)[19.3] 
35-40  N % 9110  (21.06)[78.6] 2480 (23.25)[21.4] 
>40  N  % 2404  (5.56)[78.1] 676  (6.34)[21.9] 
Total 43249 (100)[80.2] 10668 (100)[19.8] 
Mean SD 31 31 
  P<0.001 
Parity- Cat Non-missing BMI   Missing BMI 
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n(Column%)[Row%] n(Column%)[Row%] 
0 24397 (56.48)[78.2] 6813 (63.97)[21.8] 
1-3 17721 (41.03)[83.3] 3561 (33.43)[16.7] 
4 or more 1074 (2.49)[79.5] 277 (2.60)[20.5] 
Total 43192 (100)[80.2] 10651 (100)[19.8] 
  P<0.001 
Smoking 
Non-missing BMI 
n(Column%)[Row%] 
Missing BMI 
n(Column%)[Row%] 
Smoking 2959 (93.13)[88.1] 398 (92.15)[11.9] 
Non-smoking 40084 (6.87)[89.6] 4669 (7.85)[10.4] 
Total 43192 (100)[89.5] 5067 (100)[10.5] 
  P=0.01 
IMD quintile 
Non-missing BMI 
n(Column%)[Row%] 
Missing BMI 
n(Column%)[Row%] 
1 (least 
deprived) 
1143 (2.66)[68.7] 520 (4.93)[31.3] 
2 2245 (5.22)[72.5] 850 (8.06)[27.5] 
3 4779 (11.12)[77.7] 1371 (12.99)[22.3] 
4 19861 (46.22)[81.8] 4403 (41.73)[18.2] 
5 (most 
deprived) 
14943 (34.77)[81.4] 3407 (32.29)[18.6] 
Total 42971 (100)[80.3] 10551 (100)[19.7] 
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Table 8: Table comparing clinical and obstetric outcomes for deliveries 
with and without BMI measurement   
 Non missing BMI 
n(Column%)[Row%] 
  
Missing BMI 
n(Column%)[Row%] 
Non-diabetic 42098(97.3)[79.9] 10606(99.4)[20.1] 
Diabetic 1151(2.7)[94.9] 62(0.6)[5.1] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P<0.001 
Instrumental delivery 39871(92.2)[81.0] 9352(87.7)[19.0] 
Elective Caesarean 
section 
3378(7.81)[72.0] 1316(12.34)[28.0] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P<0.001 
Non Em Caesarean 
section 
34847(80.6)[80.4] 8478(79.5)[19.6] 
Emergency 
Caesarean section 
8402(19.4)[79.3] 2190(20.5)[20.7] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P=0.01 
Non Instrumental 
delivery 
37349(86.4)[80.2] 9235(86.6)[19.8] 
Instrumental 5900(13.6)[80.5] 1433(13.4)[19.5] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P=0.57 
Non-PPH 28805(67.0)[79.5] 7452(70.2)[20.6] 
PPH 14185(33.0)[81.8] 3160(29.8)[18.2] 
Total 42990(100)[80.2] 10612(100)[19.8] 
  P<0.001 
Non-macrosomic 38873(89.9)[80.2] 9600(90.0)[19.8] 
Macrosomic 4376(10.1)[80.4] 1068(10.0)[19.6] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P=0.7 
Non-NICU 40753(94.2)[80.2] 10075(94.4)[19.8] 
NICU 2496(5.8)[80.8] 593(5.6)[19.2] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P=0.04 
Live birth 42907(99.2)[80.2] 10577(99.2)[19.8] 
Perinatal death 347(0.8)[79.2] 91(0.9)[20.8] 
Total 43249(100)[80.2] 10668(100)[19.8] 
  P=0.6 
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Table 9: Association of year of delivery, maternal ethnicity, age, 
deprivation and parity with obesity 
 Obese 
n (%) 
Non-obese 
n (%) 
Crude OR 
(95%CI) 
Adjusted* 
OR (95%CI) 
P Value 
Birth Year 
2004 567 (15.4) 3114 (84.6) 1 1  
2005 595 (14.3) 3577 (85.7) 0.91 (0.81-1.03) 0.92 (0.81-1.05) 0.22 
2006 635 (13.9) 3944 (86.1) 0.88 (0.78-1.00) 0.92 (0.81-1.04) 0.19 
2007 671 (14.7) 3898 (85.3) 0.95 (0.84-1.07) 1.00(0.89-1.14) 0.94 
2008 773 (14.4) 4589 (85.6) 0.93 (0.82-1.04) 1.00 (0.89-1.14) 0.95 
2009 805 (14.6) 4716 (85.4) 0.94 (0.83-1.05) 1.01 (0.90-1.14) 0.81 
2010 866 (14.4) 5197 (85.6) 0.91 (0.82-1.02) 0.97 (0.86-1.10) 0.64 
2011 968 (15.8) 5167 (84.2) 1.03 (0.92-1.15) 1.08 (0.96-1.22) 0.19 
2012 549 (21.0) 2618 (79.0) 1.15 1.01-1.31) 1.21 (1.06-1.39) 0.01 
Maternal ethnicity 
White 2313 (10.0) 20827 (90.0) 1 1  
Black 3725 (24.4) 11563 (73.6) 2.99 (2.74-3.07) 2.37 (2.27-2.52) <0.0005 
Asian 234 (9.7) 2176 (90.3) 0.97(0.84-1.12) 0.91 (0.79-1.05) 0.21 
Chinese 76 (4.7) 1522 (98.3) 0.45 (0.36-0.57) 0.44 (0.35-0.56) <0.0005 
Other 22 (9.5) 210 (90.5) 0.94 (0.61-1.47) 0.88 (0.56-1.37) 0.56 
Maternal age 
<20 145 (9.0) 1460 (91) 0.55 (0.46-0.66) 0.61 (0.51-0.73) <0.0005 
20-24 792 (13.4) 5119 (86.6) 0.86 (0.78-0.94) 0.86 (0.78-0.94) 0.001 
25-29 1520 (15.3) 8413 (84.7) 1 1  
30-34 1955 (13.7) 12331 (86.3) 0.88 (0.82-0.94) 1.00 (0.92-1.07) 
0.95 
 
35-40 1475 (16.2) 7635 (85.8) 1.07 (0.99-1.16) 1.15 (1.06-1.25) <0.001 
>40 542 (22.5) 1862 (77.5) 1.61 (1.44-1.80) 1.49 (1.33-1.68) <0.0005 
Parity 
0 2537 (10.4) 21860 (89.6) 
1 
 
1  
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*Adj
uste
d for 
birth 
year
s, 
mate
rnal 
ethni
city, maternal age, parity, smoking and deprivation. 
1-3 3496 (19.7) 14225 (80.3) 2.12 (2.0-2.24) 1.68 (1.59-1.79) <0.0005 
≥4 389 (36.2) 685 (73.8) 4.89 (4.29-5.58) 2.92 (2.54-3.37) <0.0005 
Smoking 
Smoking 472 (16.0) 2487 (84.0) 1.09 (0.99-1.21) 1.22 (1.10-1.37) <0.0005 
No 
Smoking 
5926 (14.8) 34158 (85.2) 1   
Deprivation 
 
1 Least 
deprived 
79 (6.9) 1064 (93.1) 0.83 (0.64-1.07) 0.94 (0.72-1.21) 0.6 
2 137 (6.1) 2108 (93.9) 0.73 (0.60-0.89) 0.81 (0.66-0.99) 0.8 
  Obese 
n (%) 
Non-obese 
n (%) 
Crude OR 
(95%CI) 
Adjusted*  
OR (95%CI) 
P Value 
3 391 (8.2) 4388 (91.8) 1 1  
4 2917 (14.7) 16944 (85.3) 1.93 (1.73-2.16) 1.56 (1.39-1.75) <0.0005 
5 Most 
deprived 
2865 (23.7) 12078 (76.3) 2.66 (2.38-2.98) 1.89 (1.68-2.13) <0.005 
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Table 10: Adjusted odds ratios (95% CI) for obstetric and child outcomes 
according to maternal body mass index (excluding missing BMI data 
category) 
 
1. Odds ratios adjusted for maternal age, parity, deprivation, smoking and ethnic group.  
2. NICU/SCBU:  Neonatal Intensive Care Unit or Special Care Baby Unit 
 
 
 
Characteristic 
 
In whole 
population 
 
N (%) 
BMI Category  (Kg/m2 ) 
Underweight  
<18.5 
N (%)                 
OR1 (95%CI) 
 
Normal 
18.5-24.9 
N (%) 
OR1 
 
Overweight 
25.0-29.9 
N (%) 
OR1 (95%CI) 
Mildly obese 
30-34.9 
N (%) 
OR1 (95%CI) 
Moderately 
obese 35-39.9 
N (%) 
OR1 (95%CI) 
Morbidly 
      obese>40 
Diabetes 1151 (2.66) 
9(0.63) 
0.47(0.24-0.92) 
327(1.32) 
1.0 
337(3.17) 
2.32(1.97-2.72) 
254(5.99) 
4.48(3.75-5.36) 
151(10.08) 
7.80 (6.29-9.69) 
73(10.55) 
8.74(6.62-11.55) 
Elective CS 3378(7.81) 
79(5.52) 
0.99(0.78-1.26) 
1659(6.70) 
1.0 
891(8.37) 
1.19(1.09-1.30) 
461(10.88)  
1.52(1.35-1.71) 
182(12.15) 
1.65(1.39-1.97) 
106(15.32) 
2.37(1.90-2.97) 
Emergency CS 8402(19.43) 
180(12.59) 
0.69(0.59-0.82) 
4305(17.40) 
1.0 
2322(21.81) 
1.37(1.29-1.45) 
1019(24.04) 
1.61(1.48-1.75) 
389(25.97) 
1.84(1.62-2.10) 
187(27.02) 
1.96(1.64-2.34) 
Instrumental 
delivery 
5900(13.64) 
246(17.2) 
1.07(0.92-1.24) 
3972(16.05) 
1.0 
1192(11.20) 
0.89(0.82-0.96) 
349(8.23) 
0.77(0.68-0.86) 
91(6.07) 
0.59(0.47-0.74) 
50(7.23) 
0.72(0.53-0.97) 
Postpartum 
haemorrhage 
14185(33) 
354(24.91)  
0.78(0.68-0.88) 
7515(30.55) 
1.0 
3746(35.42) 
1.32(1.25-1.39) 
1634(38.74) 
1.55(1.44-1.67) 
628(42.23) 
1.85(1.66-2.87) 
308(44.64) 
2.08(1.78-2.43) 
Preterm 
delivery 
2694 (6.34) 
90(6.44) 
1.16(0.93-1.44) 
1345(5.56) 
1.0 
733(6.97)  
1.18(1.07-1.30) 
319(7.59)   
1.24(1.09-1.42) 
139(9.34) 
1.53(1.26-1.85) 
68(9.88) 
1.66(1.27-2.16) 
Macrosomia 4376(10.12) 
55(3.85) 
0.47(0.36-0.62) 
2153(8.70) 
1.0 
1239(11.64)  
1.53(1.41-1.65) 
563(13.28)  
1.83(1.64-2.03) 
251(16.76) 
2.42(2.09-2.81) 
115(16.62) 
2.33(1.89-2.88) 
Low birth 
weight 
4376(10.12) 
149(10.42)   
1.65(1.38-1.980) 
1493(6.03) 
1.0 
688(6.46)   
0.96(0.87-1.06) 
257(6.06)   
0.87(0.75-1.00) 
111(7.41) 
1.04(0.85-1.29) 
61(8.82) 
1.26(0.95-1.66) 
NICU/SCBU2 2496(5.77) 
72(5.03)  
0.94(0.74-1.21) 
1306(5.28) 
1.0 
653(6.13) 
1.20(1.08-1.33) 
296(6.98) 
1.41(1.23-1.62) 
114(7.61) 
1.57(1.28-1.94) 
55(7.95) 
1.63(1.22-2.17) 
Perinatal 
Death 
347(0.8) 
9(0.63) 
1.05(0.53-2.06) 
154(0.62) 
1.0 
97(0.91) 
1.20(0.91-1.57) 
58(1.37) 
1.74(1.26-2.40) 
15(1.00) 
1.17(0.66-2.04) 
14(2.02) 
2.65(1.51-4.64) 
103 
 
 
Table 11: Adjusted odds ratios (95% CI) for obstetric and child outcomes 
according to maternal obesity1, presented for the whole population and 
separately by ethnic group of the mother  
 
Obstetric and  
perinatal 
outcome 
Whole 
population 
n % 
 
Whole 
population 
OR 2 
(95% CI) 
Maternal ethnic group  
WHITE BLACK ASIAN CHINESE  
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
Interaction 
P-value 
Diabetes 1151 (2.66) 
3.86 
(3.38-4.40) 
4.74 
(3.83-5.88) 
 
3.12 
(2.61-3.730) 
 
5.82 
(3.90-8.70) 
 
4.51 
(2.28-8.93) 
 
0.004 
Elective CS 3378(7.81) 
1.53 
(1.39-1.68) 
1.44 
(1.24-1.67) 
1.61 
(1.42-1.83) 
 
1.00 
(0.61-1.63) 
 
3.38 
(1.81-6.31) 
 
0.019 
Emergency CS 8402(19.43) 
1.52 
(1.42-1.63) 
1.90 
(1.71-2.11) 
1.30 
(1.19-1.43) 
 
1.29 
(0.92-1.82) 
 
2.01 
(1.19-3.44) 
 
<0.001 
Instrumental 
delivery 
5900(13.64) 
0.74 
(0.67-0.83) 
0.79 
(0.69-0.90) 
0.66 
(0.55-0.78) 
 
0.90 
(0.59-1.36) 
 
1.07 
(0.53-2.17) 
 
0.233 
Postpartum 
haemorrhage 
14185(33) 
1.52 
(1.43-1.61) 
 
1.58 
(1.44-1.73) 
 
1.49 
(1.38-1.61) 
 
1.27 
(0.95-1.69) 
 
1.84 
(1.15-2.94) 
 
0.390 
Preterm 
Delivery 
2694(6.34) 
1.26 
(1.14-1.40) 
1.37 
(1.15-1.64) 
1.19 
(1.04-1.36) 
1.44 
(0.91-2.29) 
1.26 
(0.49-3.22) 
0.573 
Macrosomia 4376(10.2) 
1.74 
(1.60-1.89) 
1.67 
(1.48-1.89) 
1.74 
(1.54-1.97) 
 
2.44 
(1.53-3.88) 
 
2.38 
(1.27-4.46) 
 
0.353 
Low birth weight 2759(6.38) 
0.94 
(0.84-1.06) 
1.02 
(0.83-1.24) 
0.93 
(0.81-1.08) 
 
0.87 
(0.54-1.40) 
0.20 
(0.03-1.43) 
 
0.191 
NICU/SCBU 2496(5.77) 
1.38 
(1.24-1.55) 
1.75 
(1.49-2.06) 
1.18 
(1.01-1.37) 
 
1.08 
(0.63-1.85) 
 
0.98 
(0.30-3.22) 
 
0.004 
Perinatal Death 347(0.8) 
1.57 
(1.21-2.04) 
1.41 
(0.81-2.44) 
1.43 
(1.04-1.96)) 
 
3.42 
(1.49-7.84) 
 
1.95 
(0.25-15.45) 
 
0.315 
 
1. BMI 30≥ Kg/m2.  
2. Odds ratios adjusted for maternal age, parity, and deprivation  
3. P = interaction evidence 
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Table 12: Sensitivity analysis 1 using dummy variable for “BMI missing”. 
Adjusted odds ratios (95% CI) for obstetric and child outcomes according 
to maternal obesity1, presented for the whole population and separately 
by ethnic group of the mother  
 
Obstetric and  
perinatal 
outcome 
Whole 
population 
n % 
 
Whole 
population  
OR 2(95% CI) 
Maternal ethnic group 
WHITE BLACK ASIAN CHINESE 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
Diabetes 1213 (2.25) 
3.84 
(3.38-4.38) 
4.73 
(3.82-5.87) 
 
3.11 
(2.60-3.8.66) 
P=0.03 
5.80 
(3.89-8.66) 
P=0.38 
4.50 
(2.27-8.91) 
P=0.89 
Elective CS 
4694 
(8.71) 
1.56 
(1.42-1.71) 
1.46 
(1.26-1.70) 
1.61 
(1.42-1.82) 
P=0.92 
1.01 
(0.62-1.65) 
P=0.16 
3.39 
(1.81-6.33) 
P=0.01 
Emergency CS 
10592 
(19.65) 
1.51 
(1.41-1.62) 
1.89 
(1.70-2.10) 
1.30 
(1.19-1.42) 
P<0.01 
01.29 
(0.92-1.81) 
P=0.03 
2.01 
(1.18-3.43) 
P=0.83 
Instrumental 
delivery 
7333 
(14.90) 
0.75 
(0.68-0.83) 
0.79 
(0.69-0.90) 
0.66 
(0.55-0.78) 
P=0.11 
0.90 
(0.59-1.36) 
P=0.55 
1.07 
(0.53-2.17) 
P=0.41 
Postpartum 
haemorrhage 
17345 
(32.36) 
1.51 
(1.43-1.60) 
 
1.57 
(1.43-1.72) 
 
1.49 
(1.38-1.62) 
P=0.38 
1.27 
(0.95-1.68) 
P=0.16 
1.84 
(1.15-2.94) 
P=0.53 
Preterm 
Delivery 
3476 
(6.78) 
1.25 
(1.13-1.39) 
1.36 
(1.13-1.39) 
1.18 
(1.03-1.35) 
1.44 
(0.91-2.29) 
1.26 
(0.49-3.22) 
Macrosomia 
5444 
(10.1) 
1.72 
(1.58-1.87) 
1.66 
(1.48-1.87) 
1.75 
(1.55-1.97) 
P=0.63 
2.43 
(1.53-3.87) 
P=0.12 
2.38 
(1.27-4.46) 
P=0.28 
Low birth weight 
3605 
(6.69) 
0.94 
(0.84-1.05) 
1.01 
(0.83-1.24) 
0.93 
(0.81-1.07) 
P=0.51 
0.87 
(0.54-1.39) 
P=0.56 
0.20 
(0.03-1.42) 
P=0.11 
NICU/SCBU 
3089 
(5.73) 
1.36 
(1.22-1.51) 
1.74 
(1.48-2.04) 
1.16 
(0.99-1.35) 
P<0.001 
1.07 
(0.63-1.83) 
P=1.08 
0.97 
(0.29-3.19) 
P=0.35 
Perinatal Death 
438 
(0.8) 
1.58 
(1.22-2.04) 
1.41 
(0.81-2.44) 
1.44 
(1.04-1.97) 
P=0.96 
3.49 
(1.53-8.00) 
P=0.08 
1.95 
(0.25-15.47) 
P=0.76 
 
1. BMI≥ 30Kg/m2.  
2. Odds ratios adjusted for maternal age, parity, and deprivation 
3. P = interaction evidence 
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Table 13: Sensitivity analysis 2 using data from 2008 to 2012. Adjusted 
odds ratios (95% CI) for obstetric and child outcomes according to 
maternal obesity, presented for the whole population and separately by 
ethnic group of the mother  
 
Obstetric and  
perinatal 
outcome 
Whole 
population 
n % 
 
Whole 
population  
OR 2(95% CI) 
Maternal ethnic group 
WHITE BLACK ASIAN CHINESE 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
OR 2 
(95% CI) 
Diabetes 
769 
(3.29) 
4.02 
(3.41-4.73) 
4.61 
(3.55-6.00) 
3.44 
(2.74-4.32) 
6.28 
(3.75-10.51) 
2.97 
(1.08-8.19) 
Elective CS 
2459 
(10.51) 
1.55 
(1.37-1.76 
1.52 
(1.25-1.85) 
1.62 
(1.36-1.92) 
0.78 
(0.38-1.60) 
2.80 
(1.09-7.22) 
Emergency CS 
4379 
(18.72) 
1.46 
(1.33-1.61) 
1.94 
(1.67-2.25) 
1.19 
(1.04-1.35 
1.40 
(0.87-2.25) 
1.98 
(0.89-4.42) 
Instrumental 
delivery 
3260 
(15.58) 
0.76 
(0.66-0.88) 
0.80 
(0.66-0.97) 
0.69 
(0.54-0.88) 
0.95 
(0.54-1.66) 
0.64 
(0.19-2.21) 
Postpartum 
haemorrhage 
8535 
(36.74) 
1.51 
(1.3-1.64) 
1.54 
(1.36-1.75) 
1.49 
(1.34-1.67) 
1.41 
(0.96-2.08) 
1.96 
(0.98-3.92) 
Preterm 
Delivery 
1401 
(6.34) 
1.21 
(1.03-1.41) 
1.29 
(1.00-1.67) 
1.17 
(0.95-1.44) 
1.21 
(0.61-2.40 
0.95 
(0.21-4.13) 
Macrosomia 
2402 
(10.3) 
1.74 
(1.54-1.95) 
1.64 
(1.39-1.94) 
1.73 
(1.46-2.06) 
2.94 
(1.62-5.35) 
3.72 
(1.60-8.66) 
Low birth weight 
3605 
(6.69) 
0.89 
(0.75-1.05) 
0.92 
(0.69-1.24) 
0.93 
(0.75-1.16) 
0.61 
(0.29-1.30) 
0.92 
(0.69-1.24) 
NICU/SCBU 
1268 
(5.42) 
1.26 
(1.06-1.49) 
1.60 
(1.26-2.03) 
1.08 
(0.85-1.38) 
0.84 
(0.36-1.97) 
1.60 
(1.26-2.03) 
Perinatal Death 
168 
(0.72) 
1.35 
(0.90-2.02) 
0.71 
(0.26-1.99) 
1.45 
(0.89-2.36) 
3.48 
(0.91-13.36) 
0.71 
(0.26-1.99) 
 
1. BMI≥ 30 Kg/m2.  
2.  Odds ratios adjusted for maternal age, parity, and deprivation 
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Table 14: Population attributable risk fraction (PAF %) for the impact of 
obesity on obstetric and perinatal outcome 
 
 
Obstetric and  
perinatal 
outcome 
Whole 
population 
 
PAF % (95% CI) 
Maternal ethnic group 
 
WHITE 
 
BLACK ASIAN CHINESE 
PAF % (95% CI) PAF % (95% CI) PAF % (95% CI) PAF % (95% CI) 
Diabetes 
30.05 
(26.59-33.35) 
25.92 
(20.87-30.65) 
35.26 
(29.19-40.82) 
26.28 
(17.14-34.41) 
13.62 
(3.89-22.36) 
Elective CS 
6.82 
(5.19-8.44) 
3.40 
(1.76-5.01) 
13.31 
(9.63-16.83) 
-0.46 
(-5.00-3.94) 
9.62 
(2.87-15.90) 
Emergency CS 
5.20 
(4.32-6.07) 
5.55 
(4.46-6.47) 
4.84 
(3.08-6.56) 
1.97 
(-0.74-4.61) 
2.83 
(0.06-5.52) 
Instrumental 
delivery 
-2.39 
(-3.16, -1.62) 
-1.68 
(-2.48—0.88) 
-7.75 
(-10.47—5.10) 
-0.45 
(-3.04-2.07) 
-0.52 
(-2.75-1.66) 
Postpartum 
haemorrhage 
4.17 
(3.57-4.77) 
3.06 
(2.41-3.71) 
6.13 
(4.81-7.43) 
1.58 
(-0.27-3.40) 
1.86 
(0.40-3.29) 
Preterm 
delivery 
3.74 
(1.94-5.51) 
3.12 
(1.00-5.23) 
3.60 
(0.26-6.84) 
3.04 
(-0.25-8.24) 
1.05 
(-4.14-5.99) 
Macrosomia 
8.13 
(6.77-9.48) 
6.12 
(3.77-6.46) 
14.17 
(10.68-17.62) 
12.11 
(4.06-19.49) 
6.17 
(0.01-10.06) 
Small for 
gestational age 
-0.84 
(-2.50-0.77) 
-0.21 
(-2.22-1.77) 
-1.74 
(-4.76-1.19) 
-1.67 
(-5.49—1.80 
-4.38 
(-6.71-2.10) 
NICU-SCBU 
4.91 
(3.10-6.69) 
6.00 
(3.86-8.04) 
3.48 
(0.35-7.16) 
0.54 
(-5.56-4.25) 
-0.60 
(-6.33-4.83) 
Perinatal death 
9.25 
(3.25-14.88) 
5.97 
(3.86-8.04) 
3.48 
(0.35-7.16) 
3.02 
(-2.78, 8.50) 
1.18 
(-1.11, 3.41) 
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CHAPTER 5: Lifestyle interventions for overweight and obese pregnant 
women to improve pregnancy outcome: systematic review and meta-
analysis  
 
 
 
 
 
 
 
 Following the publication of the above paper, this systematic review was 
updated. It now includes material published up to February 2014. There follows 
a transcript of the published study updated as appropriate to include relevant 
recent publications. I led all aspects of this work and performed the meta-
analysis. 
 
5.1 Introduction  
 
 Both developed and developing countries are experiencing a rapid 
increase in the prevalence of obesity (1, 3, 30, 257). Twenty-four percent of 
women of reproductive age in the United Kingdom are now obese (BMI equal to 
or greater than 30kg/m2) and the prevalence appears to be increasing (37).  
Studies in UK women show that the rates of obesity in pregnancy have almost 
doubled in the last two decades (40-41). Recent estimates suggest the 
prevalence of obesity in pregnancy in the UK is at least 20% with 5% having 
severe or morbid obesity (3, 42).  
  
 Observational study data has linked obesity in pregnancy with adverse 
maternal and infant outcomes (3, 11, 17, 42). Obesity increases the risks of 
gestational diabetes (17, 42, 95, 258), hypertensive disease (including pre-
eclampsia) (6-7, 42), thromboembolism (8, 114), infection (7, 127), Caesarean 
section (9, 42), congenital fetal anomalies (137), macrosomia (6), induction 
 
Publication based on this work: 
Oteng-Ntim E, Varma R, Croker H, Poston L, Doyle P. Lifestyle interventions 
for overweight and obese pregnant women to improve pregnancy outcome: 
systematic review and meta-analysis. BMC Med. 2012; 10(1):47 
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(128), stillbirth (95), shoulder dystocia (7) and preterm delivery (13). Moreover, 
maternal obesity may impact on long-term outcomes such as the increasing 
weight of the child in infancy and the severity of obesity in future generations 
(17, 103, 259). 
 
 As most of the adverse outcomes of obese pregnancies show strong 
associations with pre-pregnancy BMI, it is reasonable to assume that the ideal 
intervention would be to reduce obesity prior to pregnancy (161). However, this 
is difficult to achieve because 50% of pregnancies in the UK are unplanned and 
a recent study concluded that only a small proportion of women planning 
pregnancy follow nutrition and lifestyle recommendations (215). As such, an 
intervention pre-pregnancy may reach only a small proportion of the intended 
women.   
 
 Alternatively, pregnancy itself may represent an ideal opportunity to 
target lifestyle change as women have increased motivation to maximise their 
own health and that of their unborn child (215). However, evidence of benefit 
from published intervention studies appears limited and inconsistent (260-278). 
We therefore sought to determine the efficacy of combined dietary activity and 
behaviour support interventions in overweight and obese pregnant women by 
undertaking a systematic review and meta-analysis according to PRISMA 
criteria for maternal clinical outcomes of weight gain, gestational diabetes and 
Caesarean section, and infant outcomes such as large for gestational age and 
macrosomia. The aim was to generate data of the highest statistical power and 
sensitivity. Therefore, in comparison to previous similar-themed systematic 
reviews (177, 279-281), we chose to interrogate multiple databases (not 
restricted to English) and also to separately meta-analyse randomised and non-
randomised clinical trials, evaluating relevant clinical outcomes including 
gestational diabetes and Caesarean section, which had not been attempted in 
prior meta-analyses. 
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5.2 Methods 
 
5.2.1 Eligibility criteria 
 
 The eligible studies included randomised and non-randomised controlled 
clinical trials that evaluated antenatal dietary and lifestyle interventions in obese 
and overweight pregnant women whose outcome measures included 
quantitative maternal and fetal health outcomes. Trials of women with existing 
gestational diabetes and trials of pre-conception or postpartum interventions 
were not included. Inclusion of trials was not restricted by language, publication 
date or country. Systematic reviews and observational studies were excluded. 
 
5.2.2 Information sources 
 
 Literature searches were performed using five mainstream electronic 
databases [Cochrane Library, MEDLINE, EMBASE, CINAHL, Maternity and 
Infant care] and nine other databases [PsyclINFO via OVID SP, PyscLNFO via 
OVID SP, Science Citation Index via Web of Science, Social Science Citation 
Index via Web of Science, Global Health, Popline, Medcarib, Nutrition database, 
RCOG website, opensigle.inist.fr].  
 
5.2.3 Search strategy  
 
 The following medical subject headings (MeSH) terms, words and 
combinations of words were used in constructing the systematic search: 
overweight or obesity; pregnancy or pregnancy complications or pregnancy 
outcome or prenatal care;  lifestyle, early intervention, education, health 
education, education, patient education hand-out,  patient education, exercise, 
exercise therapy,  health promotion, diet, carbohydrate-restricted, diet, fat-
restricted, diet, reducing, diet therapy, weight loss. Full details of the search 
strategy are shown in Table 15. The searches were unlimited by time up to 
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February 2014 and limited to human studies and clinical trials. The systematic 
search was undertaken in the mainstream databases and targeted searches 
were conducted in the other databases. The grey literature was not searched. 
 
5.2.4 Study selection  
 
 Electronic literature searches, study selection, methodology, 
appropriateness for inclusion and quality appraisal were performed. 
Disagreements between reviewers were resolved by consensus. Included 
studies were divided into two groups (RCTs and non-RCTs) and separately 
meta-analysed. 
 
5.2.5 Data collection process 
  
 Two independent reviewers extracted the data. As a first step, each 
paper was screened using the title and the abstract. In the next round studies 
were assessed for methodological quality and appropriateness for inclusion by 
two reviewers working independently from the full text of the manuscript. This 
was done without consideration of the results.      
 
5.2.6 Data items 
 
 For each included trial data was extracted on: maternal gestational 
weight gain, gestational diabetes, Caesarean section, large for gestational age 
baby (>4kg) and birth weight.  
 
5.2.7 Risk of bias in individual studies 
 
 The quality of the studies was assessed based on how the studies had 
minimised bias and error in their methods. We categorised the studies 
according to criteria based on PRISMA guidelines (282) and the Cochrane 
Library (283). For example, high quality trials reported: study aims, control 
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comparison similar to the intervention group, relevant population demographics 
pre-and post-intervention and data on each outcome. These study 
characteristics are tabulated in Tables 18 and 19. A final assessment 
categorised the studies as high, medium or low quality.    
 
5.2.8 Summary and analysis of studies that met the criteria 
 
 This is shown in Figure 7 and in a tabulated format contained within 
Tables 16 and 17. 
 
5.2.9 Summary measures and data synthesis 
  
    The meta-analyses were performed by calculating the risk ratios as the 
main measure of effect. Quantitative analysis was performed on an intention-to-
treat basis focused on data derived from the period of follow-up. There was 
heterogeneity between studies because of the smaller sample size of some of 
the studies (poor quality), variation of the study population, and the intensity and 
duration of the interventional strategies being evaluated. In light of these 
reasons, statistical meta-analysis with random effects model was used to 
combine effect sizes using STATA 12. The degree of heterogeneity was 
expressed using Tau2 rather than I2 as recommended by Rucker et al (284) .  
 
5.3 Results  
 
5.3.1 Study characteristics  
 
 The review process is outlined in Figure 7 and the selected papers are 
summarised in Tables 16 and 17.   
 
 Twenty-one trials met the inclusion criteria: 15 RCTs (260-268) and 6 
non-randomised controlled trials (217, 269-270, 272-273, 285).  All 21 trials 
were performed in developed countries: USA 5, Canada 3, Denmark 2, 
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Netherlands 1, Sweden 1, Spain 1, Brazil 1, Finland 2, Belgium 1, Australia 4 
(Tables 11 and 12). Six RCTs were judged to be of medium quality and one 
was judged to be of high quality (261, 263, 268). The rest were deemed to be 
low quality (Tables 18 and 19).   
 
 The pooled RCTs included a total of 4835 participants and the pooled 
non-randomised controlled trials included 1534 participants. Participants were 
predominantly of White ethnicity except in the studies by Asbee (261), Gray 
Donaldson (272) and Hui (267). In the Asbee study the majority were described 
as being of Hispanic ethnicity (261). 
 
 For all included RCTs the control group received no intervention or 
standard care. In the non-randomised controlled trials, most used non-parallel 
controls (217, 269, 272-273) or controls from another centre (270). The 
outcomes investigated in the trials were gestational weight gain, gestational 
diabetes, Caesarean section delivery, large for gestational age baby, and birth 
weight.  
 
5.4 Intervention characteristics  
 
 The nature of the interventions varied widely between studies; some of 
the key features of the interventions are outlined in Tables 19 and 20. In 
summary, for the six non-randomised studies, three of the interventions 
comprised individual and group/ seminar components (270, 272-273, 286), two 
were individual (269, 285) and one was unclear (217). Of the fifteen randomised 
studies, one comprised individual and group components (267), ten were 
individual (261-264, 266, 268) and three were group-based (260). Where there 
were individual and group components, the latter were usually physical activity 
sessions. All of the non-randomised trials included dietary and physical activity 
guidance, as did the majority of the randomised studies. Exceptions were two 
studies which included only nutritional guidance (263-264) and one which 
included guidelines about weight gain and weight monitoring only (262). The 
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majority of studies included dietary or physical activity guidance with one of the 
non-randomised studies (269) and three of the randomised studies (263, 266-
268) specifying that guidance was personalised.   
 
5.5 Effects of the intervention on outcomes 
 
Of the 21 trials: 17 measured gestational weight gain (12 randomised, 5 
non-randomised); 10 measured gestational diabetes (8 randomised, 2 non-
randomised) 12 measured Caesarean deliveries (8 randomised, 4 non-
randomised); 12 measured large for gestational age (8 randomised, 4 non-
randomised); and 8 measured birth weight (8 randomised). Meta-analyses for 
the different outcomes are shown in Tables 20 and 21 and Figures 8 to 16.  
 
 Meta-analysis of randomised trials showed that combined antenatal 
lifestyle, dietary and activity intervention had a borderline effect on restricting 
gestational weight gain (Table 20 and Figure 8). There was no difference in the 
prevalence of gestational diabetes in overweight and obese women (Table 20 
and Figure 9). Meta-analysis of non-randomised trials only showed weak 
evidence that lifestyle intervention reduces gestational weight gain (Table 21 
and Figure 16) and there was no evidence for reduction in the prevalence of 
gestational diabetes (Table 21 and Figure 15). There was no robust evidence 
that lifestyle intervention is associated with a lower prevalence of Caesarean 
delivery or large for gestational age or any alteration in birth weight (Tables 20 
and 21, Figures 8 to 16).    
 
5.6 Discussion 
 
5.6.1 Summary of main findings 
 
 This review provides weak evidence that antenatal lifestyle, dietary and 
activity advice for overweight and obese pregnant women restricts maternal 
weight gain during pregnancy and has no effect on the prevalence of 
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gestational diabetes in women who are overweight or obese. However, the 
quality of the study designs was generally poor. The reduction in gestational 
weight gain was observed to be statistically significant in the meta-analysis of 
randomised trials [12 RCTs; n=4835; -0.29kg (95% CI=-0.57 to -0.01kg)] but 
non-significant in the meta-analysis of non-randomised trials (6 trials, n=1534).  
No effects of antenatal lifestyle interventions were identified in obese and 
overweight pregnant women in relation to Caesarean delivery, large for 
gestational age, birth weight and macrosomia (>4kg). 
 
5.6.2 Interpretation  
 
 There is evidence to suggest antenatal lifestyle interventions may mildly 
restrict gestational weight gain and have no statistical effect on other important 
clinical outcomes, possibly due to inadequate power of the combined sample 
size. The effect on restricted weight gain was not consistent across all the trial 
populations and therefore cannot be generalised. There was also wide variation 
in the types of interventions evaluated in the studies. The majority were 
individual-based and most provided generic guidance comprising mainly of 
dietary and physical activity information, with few tailoring guidelines. There was 
considerable heterogeneity in intervention design and no obvious patterns 
between intervention type and study outcomes. For the gestational weight gain 
and gestational diabetes outcomes, both the successful and non-successful 
studies included those which were personalised, combined physical activity and 
dietary guidance and were individualised. Moreover, the degrees of weight gain 
restriction achieved were modest overall. It is even harder to draw conclusions 
regarding the specific behaviour change strategies included (e.g. monitoring 
and goal setting) or theoretical basis of interventions since these were typically 
poorly reported.   
 
 Identifying specific components of successful interventions aids 
understanding of how interventions are having an effect and clear reporting of 
intervention design allows for easier replication (287). Previous reviews have 
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attempted to draw conclusions regarding specific effective components of 
interventions.  Suggestions have been made that weight monitoring and setting 
weight goals could be useful (279), and also monitoring, along with education 
counselling and physical activity sessions (217, 288). Another review suggested 
that interventions be based on the ‘Theory of Planned Behaviour’, but the 
rationale for using this model over others in this population was unclear (289).  
None of these reviews examined intervention components systematically. A 
more recent review assessed interventions targeting gestational weight gain 
from a psychological perspective and specifically examined intervention content 
and delivery methods (226). This review comprised ten controlled trials, all 
included in the current review; only two of the studies reported based 
interventions on theory and studies used on average five behaviour change 
strategies (self-monitoring, feedback provision and setting behavioural goals 
were the most common), but no conclusions could be drawn as to their 
contribution to study outcomes. Broadly consistent with this were the six studies 
in the current review which were not reviewed by Gardner et al. (226). The 
review by Gardner et al. questioned the evidence supporting the benefits of 
weight monitoring, but tentatively suggested that information provision had been 
under-used and that it might be of benefit to have a narrower focus of 
intervention targets (226).    
 
5.6.3 Comparison with other systematic reviews and strengths 
 
 This study adds to a growing body of evidence that aims to evaluate 
lifestyle intervention as a means to minimise the adverse outcomes associated 
with obese pregnancy. In comparison to other published reviews (177, 279, 
289), I have adopted an original approach by broadening the literature source 
(multiple data sources, no language restriction), focusing on relevant clinical 
outcomes (such as Caesarean section, gestational diabetes, macrosomia), and 
improving sensitivity by meta-analysing both randomised and non-randomised 
trials. Furthermore, to minimise bias, the review methodology was registered a 
priori (Prospero number CRD420111122                    
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 http://www.crd.york.ac.uk/PROSPERO). I therefore believe this review provides 
a comprehensive and reliable analysis of the current evidence and for the first 
time highlights that lifestyle intervention in pregnancy may reduce the 
prevalence of gestational diabetes. 
 
5.6.4 Limitations of this systematic review  
 
 The evidence summarised in this work comes from available studies of 
which most are of low quality, with only four studies attaining a medium quality 
score and one achieving a high quality score. Hence, the evidence base is 
weak and calls for more robust studies. Our trial population is relatively small, 
the intensity and duration of the interventions of trials varied and trials were 
predominantly USA in origin, a phenomenon common to many public health 
reviews, especially on obesity. There was significant evidence of heterogeneity 
between studies and this was appropriately addressed by using a random effect 
model to establish pooled effect estimates as well as using Tau2 (to measure 
levels of heterogeneity), which has the added advantage that it considers 
variation between studies as a normal distribution and takes account of this.  
Secondly, the forest plots have been sub-grouped in terms of the level of quality 
of the studies which may also help in addressing heterogeneity.     
 
Although our focus was on antenatal lifestyle intervention for obese and 
overweight pregnant women, our search yielded some studies that contained a 
mixed group of obese and normal weight women and we excluded all the non-
obese from our analysis. Still, this may lead to inconsistencies in measuring the 
effect of the intervention as well as under- or over-estimating the treatment 
effect. Furthermore, even though our search was systematic and rigorous, we 
could have missed eligible studies inadvertently. This study may have a 
limitation of publication bias as it does not include unpublished data. The 
assumption with publication or information bias is that negative findings are 
often not published. For this systematic review, this is not the case as most of 
the studies, including the biggest studies to date, were published in reputable 
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journals with null results (67). I reviewed the grey literature on the 
opensigle.inist.fr in order to incorporate interventional studies which may have 
been published in the grey literature, and while there were twelve articles 
published on obesity and pregnancy, none of them were interventional studies. 
Thus, none of them met the criteria to be included in the systematic review 
meta-analysis. 
 
5.6.5 Conclusions and policy implications 
 
 This review reveals that lifestyle intervention for obese and overweight 
women during pregnancy had a borderline effect on restricting gestational 
weight gain but the quality of the published studies is mainly poor. This then 
highlights a paradox. At a time when solutions to address adverse outcomes 
associated with maternal overweight and obesity are identified as a public 
health priority, we find that most of the research evidence lacks robustness to 
inform future evidence-based lifestyle interventions for obese pregnant women.  
There is thus a research gap regarding the effectiveness of lifestyle intervention 
in pregnancy. It is unlikely that further meta-analysis will help to refine the 
quality of evidence since studies demonstrated significant heterogeneity in 
relation to demography, outcome measurement, follow-up and degrees of 
intervention. Hence, I conclude that there is the need for a well-designed large-
scale prospective trial which examines combined antenatal lifestyle 
interventions in obese pregnant women that is suitably powered and 
incorporates robust methodology in accordance with standards set by the 
Medical Research Council’s framework for evaluating complex interventions 
(290). There are two such studies which are currently ongoing, called LIMIT 
(ACTRN 12607000161426) and UPBEAT (ISRCTN89971375). LIMIT has 
recently been published, showing that lifestyle intervention does not improve 
pregnancy outcome and it does not result in any harm. The criticism with the 
LIMIT study was that the intervention was not intensive enough (i.e. six 
sessions with two face-to-face contact sessions and four telephone contact 
sessions). UPBEAT, which utilises eight sessions, with all eight offering face-to-
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face contact, focused on obese pregnant women, and may be intense enough 
to show a difference. Both of these studies are appropriately powered to show 
convincingly whether lifestyle intervention is most likely to improve pregnancy 
outcomes or not. Neither of these studies is delivered in a community setting, 
which will ensure easy translation of the intervention to a wider population, 
including deprived and diverse communities.    
  
Table 15: Search strategy utilised for MEDLINE from 1946 to February 
2014 
 
Batch Search term (MESH)  Combination Result 
1 Pregnancy Complications/ OR 
Pregnancy/ OR Pregnancy Outcome/ 
OR Pregnancy, High Risk/ 
 646055 
2 Prenatal Care/ OR Pregnancy/ OR 
Pregnancy Complications 
 647726 
3 Antenatal.mp.  18393 
4 Gestation intervention.mp.  4 
5  1 OR 2 OR 3 OR 4 651321 
6 Overweight.mp. OR Obesity/ OR 
Overweight/ OR Body Weight/ 
 249097 
7 Obesity/ OR Obesity, Morbid/ or 
Obesity.mp. 
 145882 
8 Body Weight/ OR Obesity/ OR Body 
Mass Index/ or BMI.mp. OR Overweight/ 
 293584 
9  6 OR 7 OR 8 328089 
10  5 AND 9 21583 
11 Diet, Fat-Restricted/ OR Diet/ OR Diet, 
Protein-Restricted/ OR Diet, 
Carbohydrate-Restricted/ OR Diet.mp. 
OR Diet, Reducing/ OR Diet Therapy/ 
 255985 
12 Life Style/  36837 
13 Health Education/  48625 
14 Patient Education as Topic/  63238 
15 Exercise.mp. OR Exercise/ OR 
Exercise, Therapy/ 
 192937 
16 Health Promotion/  43967 
17 Weight Loss/  19434 
18  11 OR 12 OR 13 OR 14 OR 15 OR 601919 
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Batch Search term (MESH)  Combination Result 
16 OR 17 
19  10 AND 18 3769 
20  LIMIT 19 TO (female or humans or 
pregnancy) and (clinical trial, all OR 
clinical trial, phase i OR clinical trial, 
phase ii OR clinical trial, phase iii 
OR clinical trial, phase iv OR clinical 
trial OR controlled clinical trial OR 
RCT) 
154 
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Table 16: A summary of the studies that met the criteria of the systematic review on lifestyle interventions in 
overweight and obese pregnant women: randomised trials 
 
Author (year)  Ethnic group/ 
Country 
Participant/ 
setting 
Sample size  Intervention  Outcome measure(s)  Conclusion  
Polley et al. (2002) 
(266) 
31% Black and 
61% White/USA 
Recruited before 20 weeks of 
pregnancy (normal BMI >19.5 
to 24.9; overweight BMI ≥25 to 
<30 kg/m2)/ Hospital based 
120, including 49 
overweight 
59 in control arm; 61 
in intervention arm 
Exercise and nutrition information 
(oral and newsletter)  
Personalised graphs and behavioural 
counselling 
Gestational weight gain; 
gestational diabetes; 
Caesarean section; birth 
weight 
No statistically significant reduction in 
gestational weight, prevalence of 
gestational diabetes, Caesarean 
section, or large for gestational age 
baby 
 
Hui et al. (2006) 
(267)  
Predominantly 
Caucasian/ 
Canada 
Less than 26 weeks pregnant 
(community-based and 
antenatal clinics). All BMI 
categories. Mean BMI of non-
intervention arm = 25.7 
(SD = 6.3) and for intervention 
arm = 23.4 (SD = 3.9) 
45  
21 in non-intervention 
arm; 24 in intervention 
arm  
Physical exercise (group-sessions 
home-based exercise)  
Individualised nutrition plans  
Gestational weight gain  No statistically significant reduction in 
gestational weight gain  
Wolff et al., 2008 
(264) 
100% 
Caucasian/Denm
ark 
Obese (BMI ≥30 kg/m2) 
women enrolled at 15 weeks 
gestation  
50 analysed 
23 in control arm; 27 
in intervention arm 
Intensive intervention with 10 one-
hour visits with a dietician at each 
antenatal visit, dietary guidance 
provided  
Gestational weight gain; 
gestational diabetes; 
Caesarean section; birth 
weight 
Statistically significant reduction in 
gestational weight gain, no statistically 
significant reduction in prevalence of 
gestational diabetes or Caesarean 
section, or birth weight  
Jeffries et al., 
2009 (262) 
>90% 
Caucasian/Austral
ia 
Women at or below 14 weeks 
gestation. All BMI categories 
included 
 
286  
138 in control arm; 
148 in intervention 
arm 
 
Personalised weight measurement 
card (based on Institute of Medicine 
guidelines)  
Control had only single measurement 
at enrolment  
Gestational weight gain  No statistically significant reduction in 
gestational weight gain.  
Ong et al., 2009 
(276)  
Predominantly 
Caucasian/Austral
ia 
Pregnant obese women 
recruited at 18 weeks 
gestation 
12 
six in control arm; six 
in intervention arm 
Personalised 10 weeks of home-
based supervised exercise (three 
sessions per week) 
Maternal aerobic fitness and 
gestational diabetes 
No statistically significant difference in 
aerobic fitness or gestational diabetes 
Barakat et al., 
2011 (291) 
100% 
Caucasian/Spain 
All BMI categories 160 
80 in control arm; 80 
in intervention arm 
Three group-based sessions per 
week, light resistance and toning 
exercise from the second trimester 
Gestational weight gain and 
birth weight 
No statistically significant difference in 
gestational weight gain and birth weight. 
Exercise intervention might attenuate 
adverse consequences of maternal BMI 
on newborn birth size 
Asbee et al., 2009 26% African Pregnant women recruited 100 One session of dietetic counselling Gestational weight gain; Statistically significant reduction in 
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Author (year)  Ethnic group/ 
Country 
Participant/ 
setting 
Sample size  Intervention  Outcome measure(s)  Conclusion  
(261)  American/USA before 16 weeks gestation. All 
BMI categories except those of 
BMI >40 kg/m2  
43 in control arm; 53 
in intervention arm 
 
and activity 
 
pregnancy outcome  gestational weight gain. No effect on 
pregnancy outcome 
Thornton et al., 
2009 (263) 
 
41% African 
American/USA  
Obese pregnant women 
(BMI ≥30 kg/m2 ) recruited 
between 12 and 28 weeks 
gestation 
257 randomised. 25 
lost to follow up. 116 
in control arm; 116 in 
intervention arm 
Nutritional regime for gestational 
diabetes  
Gestational weight gain; 
gestational diabetes; 
Caesarean section; 
pregnancy outcome 
Statistically significant reduction in 
gestational weight gain, no statistically 
significant reduction in prevalence of 
gestational diabetes, Caesarean section 
or birth weight 
Guelinckx et al., 
2010 (260)  
100% 
Caucasian/Belgiu
m 
Obese (BMI >30kg /m2) 
women enrolled at 15 weeks 
gestation.  
195 randomised 
85 analysed 
65 in control arm; 65 
in passive arm, 65 in 
intervention arm 
 
Three arms: group sessions with a 
dietician; written brochures; and 
standard care 
Dietary and physical activity guidance 
provided by dietician and in written 
brochures 
Nutritional habits; gestational 
weight gain; gestational 
diabetes; Caesarean section; 
birth weight 
Improved nutritional habits; no 
statistically significant reduction in 
gestational weight gain, prevalence of 
gestational diabetes, Caesarean section 
or birth weight.  
Phelan et al., 2011 
(268) 
67% White/USA Pregnant women BMI between 
19.8 and 40 kg/m2 recruited 
between 10 and 16 weeks 
gestation 
401 randomised.  
201 in non-
intervention arm; 200 
in intervention arm 
Exercise and nutrition information 
(oral and newsletter)  
Personalised graphs and behavioural 
counselling 
Gestational weight gain; 
gestational diabetes; 
Caesarean section; 
pregnancy outcome 
Significant reduction in gestational 
weight gain; no statistically significant 
reduction in prevalence of gestational 
diabetes, Caesarean section or birth 
weight  
Quinlivan et al., 
2011 (292) 
73% White, 19% 
Asian/ Australia 
Pregnant women: overweight 
(BMI 25 to 29.9 kg/m2 ) and 
obese (BMI ≥30 kg/m2 )  
132 randomised.  
65 in non-intervention 
arm; 67 in intervention 
arm  
Attended a study- specific antenatal 
clinic providing continuity of care, 
weighing on arrival, brief dietary 
intervention by food technologist and 
psychological assessment and 
intervention if indicated 
Gestational weight gain; 
gestational diabetes; birth 
weight 
Statistically significant reduction in 
gestational weight gain and prevalence 
of gestational weight gain. No 
statistically significant reduction in birth 
weight. 
Luoto et al., 2011 
(277)  
Predominantly 
White/Finland 
Pregnant women at risk of 
gestational diabetes. All BMI 
ranges 
399 cluster random-
ised. 219 in non-
intervention arm; 180 
in intervention arm 
Attended a study-specific individual 
antenatal lifestyle counselling clinic 
including group exercise 
Gestational diabetes; 
gestational weight gain; birth 
weight 
Statistically significant reduction in birth 
weight and macrosomia but no 
statistically significant difference in 
gestational diabetes  
Nascimento et al., 
2011 (278)  
Predominantly 
White/Brazil 
Pregnant women of all BMI 
categories 
82 randomised.  
42 in non-intervention 
arm; 40 in intervention 
arm  
Attended a group-based exercise 
under supervision and received a 
home exercise counselling 
Gestational weight gain; 
raised blood pressure; 
perinatal outcome 
No statistically significant difference in 
gestational weight gain in terms of 
gestational weight gain, raised blood 
pressure or perinatal outcome 
Vinter et al., 2011 White/Denmark Pregnant women who are 
obese 
360 randomised. 154 
in non-intervention 
arm; 150 in 
intervention arm 
Attended a 6 group-based exercise 
under physiotherapist supervision 
and 4 grouped based dietician advice 
Free membership to a gym for 6 
months 
Gestational weight gain; 
raised blood pressure; 
perinatal outcome 
Statistically significant reduction in 
restricted gestational weight gain and 
no change in other obstetric and 
perinatal outcomes 
Dodd et al., 2014 White/Australia Pregnant women who are 2512 randomised. Comprehensive dietary and exercise Gestational diabetes and No statistically significant difference in 
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Author (year)  Ethnic group/ 
Country 
Participant/ 
setting 
Sample size  Intervention  Outcome measure(s)  Conclusion  
obese 1104 in the non-
intervention arm;1108 
in intervention arm 
and behaviour change advice 
delivered by research dietician and 
trained research assistants.  
Attended 2 individual sessions one at 
planning stage, the other face to face 
at 36 weeks by the research 
dietician. 4 telephone contacts by 
research assistants in order to re-
enforce the lifestyle advice.   
large for gestational age infant gestational diabetes and large for 
gestational age infants.  
There was a significant reduction in 
macrosomia in the intervention group 
compared to the control group 
otherwise all other secondary outcomes 
showed no statistically significant 
difference. 
 
1. BMI: body mass index 
2. SD: standard deviation  
 
Table 17: Summary of the studies that met the criteria of the systematic review on lifestyle interventions in 
overweight and obese pregnant women: non-randomised trials 
 
Author (year) Ethnic group/country Participants/setting Sample size Intervention Outcome measure(s) Conclusion 
Gray-Donald et al. 
(2000) (272) 
Native Americans/ 
Canada  
 
  
Recruited before the 26th week of 
pregnancy, non-parallel recruitment 
of control and intervention arms.  
Mean BMI = 29.6 kg/m2 (SD = 6.45) 
in non-intervention arm and mean 
BMI = 30.8 kg/m2 (SD = 6.85) in 
intervention arm at baseline.  
219  
107 in non-
intervention arm; 
112 in intervention 
arm  
Dietary and weight counselling 
Exercise groups provided 
 
Gestational weight gain; 
gestational diabetes;  
Caesarean section; 
birth weight; 
postpartum weight retention 
 
No statistically significant 
difference in gestational weight 
gain, prevalence of gestational 
diabetes, Caesarean section or 
large for gestational age baby 
 
 
 
Olson et al. (2004) 
(293)  
96% white/USA Recruited before third trimester. 
Hospital and clinic setting 
BMI range: 19.8 to 29 kg/m2 
498 
381 in non-
intervention arm; 
Used the Institute of Medicine 
recommended guidelines on 
weight gain; ‘health book’ 
Gestational weight gain ; birth 
weight 
No statistically significant 
reduction in gestational weight 
gain or prevalence of large for 
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Author (year) Ethnic group/country Participants/setting Sample size Intervention Outcome measure(s) Conclusion 
117 in the 
intervention arm  
 
used to record diet and 
exercise and contained 
healthy eating and exercise 
information  
gestational age baby  
Claesson et al. 
(2007) (270) 
Not stated. 
Predominantly 
Caucasian/ Sweden 
Obese and registered at antenatal 
care clinic. 
BMI ≥30 kg/m2 
348 
193 in non-
intervention arm; 
155 in intervention 
arm 
Nutritional habits interview, 
weekly counselling and aqua 
aerobic sessions 
Gestational weight gain; 
Caesarean section. 
Statistically significant reduction 
in gestational weight gain; no 
difference in prevalence of 
Caesarean section 
Kinnunen et al. 
(2007) (285)  
Over 90% 
Caucasian/Finland 
First-time pregnant women who 
were obese (BMI ≥30 kg/m2) 
196  
95 in non-
intervention arm; 
101 in intervention 
arm 
Individual counselling at each 
antenatal visits. Dietary 
guidance and optional activity 
sessions. 
Gestational weight gain; diet 
change; birth weight  
No statistically significant 
reduction in gestational weight 
gain or prevalence of large for 
gestational age baby. 
Statistically significant reduction 
in dietary glycaemic load. 
Shirazian et al., 
2010 (273) 
33% Blacks; 67% 
Latino/ USA 
Singleton obese (≥30 kg/m2) 
pregnant women recruited in the first 
trimester. Historical non-intervention 
group. 
54 
28 in non-parallel 
control arm; 28 in 
intervention arm) 
One-to-one counselling; six 
structured seminars on healthy 
living (healthy eating and 
walking) 
Gestational weight gain; 
gestational diabetes; Caesarean 
section 
Statistically significant reduction 
in gestational weight gain; no 
difference in prevalence of 
gestational diabetes  
 
Mottola et al., 
(2010) (269) 
Not stated/ Canada Overweight (BMI ≥25 to 29.9 kg/m2) 
and obese (BMI ≥30 kg/m2) pregnant 
women recruited before 16 weeks 
gestation; historical non-intervention 
group.  
65  matched non-
parallel control of 
260     
Individualised nutrition plan; 
exercise consisted of walking 
(three to four times per week, 
used pedometers) 
Gestational weight gain; 
Caesarean section; birth weight; 
peripartum weight retention  
Possible reduction in gestational 
weight gain; no difference in 
prevalence of Caesarean section 
or large for gestational age baby; 
minimal effect on peripartum 
weight retention 
 
1. BMI: body mass index 
2. SD: standard deviation
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Table 18: Assessment of the quality of the included trials: non-
randomised trials 
 
Author (year) Population 
representa-
tiveness 
Adequacy of 
sequence 
generation 
Masking/ 
selection 
bias 
Incomplete  
outcome 
data 
Contamination Sample 
size 
Grade of 
quality 
Gray-Donald et al. 
(2000) (272) 
Yes: Registered 
from clinic  
 
No No  No 
 
No: non-parallel 
control 
 219 Low 
 
Olson et al. (2004) 
(293) 
Yes No No  No  No: non-parallel 
control 
 560  Low  
Claesson et al. 
(2007) (270)  
Yes: Registered 
from clinic 
 No No Yes No: selected from 
nearby city 
 315  Low 
Kinnunen et al. 
(2007) (285)  
Yes  No  No No Yes 55  Low 
Shirazian et al. 
(2010) (273)  
Yes  No No Yes No: non-parallel 
control 
28  Low 
 
Mottola et al. 
(2010) (269)  
Yes  No 
  
No  Yes No: non-parallel 
control 
65  Low 
 
Table 19: Assessment of the risk of bias of the included trials: randomised 
trials 
Author 
(year)  
Population 
representa-
tiveness 
Adequacy of 
sequence 
generation 
Masking/ 
selection 
bias 
Intention to 
treat 
Incomplete 
outcome 
data 
Loss to 
follow up 
Sample 
size 
Grade of 
quality 
Polley et al. 
2002 (266)  
Yes Yes:  No Not reported No Yes 120 Low 
Hui et al. 
(2006) (267)  
 Yes: from 
clinic 
Exact method 
not described 
No Not reported No Yes 52 Low 
Wolff et al., 
2008 (264)  
Yes Yes: computer 
generated 
No Not reported  Yes Yes 50 Low 
Jeffries et al., 
2009 (262) 
Yes Yes: opaque 
envelope 
Yes 
 
Not reported Yes Yes 286 Low 
Ong et al., 
2009 (276)  
Yes Exact method 
not described 
No Not reported No No 12 Low 
Barakat et 
al., 2011 
(291)  
Yes Yes Yes Yes Yes Yes 160 Medium 
Asbee et al. 
2009 (261) 
Yes Yes No Not reported Yes No 100 Low 
Thornton et 
al., 2009 
(263)  
Yes Yes Yes Not reported Yes Yes 257 Medium 
Guelinckx et 
al., 2010 
(260)[26] 
Not reported Randomised 
but not 
reported how 
Not 
reported 
 
Not reported Yes 
 
Not 
reported 
99 Low 
Phelan et al., 
2011 (268) 
Yes Yes: opaque 
envelope 
Yes Yes Yes Yes 401 Medium, 
Quinlivan et 
al., 2011 
(292)  
Yes Yes: opaque 
envelope 
Yes Yes Yes Yes 124 Medium 
Luoto et al., 
2011 (277)  
Yes Yes  Yes Yes Yes Yes 399 Medium 
Nascimento 
et al., 2011 
(278) 
Yes Yes: opaque 
envelope 
Yes Yes Yes Yes 82 Low 
Vinter, 2012 Yes Yes: opaque 
envelope 
Yes Yes Yes, big Yes, but 
big 
360 Medium 
Dodd et al., 
2014 
Yes Yes. 
Computer 
generated 
No Yes Yes but small Yes, but 
small 
2152 High 
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Table 20: Effect estimates for randomised trials of lifestyle advice versus 
standard care 
 
Outcome or subgroup Studies Participants Statistical method Effect 
estimate 
Gestational weight gain 
(kg) 
12  4835 Mean difference  
(Tau2, 95% CI) 
 -1.67 
(-3.34- 0.01) 
Gestational diabetes  8  4231 Odds ratio  
(Tau2, 95% CI) 
 0.92 
(0.65-1.30) 
Caesarean delivery 8  3977 Odds ratio  
(Tau2, 95% CI) 
 0.98 
(0.88-1.09) 
Large for gestational 
age  
8  4326 Odds ratio  
(Tau2, 95% CI 
 0.95 
(0.77-1.18) 
Birth weight (g) 8  1876 Mean difference 
(Tau2, 95% CI) 
 -.01 
(-0.09-0.07) 
 
a Statistically significant pooled estimates. CI: confidence interval 
 
Table 21: Effect estimates for non-randomised trials of lifestyle advice 
versus standard care 
 
Outcome or subgroup Studies Participants Statistical method Effect 
estimate 
Gestational weight gain 
(kg) 
5 1534 Mean difference 
(Tau2, 95% CI) 
-1.41 
(-3.36-0.55) 
Gestational diabetes  2 233 Odds ratio  
(Tau2, 95% CI) 
1.42  
(0.76-2.63) 
Caesarean delivery 4 1246 Odds ratio  
(Tau2, 95% CI) 
1.13 
(0.82-1.55) 
Large for gestational 
age  
3 1199 Odd ratio 
(Tau2, 95% CI) 
0.92 
(0.64-1.32) 
 
CI: confidence interval 
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Figure 7: Flow diagram of study selection 
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Figure 8: Forest plot of randomised trials investigating the effect of 
lifestyle advice versus standard care on gestational weight gain (kg)  
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Figure 9: Forest plot of randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of gestational diabetes 
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Figure 10: Forest plot of randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of Caesarean delivery  
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Figure 11: Forest plot of randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of large for gestational age 
baby 
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Figure 12: Forest plot of randomised trials investigating the effect of 
lifestyle advice versus standard care on birth weight 
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Figure 13: Forest plot of non-randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of large for gestational age 
baby 
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Figure 14: Forest plot of non-randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of Caesarean section 
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Figure 15: Forest plot of non-randomised trials investigating the effect of 
lifestyle advice versus standard care on risk of gestational diabetes 
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Figure 16: Forest plot of non-randomised trials investigating the effect of 
lifestyle advice versus standard care on gestational weight gain (kg) 
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CHAPTER 6: Development of the CAN intervention using the MRC 
framework for designing a complex intervention to improve health 
 
6.1 Introduction 
 
 Previous chapters explored the challenge posed by overweight and 
obesity in pregnancy worldwide and provided evidence from the literature to 
explain why obesity is viewed by both the public and professionals as one of the 
most important public health problems in pregnancy. The challenge is even 
greater at the local South East London level, as shown by the data in Chapter 
Four, which establishes that the impact of obesity (on the mother, the delivery 
and the infant) is higher in Blacks than in other ethnic groups.  
 
As demonstrated in Chapter Five, there is so far insufficient evidence 
that lifestyle interventions result in improved pregnancy outcomes. Despite 
obesity having more of an impact on Blacks, none of the published 
interventional studies had a sufficient number of black participants to assess 
effectiveness in this population (67). There has been a recommendation for 
well-designed interventional studies for obese pregnant women that engage 
with diverse multi-ethnic deprived communities with a view to preventing racial 
and ethnic disparities in obesity risk (76, 221). Obese pregnant women from all 
backgrounds deserve evidence-based lifestyle advice which will aid them to 
make informed lifestyle decisions. Pregnancy may be a critical period in which 
to provide interventions that may lead to restricted postpartum weight retention 
in women and prevent macrosomia and hence future obesity in the offspring 
(18, 76). A series of animal studies involving rodents and nonhuman primates 
provides the evidence that a dietary change that takes place prenatally may 
orchestrate alterations in infant adiposity and metabolism which may be long-
lasting. This phenomenon has been attributed to epigenetic mechanisms (253).  
Thus, timely prenatal interventions instituted during a period of plasticity in fetal 
development (as opposed to corrective attempts made later in life) may result in 
improved health outcomes which are lasting. If these interventions reach out to 
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deprived and ethnically diverse pregnant obese populations, as highlighted by 
the Marmot report, it may also be the best time to address the inequality 
associated with obesity (178). 
 
6.2 Aim  
 
 The aim of this work was to develop a multi-component community-
based activity and nutrition (CAN) programme for obese pregnant women in a 
deprived diverse community setting in South East London. 
 
6.3 Framework and method for designing the CAN intervention 
 
The development of the CAN intervention used the framework for design and 
evaluation of complex interventions to improve health. 
(http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871; 
BMJ, 2000, www.mrc.ac.uk/complexpackages.html, 
http://www.mrc.ac.uk/utilities/documentrecord/index.htm?d=MRC004871) (290) 
 
 Complex interventions are those that include several components   
(www.mrc.ac.uk/complex interventions guidance). CAN is a complex 
intervention because it meets the criteria of the Medical Research Council’s 
guidelines on what constitutes a complex intervention: it has three components 
of physical activity improvement, nutritional advice, and behavioural support by 
professionals (with health trainers delivering the intervention) (245). 
 
 The development of the intervention was undertaken by the author and   
Professor Lucilla Poston (Head of Division for Women’s Health Research, 
King’s College, London group). This intervention was used in two separate pilot 
studies: UPBEAT and CAN. The intervention study called UPBEAT (United 
Kingdom Better Eating Activity Trial) is a multi-centred hospital-based study, a 
complex behavioural intervention comprising dietary and physical activity 
change in obese pregnant women. This is led by Lucilla Poston. CAN 
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(Community, Activity and Nutrition programme) piloted the same intervention in 
a community setting at Sure Start/children’s centres in order to establish the 
feasibility and translation of this multi-component intervention in a deprived 
diverse community in South East London. The author is leading this study. My 
role in developing the intervention was to contribute intellectually to the debate 
and formulation of the interventions. I was present at all of the meetings and 
during the writing up of the intervention manual. I also sought the views of local 
experts involved in providing lifestyle intervention services in both Lambeth and 
Southwark boroughs and identified places where mothers could obtain healthy 
and cheap food in the boroughs. I also identified all the leisure centres in these 
communities where mothers would be able attend to improve their activities. 
  
 Table 22 describes the steps taken in the development and evaluation of 
UPBEAT/CAN as a complex intervention using the MRC framework for complex 
interventions, including my personal role in each step. Professor Poston has 
written a letter confirming my role in this process (appendix J).  
 
Pre-clinical or theoretical phase 
 
 The theoretical phase looked at the evidence (E) available for doing the 
study, the population and the problem (P) being studied, the intervention (I), the 
comparator (C), outcome (O) and design of study, in this case a trial (T) i.e. 
EPICOT. 
 
Evidence 
 
 Chapters Two, Three and Four provide strong evidence for the effect and 
impact of obesity on adverse pregnancy outcomes, particularly in a diverse, 
deprived community. This justifies and provides a robust evidence for the need 
to develop an intervention to mitigate these adverse associations. The 
developmental over-nutrition hypothesis highlights that over-nutrition results in 
excessive glucose being transferred through the placenta to the fetus, resulting 
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in fetal insulinaemia and ultimately large for gestational age delivery and 
macrosomia (294). Chapter Three provides a robust rationale for a behaviour 
intervention incorporating low glycaemic index diets and increased activity 
(100). 
 
Population and problem 
 
 The intervention focuses on obese pregnant women. The theory and 
reason for this is fully described in previous chapters. Obesity has a strong 
effect and impact on adverse pregnancy outcomes. Moreover, Chapter Four 
alludes to obesity being over-represented in Blacks and deprived groups; 
hence, any intervention should make an attempt to engage with the users and 
ensure the sample population is representative of the population for which the 
intervention is eventually intended. 
 
Intervention 
 
 The CAN community activity and nutrition programme incorporates low 
glycaemic index diet, improved activity, and behavioural support during 
pregnancy. The theory behind the intervention is described in Chapter Three 
incorporating SMART goals (226, 295-296). The intervention itself is described 
in Chapter Eight.   
 
Comparator 
 
 The comparator group is a non-intervention group following a local 
clinical guideline. 
 
Outcomes 
 
 The outcome selected for the pilot is changed behaviour in terms of 
reduced glycaemic load in the diet and improved activity. For the main CAN trial 
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the outcomes are macrosomia for the infant and gestational diabetes for the 
mother. 
 
The design of the trial 
 
 The design of the trial is a pragmatic randomised controlled trial. 
 
Phase I: Defining the components of the intervention  
 
 The components of nutrition, activity and behavioural support were 
developed by a multidisciplinary team, of which I was a member. Having 
decided that the intervention would incorporate eight behaviour change 
sessions focused on a low glycaemic index diet and improved activity (see 
Chapter Eight for details), it was important to conduct qualitative studies to ask 
providers and users (obese women from South East London) how they 
envisaged or would engage with an ideal service. The findings and details of 
these qualitative studies form the basis of Chapter Seven. Findings from these 
studies were incorporated into the development of the CAN intervention, 
described in Chapter Eight. 
 
Phase II: Pilot study  
 
 In Phase II, I evaluated whether the intervention (CAN) delivered in a 
community Sure Start/children’s centre setting was feasible, and secondly, 
whether it resulted in a change of behaviour. Methods and findings of the pilot 
study are presented in Chapter Eight. 
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Table 22: Steps taken in the development and evaluation of CAN as a 
complex intervention using the MRC framework 
 
Steps MRC 2000, BMJ 2004 
and MRC 2008 
CAN My role 
Theory or preclinical phase Evidence was identified for 
CAN by performing a literature 
review on two aspects of 
maternal obesity.  
 
a. The problems of obesity 
and reproductive health 
(297). This has been 
updated for my thesis in 
Chapter Two. 
 
 
 
b. A comprehensive review of 
the effectiveness on 
lifestyle interventions 
during pregnancy, pre-
pregnancy and post-
delivery (289).   
I came up with the idea, 
conducted the literature review 
and led the writing of the 
papers (289, 297).  
 
I applied for a grant to address 
the question of whether a 
community-based maternal 
obesity programme was 
needed. 
I came up with the idea and 
co-wrote the manuscript for 
publication (296). 
I applied and was successful in 
acquiring a grant to conduct a 
health needs assessment of 
maternal obesity in South East 
London. I have compiled and 
written a report on this (296). 
An executive summary is 
attached as Appendix A. 
Phase I: Defining the 
components of the 
intervention 
The components of nutrition, 
activity and behavioural 
support used for CAN and 
UPBEAT were developed by a 
multidisciplinary expert group 
(including myself) led by 
Professor Lucilla Poston.   
 
 
 
 
 
I obtained a second grant to 
develop and evaluate a 
lifestyle intervention for 
maternal obesity. As reported 
above, I compiled and co-
authored a report on health 
needs assessment for 
maternal obesity in Lambeth 
(296). The executive summary 
is appended and the full report 
is on the CAN website.  
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Steps MRC 2000, BMJ 2004 
and MRC 2008 
CAN My role 
The feasibility of delivering the 
intervention in the community 
was evaluated, the 
acceptability to providers was 
tested and the providers’ views 
were published (Chapter 
Seven). 
Local guideline on the 
management of maternal 
obesity was written to establish 
agreed uniform care that we 
provide for obese pregnant 
women and this was altered 
appropriately in agreement 
with NICE guidelines. 
This was performed by me 
from the secured grant and 
two manuscripts for publication 
on this (298-299). 
 
 
I wrote and produced local 
evidence-based clinical 
guidelines for the care we 
provide for obese women in 
pregnancy. This is used as the 
care in the control group 
(Appendix B). 
 Phase II: Pilot study 
 
The intervention in a Sure 
Start/children’s centre 
community setting was trialled 
in order to establish whether it 
was feasible and whether it 
would change behaviour in 
terms of reported low 
glycaemic index diet and 
improved activity. 
I performed the 
implementation of this trial in 
the community.  
I established the translation of 
this intervention into the 
community. 
The intervention itself The intervention itself (used in 
CAN) is based on Phases I 
and II above and, collaborating 
with the United Kingdom Better 
Eating and Activity trial 
(UPBEAT) team, an agreed 
intervention was decided upon.  
Using the findings from the 
health needs assessment and 
as part of the UPBEAT group, 
the CAN/UPBEAT intervention 
was developed which is 
described in detail in the CAN 
participant manual (attached at 
the back of this thesis in the 
form of a CD as Appendix G).   
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CHAPTER 7: Developing a community-based maternal obesity 
intervention: a qualitative study of service providers’ views 
 
  
 
 
 
  
 
 
There follows below an expanded and updated version of the published paper. 
 
7.1 Introduction 
 
 Obesity is a global epidemic and, if current trends continue, 50% of the 
UK adult female population is predicted to be obese by 2050 (300). An 
escalating proportion of pregnant women are obese (301) and obesity is 
associated with an increase in maternal and perinatal complications (Chapters 
One, Two and Four).  Maternal obesity is also a contributor to childhood obesity 
(17-18). The national prevalence of maternal obesity is estimated to be 18% 
(41). However, the confidential enquiry into maternal and child health 
(CEMACH) found that 27% of pregnant women who died between 2003-2005 
were obese and that 30% of mothers who had a stillbirth or neonatal death were 
obese, suggesting that obesity is a contributor to poor outcome (5). In response 
to these findings, CEMACH provided recommendations for the management of 
maternal obesity including the need for the development of national guidelines 
(5). The English government has put in place a strategy to tackle obesity 
(Healthy Weight, Healthy Lives), recognising the challenge posed by obesity in 
pregnancy and making recommendations to mitigate its effect. At the local level, 
Primary Care Trusts (PCTs) are expected to commission or develop services 
that assist with the identification and treatment of pregnant obese women.  
However, recent systematic reviews on weight management in pregnancy 
Publication based on this work:  
Oteng-Ntim E, Pheasant H, Khazaezadeh N, Mohhidin A, Bewley S, Wong 
J, Oke B. Developing a community-based maternal obesity intervention: a 
qualitative study of service providers’ views.  British Journal of Obstetrics 
and Gynaecology. 2010. 117(13):1651-5 
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concluded that there is no evidence on the effectiveness of dietary and/or 
physical activity interventions in pregnancy (177, 302). No published study 
could be found in the literature on providers’ views of interventions to address 
obesity in pregnancy. The aim of this study was to gain insight into the thoughts 
and views of health care providers managing obese pregnant women in order to 
help inform the development of an intervention for obese pregnant women.   
 
7.2 Method 
 
This was a qualitative study using personal telephone interviews with 
providers of care and advice for people with obesity. These providers are 
referred to here as stakeholders. Stakeholder interviews were organised with 
both internal service providers and external private providers. Internal 
stakeholders were consulted in order to understand the current service 
provision for the target population groups, to record improvements that could be 
made to meet the unmet needs of these service users, and to note 
recommendations for the design of the proposed Phase II intervention. External 
stakeholder interviews involved detailed discussions around their existing 
provision of obesity services, the potential to adapt the programme where 
necessary to tackle maternal obesity, and recommendations for the 
development of a service to meet health needs. 
 
7.2.1 Selection of study sample 
 
 Internal service providers were identified within the borough of Lambeth 
(inner city London borough with high levels of deprivation) using lists of 
employees (303). Internal service providers were consulted in order to identify 
and understand the current service provision for obese women who are 
pregnant, and to record current provision and recommendations for any 
proposed intervention to improve services. A sample was selected using 
purposive sampling provided by the public health team for Southwark and 
Lambeth. Purposive sampling may not produce a representative sample of all 
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service providers, but this method of sampling is acceptable in qualitative 
research within the context of exploratory study (303). External stakeholders 
(third sector/private providers) of obesity services were identified using snowball 
(network) sampling (snowball sampling starts with known providers who are 
asked to recommend further providers who can be interviewed, so that the 
sample builds up like a snowball) (303). The external stakeholders were 
involved in order to understand their existing provision of obesity services and 
the potential for adaptation to tackle maternal obesity and to obtain their 
recommendations for the development of a new maternal obesity service. A 
total of 22 service providers were identified. Twelve were internal to the National 
Health Service (NHS), eight of whom were clinical. Ten were external, three of 
whom were experienced in tackling maternal obesity (Table 23). 
 
7.2.2 Interviews 
 
All stakeholders were contacted to ask whether they would consent to be 
interviewed and to agree a convenient time for the interview to take place. The 
interviews were semi-structured, based upon an agreed topic guide (as shown 
in the table below), and undertaken as telephone interviews, each lasting 
approximately one hour. The interviews were not recorded but detailed notes 
were taken throughout the discussions.   
 
The interview guide used was as follows: 
 
1. What services are available to improve physical activity and healthy living 
for obese pregnant women? 
2. What services are available to improve healthy nutrition for obese 
pregnant women? 
3. What pathways are available for obese pregnant women? 
4. What are the challenges to tackling obesity pre-pregnancy and during 
pregnancy? 
5. What should the development of a new intervention entail? 
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6. What should the content be? 
7. What should the structure be? 
8. Who should deliver the intervention? 
9. Where could the intervention be delivered? 
10. How often, and with what time interval? 
11. How could a developed intervention be incorporated into existing 
pathways and interventions? 
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The topic guide used for service provider interviews was as follows: 
 
Theme Details 
1. Current practice a. Identification 
b. Management 
2. Challenges to tackling maternal 
obesity 
a. Patient 
b. Health care system and 
environment 
c. Evidence and guidance 
3. Developing a new intervention a. Content 
b. Structure 
c. Staff 
d. Setting 
e. Frequency 
f. Stage of pregnancy and 
recruitment 
g. Integrating the new intervention 
within existing services 
 
 
Table 23: Internal and external service providers interviewed 
 
 Internal service providers  External service providers 
(indicating the specific service they 
usually provide) 
 Community midwife 
 Community dietician 
 Consultant obstetrician 
 Clinical director for maternity 
services 
 Head of obstetrics 
 Fertility treatment lead 
 MEND (childhood obesity) 
 Traffic Light programme (childhood 
obesity) 
 Empower (preventing childhood 
obesity but links with treating 
maternal obesity postnatally) 
 Watch It (childhood obesity) 
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 Clinical health psychologist 
 General practitioner 
 Obesity lead at the PCT 
 Maternity services manager at the 
PCT 
 Head of family support and 
children’s services 
 Director of nursing (health visitor) 
 Shape-Up (adult obesity) 
 Counterweight programme (adult 
obesity) 
 Slimming-on-referral (adult obesity) 
 Slimming World for pregnant 
mothers (maternal obesity – 
antenatal) 
 Weight Watchers referral scheme 
(adult obesity) 
 Pushy Mothers (maternal obesity – 
postnatal) 
 
7.2.3 Data Analysis 
 
 The semi-structured interviews were analysed in detail using a modified 
version of ‘Framework Analysis’, i.e. charting and collating the interview 
responses under headings and subheadings, followed by thorough analysis and 
mapping of the grids to allow identification of key themes (e.g. current practice, 
challenges to tackling maternal obesity and development of a new intervention) 
(304). It is acknowledged that saturation was not achieved for the stakeholder 
interviews. 
 
7.3 Results 
 
7.3.1 Theme 1: Current practice – lack of existing services 
 
 All stakeholders said that a number of services and projects currently 
exist in Lambeth to increase physical activity, improve healthy eating and 
manage obesity in adults and children. They all alluded to the fact that limited 
services within the borough have been established to tackle maternal obesity 
and there is no maternal obesity care pathway for the structured management 
of pregnant women. All stakeholders provided information that midwives provide 
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first line healthy eating and physical activity advice for those women identified 
as obese but the external stakeholders reported inconsistency in the advice 
given and lack of available written resources for patients to support the verbal 
information. Dietetic and psychology provision is available for cases that are 
considered specialist or high-risk, e.g. patients developing gestational diabetes 
or those experiencing severe mental health issues. Overall, all stakeholders 
acknowledged the inadequate service provision and management of pregnant 
obese women. 
 
7.3.2 Theme 2: Challenges to tackling maternal obesity (pregnant obese 
women and obese women trying to conceive) 
 
 One external stakeholder (from Slimming World) considered cultural and 
language barriers as potential issues to take into account when designing a new 
service (e.g. meeting the needs of all ethnic groups). All internal stakeholders 
also commented on the need for attempting to tackle maternal obesity in 
different cultural groups and reinforced the issue by explaining that Lambeth is 
an ethnically diverse community. Clinical stakeholders expressed concern that 
some women, in particular Black and Minority Ethnic (BME) groups, do not 
attend antenatal appointments on a regular basis and therefore ‘slip through the 
net’. In addition, a clinical stakeholder (midwife) noted the issue of managing 
weight in Afro-Caribbean women who regard weight as a sign of beauty in their 
culture. 
 
 Half of the external stakeholders (Slimming World, Counterweight, 
MEND, Weight Watchers and Traffic Light) said that lack of motivation and 
readiness to change handicapped the effectiveness of any interventions 
introduced to tackle maternal obesity. However, they also commented that 
pregnancy may be a time when patients are more receptive and motivated to 
change. This was highlighted as being particularly important for obese women 
trying to conceive. Two external stakeholders (Weight Watchers and Shape Up) 
suggested adopting a screening tool to ensure that only motivated patients are 
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recruited to any new services. Three of the four non-clinical stakeholders and 
six of the eight clinical stakeholders also mentioned lack of motivation as a 
barrier to tackling obesity but one suggested that younger women may be more 
motivated to change than older women. In addition, a clinical stakeholder 
(obstetrician) confirmed that obese women wanting to become pregnant do not 
lack motivation as they are aware that if they lose weight they will be able to 
receive fertility treatment. 
 
 Health care professional engagement was raised as a challenge by two 
clinical stakeholders (midwife and GP) who doubted that all professionals were 
aware that tackling obesity should be a priority area. Comparison was made 
with smoking as all health care professionals now recognise the risks 
associated with smoking, particularly whilst pregnant, and are aware of the 
need to prevent smoking in pregnant women. They considered that a similar 
approach should be pursued to tackle obesity. This links with the concern over 
raising the issue of weight, which was mentioned by three internal stakeholders, 
who explained that health care professionals may not feel comfortable 
broaching the subject of obesity with patients. A clinical stakeholder (GP) 
suggested investigating how to raise the issue of weight with obese women and 
what terminology and language should be used. A non-clinical stakeholder 
(Weight Watchers) suggested running training for all health care professionals.  
 
7.3.3 Theme 3: Developing a proposed new intervention 
 
Content 
  
 Sixteen stakeholders recommended some form of multi-component 
intervention that incorporates nutrition, physical activity and behavioural change 
elements. The key features of the nutrition component included providing 
culturally specific healthy eating advice adapted for women during pregnancy 
and encompassing advice for breastfeeding and weaning for the mother and 
baby (postnatal phase). Key features of the physical activity component 
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included advice and exercise sessions that are tailored for women during 
pregnancy such as low impact exercises, e.g. walking, aquanatal and 
yoga/pilates. The key feature of the behavioural change component involved 
some form of motivational interviewing technique to assist with adopting 
improved behaviour around eating and activity. In addition, one stakeholder 
(GP) highlighted the need for practical interactive sessions, e.g. supermarket 
tours, practising reading food labels and shopping on a budget.  
  
Six stakeholders did not recommend a multi-component intervention and 
advised a focus mainly on diet. These were the midwife, dietician, director of 
nursing, head of family support, maternity services manager and fertility lead. 
They were all concerned about exercising in pregnancy and the fact that this 
may be associated with miscarriage.  
 
Structure of intervention 
 
 Stakeholders expressed different views regarding whether the service 
should be one-to-one or group-based or a combination of the two types of 
sessions. One-to-one sessions were favoured for their ability to provide 
individualised and personal care and the sensitivity of the subject area requiring 
a confidential and closed environment. In comparison, group-based sessions 
were deemed advantageous because of the peer support factor that helps to 
motivate patients.   
 
Staff to deliver intervention 
 
 Stakeholders agreed unanimously that a multidisciplinary team to 
manage any new interventions with health trainers should be considered key 
because they already provide healthy weight and healthy lifestyle intervention to 
women who are not pregnant. Different views were expressed by stakeholders 
regarding the use of specialist and non-specialist staff to deliver the 
programme. Stakeholders who suggested using specialist staff mentioned 
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dieticians, exercise specialists and psychologists, whereas all of the other 
stakeholders recommended non-specialist staff, e.g. health trainers and 
community food workers, supported by midwives and health visitors. The 
reasons expressed for favouring specialist staff included the fact that maternal 
obesity is a condition associated with additional risks and therefore specialist 
staff may be better placed to manage these issues and risks. In comparison, 
reasons for supporting non-specialist staff included increased cost 
effectiveness, limited time and capacity of specialist staff and the need to 
reserve specialist staff for high-risk cases. All stakeholders commented on the 
fact that staff would need to be trained in the delivery of the intervention with 
non-specialist staff requiring more intensive training. The need for standardised 
resources to support the training of the staff and dissemination to all patients 
was highlighted by three stakeholders. 
 
Setting for delivery of intervention 
 
 A number of settings were identified by the stakeholders, ranging across 
community, primary and secondary care. Community clinics (e.g. children’s 
centres) are particularly useful when involving women in weight management 
programmes, because they are already used and are easy to access; 18 of the 
22 interviewees suggested the community-based setting in Sure Start children’s 
centres. 
 
Frequency of sessions 
 
 Some stakeholders suggested a regular service, e.g. using the same 
venue and time every week as consistency maximises attendance. The 
recommended length of the programme suggested by all of the stakeholders 
was between 8-12 weeks to ensure that drop-out rates are kept to a minimum, 
although stakeholders acknowledged the programme length would need to be 
longer to incorporate both the antenatal and postnatal phases.  
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Stage of pregnancy and recruitment 
 
 All stakeholders discussed recruitment, stating that obese pregnant 
women should be identified and targeted using their pre-pregnancy weight or 
BMI at first booking appointment.  
 
Integrating the new intervention within existing services 
 
 All stakeholders recommended developing a local maternal obesity care 
pathway to improve and standardise both the identification and management of 
obese pregnant women. This would incorporate any proposed new 
interventions, thus assisting with the identification and recruitment of women 
into the programme. Lastly, all stakeholders agreed the need to pilot the service 
and also to ensure that effective monitoring and evaluation mechanisms are put 
in place to make incremental improvements to the design and to increase the 
currently limited evidence base.  
 
7.4 Discussion 
 
7.4.1 Main findings 
 
 The London borough of Lambeth is an inner city London borough with 
high levels of deprivation; 82% of the population live in areas in the top two UK 
quintiles of deprivation and 46% of the pregnant population are from BME 
backgrounds. It lacks dedicated services for tackling maternal obesity, and 
therefore many obese pregnant women have unmet health needs. Service 
providers recognise and support the need for the design and implementation of 
a multi-component (healthy eating, physical activity and behaviour change) 
intervention, both antenatally and postnatally. New services should be 
established at community-based settings and administered by trained non-
health care professionals supported by midwives and health visitors. The 
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sessions could be flexible to meet the needs of the women, incorporating either 
group-based, one-to-one or telephone support as stakeholders favoured all of 
these options. Monitoring and evaluation should be included as part of the 
intervention to enable continuous service improvement and to add to the 
currently limited evidence base. This was alluded to by all stakeholders. All 
stakeholders highlighted that interventions require improved identification of 
obese pregnant women using BMI calculation at the booking appointment. 
 
7.4.2 What is already known on this topic? 
 
 Maternal obesity is now being acknowledged as a serious public health 
problem (180). Health care professionals are aware that programmes need to 
be implemented to tackle obesity in pregnant women but few Primary Care 
Trusts (PCTs) are developing care pathways or protocols. Those PCTs trying to 
address the unmet health needs of their population are faced with inadequate 
evidence and guidelines to support their decisions. 
 
7.4.3 What this study adds 
 
 A limited number of studies have already been published on 
interventions for maternal obesity, but none have reported the thoughts, views 
and recommendations of stakeholders. This article reports a qualitative study 
from the perspectives of those managing obese pregnant women, both in the 
NHS and the voluntary/private sectors. The findings will inform the development 
of maternal obesity programmes and should be of value to people from a broad 
range of disciplines including academics, researchers, clinicians, public health 
professionals, commissioners, and governmental organisations. 
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7.4.4 Strengths and limitations 
 
Strengths 
 
This study interviewed a broad group of stakeholders, both within the 
NHS and in the private sector, hospital-based as well as community-based and 
from a broad range of disciplines. Hence, the findings from the study may be 
transferable (305). In this study, there has been clear description of the method 
by which the data was collected (306). The selection of stakeholders could be 
considered fair due to its inclusion of both public and private sectors and the 
widened nature of the selection. At the time of completing this work, there were 
very few publications in the literature about providers’ views on developing 
obesity interventions and hence, despite the limitations, its acceptance for 
publication was based mainly on its originality. The sampling methods adopted, 
i.e. purposive sampling and snowball samplings, are well recognised in 
qualitative methods in initial exploratory studies. It allowed information to be 
gained for the development of a new service or for a complex intervention and 
its evaluation to be performed (245). This study not only focuses on positive 
case analysis but also on negative case analysis; it reported on both and thus 
attempts to provide a balanced perspective of the findings. The author’s 
knowledge of the area being studied may be a positive stimulus to performing 
this study and may have contributed to the data being obtained successfully 
(307). This study allowed the author to gain knowledge that contributed to the 
design of a lifestyle intervention as recommended by the MRC framework (245). 
 
Limitations  
 
 The design and conduct of the study had several limitations, 
including possible biases associated with the method of sample selection, data 
collection and interpretation of findings. It is important to consider how my 
presence in the research setting contributed to the data collected, for example. 
As the researcher, my values could have tainted the research, particularly in the 
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selection of who to interview, and the way in which I asked the questions may 
have encouraged a particular answer (296, 303). In qualitative research, it is 
almost impossible for the researcher to remain completely outside the values 
and subjectivity of the study. It is, however, essential to the principle of 
reflexivity that I subject my own research practices to the same critical analysis 
deployed in the study. For example, why did I choose to do purposive sampling 
instead of random sampling of subjects? Random sampling would have 
ensured that I reduced systematic bias and that each subject would have the 
same chance of being selected, hence making the results more likely to be 
representative of the population being studied. Random sampling in this case 
may have been impossible as a sampling frame did not exist at the primary care 
trust, public health Lambeth and the acute Trusts. The ability to create one was 
limited as the study population was widely dispersed and there were no 
denominator data. Random sampling would have been more expensive in terms 
of both resources and time.   
 
I may also have chosen not to interview a stakeholder because of a 
preconceived view that he/she might be difficult. The second impact I may have 
had was on how I was perceived by the responders; especially, being a 
consultant obstetrician, I may be deemed influential, which may attract certain 
responses or restrict the interviewee from saying what he/she genuinely wants 
to say. There may have been similar issues regarding my being male. I could 
have overcome these issues by allowing another researcher to repeat the 
interviews to see if the interviewees gave the same responses (308).   
 
The medium through which the information was collected was 
transcription, which may be open to bias. The author may have been selective 
regarding which information to transcribe and which to omit. The high-standard 
medium for collecting verbal data is either audio-recording or video recording.  
These methods minimise data misrepresentation or misinterpretation (309-310).  
In scenarios where transcription is used, it would have been most appropriate to 
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use standardised rules for transcribing, as recommended by Waitzkin et al. 
(309).  
   
I interviewed by telephone, instead of conducting face-to-face interviews. 
Telephone interview may deter subjects from disclosing sensitive information, 
as there is less chance of developing a good rapport and building the 
appropriate level of trust to disclose information freely. On the other hand, the 
subject, not knowing the interviewer and communicating through telephone, 
may arrive at the conclusion that it is unlikely that a true response to the 
answers may be traced back to the interviewee, and hence might be happy to 
freely share any sensitive information. Furthermore, telephone interviews were 
convenient for both the interviewers and interviewees. The information was not 
recorded because I did not have the ethical permission to do so and the 
assumption was that this would have been intrusive. It is, however, 
acknowledged that recorded information may reduce information bias as the 
reference material or information is there to be referred to at any time. With a 
planned interview guide and detailed transcription of notes, this may have 
diminished information bias and may also have allowed the point of saturation 
to be clearly identified.  
 
Another important issue to consider in the conduct of the study is that the 
principle of saturation was not applied. Once the point of saturation is reached 
in a study, additional stakeholders no longer provide extra information or insight. 
The study had limited funding and time and hence it was not possible to wait for 
saturation to be reached. The fact that saturation was not reached in this study 
may limit the interpretation as more stakeholders could have provided new 
information relevant for setting up the intervention. However, despite this, a 
wide range of stakeholders from a broad spectrum of disciplines was 
interviewed. 
 
Finally, although a sample of service providers was identified, the views 
of pregnant service users will be essential when developing any new service.  
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Further and more extensive research should take place with women at different 
stages of pregnancy; pre-conception, antenatally and postnatally (299). In 
addition, the responses of the service providers (internal stakeholders) are 
specific to Lambeth which limits the generalisability to diverse inner city areas in 
the UK and elsewhere.  
 
7.4.5 Conclusions  
 
 This qualitative study sought the views of stakeholders and, despite its 
limitations, highlights providers’ views that an intervention to tackle maternal 
obesity is needed. The existing evidence shows that the effectiveness of 
services provided to this target population group is limited and therefore the 
design of any new programme requires consultation with service users. 
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CHAPTER 8: The CAN intervention   
 
8.1 Introduction 
 
 Having followed the MRC framework for developing a complex 
intervention to establish the burden of obesity in pregnancy; having developed a 
strong theoretical rationale for the nature of a lifestyle intervention that can be 
utilised; having performed a systematic review and meta-analysis of the lifestyle 
intervention; having explored users’ (299) and providers’ views on how they 
envisage such a service and having secured their engagement; and working 
with an expert group of researchers, the CAN intervention was developed. 
 
8.2 The CAN intervention 
 
Details of the CAN intervention programme in the form of a participant 
manual are presented in Appendix as the last appendix. A brief summary of the 
intervention is given below. 
 
 CAN is an integrated diet and activity behaviour-change intervention 
which is delivered over 8 weeks starting at 17+0-18+6 weeks and finishing at 
26-28 weeks of gestation. Participants are followed for up to 6 months post-
delivery. The intervention is delivered using a combination of one-to-one and 
group-based activities (weekly), as well as telephone contacts, SMS text 
messages, e-mail and web-based support. Dietary advice focuses on 
decreasing glycaemic load, restricting saturated fatty acid and free sugar intake, 
and increasing fruit and vegetable consumption. The advice also includes 
spacing meals evenly to attenuate change in plasma glucose levels. Diets 
include foods with low glycaemic index (GI). Subjects are advised to spread 
their intake of food over smaller meals but with substitutions of starchy foods 
with a lower glycaemic index, including brown bread, basmati rice in place of 
white long grain rice, pasta in place of potatoes, and low glycaemic index 
breakfast cereals rather than high ones. Activity focuses on increasing total 
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activity such as walking, swimming, step aerobics and gym-based exercises.  
The intervention is delivered by a trained health facilitator in a community 
health/leisure centre setting in South East London. The stakeholders (users and 
providers) recommended the setting to be in the community (Chapter 7). 
 
 The programme comprises of sessions combining group-based activity 
(nutrition and exercise components) lasting two hours and one-to-one sessions 
lasting ninety minutes to provide motivational support and personalised goal-
setting, tailored to meet the needs of the individual. 
 
 Information leaflets and a participant manual are given to the applicants.  
The information and activities that comprise the intervention are culturally 
specific and sensitive to the needs of obese women and their partners and 
families.  
 
The components of the programme include the following: 
 
8.3 Nutrition 
 
At the group sessions healthy eating topics include recommendations for: 
 Low glycaemic index food which is patient and culturally focused 
 Fruits and vegetables 
 Reduced saturated fat intake 
 Food label reading 
 Appropriate portion sizes 
 Eating less, more often, rather than three big meals a day 
 Reduced free sugar intake (especially sugar-rich beverages)  
 
8.4 Physical activity 
 
 A menu of exercise choices, based on the participant’s wishes and local 
availability, is offered. A participant may choose, for example, weekly exercise 
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sessions (land-based low impact exercise such as cycling and dancing, and 
water-based exercise such as swimming and aqua-aerobics) which are 
provided in Lambeth by such organisations as Aqua Natal and Sport England.  
Group exercise sessions are planned to be fun, structured and non-competitive.  
For those who prefer exercising alone, walking is one of the menu options as 
the means to achieving agreed personal goals. 
 
 Postnatal women are referred on to existing and well-established 
resources in the children’s centres including breastfeeding cafés, mother and 
baby exercise classes, and baby massage courses. 
 
8.5 Behavioural change  
 
 This psychology-based component helps women to change their lifestyle 
through both one-to-one and group-based motivational sessions using a 
solution-based problem-solving approach. The theory behind this is based on 
social cognitive theory and behavioural self-management approaches designed 
to help participants set SMART goals (311-313). 
 
 At the one-to-one sessions SMART goals are agreed between each 
woman and the programme leader. These are reviewed at one-to-one sessions 
during the course of the programme/pregnancy/post-natal maintenance period.  
SMART goals are Specific, Measurable, Achievable, Relevant, and Timely; for 
example: “I will walk to the children’s centre, which takes 30 minutes, three days 
a week on Monday, Wednesday and Friday instead of taking the bus” or “I will 
eat three portions of fruit and vegetables every day over the next week”.  The 
goal can then be reviewed and reset, for example to five portions a day, always 
ensuring each goal is achievable. One or two SMART goals are set at each 
session, relevant to the improvement needed for each woman. One woman 
may need to increase her physical activity levels whilst another woman may 
need to focus on reducing her high calorie snack intake. The programme 
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leaders use a variety of prompts (e.g. meetings, telephone calls, texts, letters) to 
encourage the maintenance of improved lifestyle choices.  
 
 The peer support arising from group sessions motivates women to have 
contact with other women. The programme offers weekly sessions for each 
participant at the same time of day and on the same day of the week. Evidence 
on the effectiveness of adult and childhood obesity interventions, and 
stakeholder interviews with private providers, suggests that regular weekly 
sessions maintain motivation. The evidence suggests that programmes that are 
held more frequently have lower rates of attendance. 
 
 There are two main contact points for data collection, at 17+6 and 28 
weeks gestation. The programme commences at approximately 17+6 weeks 
into pregnancy. The programme lasts for approximately 8 weeks. The 
community-based programme finishes at 27 weeks gestation. Following 
completion of the programme there will be motivational support (for example, 
via mobile texts, podcasts or mail) for a further period until delivery.  
 
8.6 Staff   
 
 The programme is delivered by health care professionals who co-
ordinate the programme, working in partnership with the existing health trainers 
and peer educators in Lambeth. We recruited staff with the desire, ability and 
personality to motivate and act as role models for the women. All staff were 
trained to ensure that they are competent at organising and leading the 
programme. 
 
8.7 Settings at which the intervention was delivered  
 
 The intervention was delivered within the community at Sure Start and 
children’s centres. The pictures below show one of the children’s centres where 
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the intervention is being delivered, with two of the health trainers appointed to 
deliver the intervention. 
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CHAPTER 9: Pilot study for the CAN intervention in South London  
 
9.1 Introduction 
  
This chapter describes a pilot study undertaken to assess the feasibility 
of the CAN (community activity and nutrition) programme designed to help 
obese pregnant women in a disadvantaged community (South London) to eat 
more healthily and become more active. CAN incorporates dedicated health 
trainers who set up and run one-to-one and group-based sessions for a period 
of 8 weeks starting from 18-20 weeks of gestation.   
 
The objectives of the pilot were to:  
 
1. Measure the feasibility of the study; and 
2. Make preliminary assessments regarding whether the intervention is 
associated with changes in behaviour (dietary or activity behaviour), 
and, where possible, clinical outcomes. 
 
9.2 Trial method and protocol 
 
 This method builds on the findings and recommendations of studies 
undertaken in 2009, the primary outcome of which was stakeholder agreement 
that a community-based service targeting obese pregnant women was both 
desirable and theoretically feasible (Chapter Seven). 
 
 The intervention was developed jointly by the author and Professor 
Lucilla Poston with a King’s College, London team trialling a hospital-based 
intervention called UPBEAT (United Kingdom Pregnancy, Better Eating and 
Activity Trial). 
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9.2.1 Study design  
 
 Pilot RCT of community-based multi-component (activity, nutrition, 
behavioural support) programme for obese pregnant women (BMI>/=30 kg/m2) 
aged between 18 and 40 years with no co-morbidity.   
 
9.2.2 Study hypothesis  
 
 A community-based intervention of dietary and physical activity advice 
combined with behavioural support (CAN) for obese singleton pregnant women 
will alter dietary and activity behaviour and have a positive impact on maternal 
glucose homeostasis and birth weight. 
 
The study was designed by the author, and the setting up in the 
community and recruitment from King’s College Hospital were both organised 
by the author. The initial recruitment of the pilot population was done by the 
author and a research midwife. The setting in selected children’s centres was to 
attract participants from Black and ethnic minorities, identified as a risk group 
(Chapter 4). The method and protocol for CAN was developed by the author, as 
well as seeking ethical approval. All the analyses in this chapter were performed 
by the author apart from the nutritional analysis, for which the author sought 
help from the nutritionist involved in the study.  
 
9.2.3 Study population  
 
 Women were recruited from King’s College Hospital Foundation Trust 
maternity unit. In total 4700 pregnant women deliver at KCH per year, 
approximately 14% of whom are obese. 
 
The study population was comprised of pregnant singleton women at 
less than 17 weeks and six days’ gestation, attending the KCH maternity unit, 
who were obese and had no co-morbidity. Obese women with multiple 
 169 
 
 
pregnancies or with medical co-morbidity (diabetes, thyroid disease, 
hypertension, stroke or myocardial infarction) were excluded from the study. 
 
9.2.4 Recruitment and randomisation  
 
 All new patients fulfilling the inclusion criteria were approached by the 
research midwife, and given an information leaflet about the study. An opt-out 
approach was taken, and each patient was contacted the next day by the 
research midwife via telephone and recruited into the study if consent was given 
and if eligibility was confirmed. All essential information (age, address, 
postcode, ethnicity, cigarette smoking, GP address), including weight, height 
and BMI, was recorded on the study database (web-based). 
 
Once consent was given, intervention was allocated using a 
randomisation procedure incorporated within the online database to minimise 
treatment groups by ethnicity (ONS categories: Black, White, Asian, Other), BMI 
group (30-35 kg/m2, 36-40, greater than 40) and age (18-25, 26-30, 31-40, 
>40). The computer software informed the midwife of the next study number 
and allocation. The research midwife arranged appropriate visits and training 
sessions. 
 
9.2.5 The intervention  
 
 This study used the intervention developed in conjunction with the trial 
for pregnant obese women, which uses a hospital-based intervention 
(UPBEAT), and findings from provider consultation (Chapter seven). Details of 
the intervention are described in Chapter Eight and in the CAN participants’ 
manual attached (the last Appendix ). 
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9.2.6 Care in the control group 
 
 Patients allocated to the non-intervention group had routine antenatal 
care, which was referral to their linked consultant. The local guideline for 
managing obese pregnant woman is attached as an appendix (Appendix B).   
 
9.2.7 Follow-up and outcome measurement 
 
a) Assessment of behavioural change. Physical activity was measured by 
an accelerometer over the previous week before randomisation, at 28 to 
30 weeks, at 34 weeks and at 6 months post-delivery (details in Section 
9.2.9). Diet was assessed at recruitment, 28 weeks, 36 weeks of 
gestation and 6 months post-delivery using the 24 hour recall developed 
for the CAN and UPBEAT studies (details in Section 9.2.8).  In the non-
intervention group, diet and physical activity were assessed in the same 
way and at similar time points.  
 
b) Glucose homeostasis. Glucose tolerance tests were performed in all 
women at 27+0 to 28+6 weeks, which included fasting glucose, 1 hour 
after 75 g of glucose challenge and 2 hours after glucose challenge in 
both the intervention and non-intervention arms.  
 
c) Weight change was assessed in study-specific visits to the research 
midwife at recruitment, 28+6 and 34+0 to 36+6 weeks gestation and 6 
months post-delivery. In the non-intervention group, weight was 
measured at the same time points. 
 
d) Evaluation of the feasibility, acceptability and fidelity of delivery of the 
intervention: The success, accessibility and acceptability of the 
intervention delivery and compliance with the protocol of the intervention 
were assessed by monitoring attendance at contact points 18+6 weeks 
and 28 weeks and via telephone calls. The proportion recruited and 
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declining was assessed. The reasons for refusal and drop-out, plus 
adverse events and attitudes were recorded and assessed.     
 
e) Obstetric outcome was assessed during pregnancy and delivery. These 
include gestational diabetes, pre-eclampsia and severe pre-eclampsia, 
Caesarean section (elective and emergency) and reasons for section, 
induction of labour, blood loss at delivery (ml), birth weight, prematurity, 
death (stillbirths and neonatal deaths up to 28 days), gestational age at 
delivery, placental weight, inpatient nights (antenatal and total), 
breastfeeding initiation rates and smoking cessation rates. 
 
9.2.8 Methods for assessing dietary change 
 
 Dietary data analysis was undertaken to assess dietary intake at 
baseline in all women before randomisation (15+0 to 17+6 weeks gestation) 
and again, to evaluate the effect of the intervention, in both control and 
intervention arms at 26-28+6 weeks gestation. Dietary recalls were performed 
by midwives trained in dietary assessment techniques, using a triple pass 24-
hour dietary recall method performed at baseline and again following the 
intervention. The quality of dietary data was checked within a web-based 
database (MedSciNet™) by a research dietician. Dietary coding was inputted by 
the same research dietician using food codes from McCance and Widdowson's 
Composition of Foods (Summary Edition [6th Edition]) within the MedSciNet 
database. Dietary composition analysis was undertaken by the research 
dietician using the dietary analysis software WISP version 3.0 (Tinuviel 
software).  Mean (SD) and percentage macronutrient and selected micronutrient 
intakes (of particular relevance to pregnancy) were reported.  
 
 A wide range of dietary variables were assessed. To determine whether 
the intervention had influenced dietary intake according to the dietary advice 
given, and without detriment to micronutrient intake, the following relevant 
parameters are reported: 1) energy intake; 2) the glycaemic index (GI) and the 
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glycaemic load (GL); 3) carbohydrate intake; 4) protein intake; 5) fat intake - 
total, monounsaturated, saturated and polyunsaturated; 6) sugar intake; 7) 
dietary fibre; and 8) dietary iron, zinc, vitamin D, folate and calcium.   
 
 The GI is a system for classifying carbohydrate-containing foods 
according to their glycaemic response, whereas GL also takes into account the 
amount of carbohydrate consumed. Mean dietary GI and GL were calculated 
within the WISP version 3.0 software which contains previously published GI 
values (Atkinson et al., 2008) (314). Where GI values were missing, additional 
UK published values (Henry et al., 2005; Aston et al., 2008) were inputted, 
where available, using glucose as the standard reference value of 100 (315-
316). Where dietary GI values were not available, values were inputted 
according to previously published methodology (Aston et al., 2010), developed 
for consistent assignment of GI values to foods (317).    
 
9.2.9 Method for assessing activity change 
 
 Physical activity was assessed using an actigraph accelerometer 
(www.theactigraph.com) for a week, seven days before randomisation. To 
assess the effect of the intervention, participants in both the intervention and 
non-intervention arms were also asked to wear the accelerometer for a week 
following the OGTT (28 to 29+6 weeks). Accelerometers allow objective 
evaluation of physical activity, providing information on the frequency, intensity 
and duration of both physical activity and sedentary behaviour (ONS, 2010).  
They also have the advantage of providing standardised measures when 
compared to self-reporting of activity, hence, reducing recall bias and 
subjectivity. The disadvantage is that when the monitor is not being worn 
activity is missed, and also the accelerometer fails to measure water activities 
such as swimming. Sedentary activity was defined as <100 counts per minute 
(cpm), light activity 100-1951cpm, moderate activity as 1952-5725 cpm and 
vigorous activity as >5725cpm. As periods of vigorous activity were low, 
minutes for moderate to vigorous activities were combined (MVPA). 
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9.2.10 Data management  
 
 All data were entered onto a dedicated study database shortly after being 
obtained and checked for consistency and accuracy at regular intervals. Back-
up copies of the database were made and confidentiality of access and storage 
of both electronic and paper information was ensured. 
 
9.2.11 Statistical analysis 
 
 For assessment of dietary behaviour change, data analysis was 
undertaken using the Predictive Analytics SoftWare (PAWS) Statistics 18 
(Statistical Package for the Social Sciences Inc.). Normality of data was 
checked using standard distributional plots. The independent samples t-test and 
the Mann-Whitney U test were used to determine differences in dietary intake 
between control and intervention groups at 28 weeks gestation. 
 
For binomial outcomes, analysis compared proportions of women with 
the outcomes of interest in the intervention and the non-intervention arms of the 
study. For example, the proportions of women in the two arms of the study who 
achieved a restricted weight gain following randomisation were compared.   
Similar analysis include comparisons of the proportion of women with improved 
glycaemic control at 28 weeks, changes in activity and dietary habits and 
measures of improved wellbeing at 28 weeks and 6 months post-delivery. Mean 
age, BMI, IMD scores and activity levels in the two groups were compared 
using t tests. 
 
9.2.12 Sample size and power 
 
 The aim of the pilot was to measure the feasibility of the study rather 
than estimate the effect of the intervention on health outcomes.    
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 For the eventual main trial, the primary outcome for the mother will be 
abnormal oral glucose tolerance test at 27+0 to 28+6 weeks of gestation and for 
the infant, large for gestational age delivery (>90th customised birth weight 
centile). The sample size for the eventual study will be calculated to have at 
least 80% power to detect a statistically significant difference in the proportion 
of women who have an abnormal glucose tolerance test at 28 weeks and also 
large for gestational age baby at delivery in the intervention arm, compared to 
the control arm.  
 
 The rationale for using abnormal glucose tolerance test is that it has 
been shown to correlate with important clinical outcomes that affect the mother 
(e.g. gestational diabetes, pre-eclampsia) and the baby (e.g. congenital defect) 
(127). The rationale for using large for gestational age delivery is that it has 
been shown to correlate with adverse delivery outcome (e.g. Caesarean 
section, dystocia and shoulder dystocia).     
 
9.3 Results  
 
9.3.1 Recruitment and retention   
 
 Figure 21 shows patient flow through the trial for a period of eight 
months. Potentially it was estimated that 440 obese patients would be available 
over the eight-month period of the study (4700×14% obese×8/12=440). Of 
these, 45% were approached (198 women). Of those who were approached, 
75% declined to take part in the trial (150 women). Of those who agreed to take 
part, 19% were ineligible (9 women). Of the 39 eligible women, all of them were 
randomised with 19 in the intervention arm and 20 in the non-intervention arm. 
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 Figure 21: Patient flow through the trial over an 8-month period 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reasons for low approach rate 
 
 The number of eligible participants was not a limiting factor. In 
interviewing the eligible women and the research midwives, the main reason 
cited for the low number of eligible women being approached was too few staff 
involved with recruitment i.e. the relative lack of research midwifery time 
available for recruitment. The clinical midwives were also either unaware of the 
study or lacked time to mention the study to the patients, leading to fewer 
referrals from the clinical midwives. The referral pathway has mainly been 
organised through the fetal medicine centre in order to approach women having 
their first trimester scan, and was not used via the midwives doing the booking, 
hence reaching less than half the number of potential participants. As there was 
only one part-time midwife (three days/week) working on the study, the amount 
of research midwifery time focused on recruiting was low, as a considerable 
Number of obese women potentially 
available to be approached: 440 
Number approached: 198  
Number refused:  
150  
Number  
eligible: 39  
Number  
ineligible: 9 
Number in intervention:19 
0 
Number  in non-intervention 
group:20     9 
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proportion of available time was spent on acquiring outcome data rather than on 
recruitment. 
 
Reasons given by patients for declining to take part in the study when asked by 
the research midwife at the time they declined 
 
 Several reasons were given by participants for refusing. Thematically 
these can be grouped into: finding time during the day to come to yet more 
appointments and inflexibility with the time that the intervention is delivered, as 
children’s centres open between 0900 and 1700, which is likely not to be 
conducive to the requirements of working mothers. In addition, a high proportion 
of mothers who declined turned down entry into the study because of difficulty 
finding childcare. Some participants were concerned about stigma and being 
labelled as obese once they joined the study. A few of the participants who 
declined did not view obesity as high-risk in pregnancy and so did not see the 
need for the study (table 24)   
 
Table 24: Summary of reasons for declining by obese pregnant women 
who refused to take part in the study 
 
Reasons for refusal  
(Where two or more reasons are given, 
the first answer is included here) 
Number out of 150 Proportion 
Not able to find time because of travel, too 
many antenatal appointments or patient 
being a carer 
24 16% 
Work commitment 47 31% 
Not able to get childcare 37 25% 
Away on holidays 5 3% 
Stigma 4 3% 
Refusal from significant other (partner) 9 6% 
No reason given 24 16% 
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Sociodemographic characteristics of those who refused and those who 
accepted 
 
 There were no major demographic differences between those who 
declined and those who agreed to come into the study. Black and ethnic 
minorities were well represented in the recruitment (Table 25). 
 
Table 25: Socioeconomic characteristics of those who agreed and did not 
agree to come into the study 
 
 Refused 
N=150 
Recruited 
N=39 
P Value 
Mean age (SD) 30.07(5.96) 30.13 (5.41) 0.96 
Mean BMI (SD) 35.09 (4.10) 36.68 (5.37) 0.08 
Ethnicity  
0.73 
 
White N(%) 40(29) 14 (36) 
Black  N(%) 89 (64) 22(56) 
Asian  N(%) 4(3) 2(5) 
Other  N(%) 5(4) 1(3) 
English Quintiles of Index multiple 
deprivation- English  
 0.18 
1 (Least deprived) 0 (0%) 0 (0%)   
 
 
0.18 
2 0 (0%) 0 (0%) 
3 3 (2%) 3 (8%) 
4 52 (34%)             12 (32%)             
5 (Most deprived) 99 (64%)             23 (61%)             
  
Retention and drop-out results 
 
 Of the 19 participants in the intervention arm, 17 participated in at least 4 
sessions and 15 in at least 6 or more (80%) (Table 26). The mean number of 
sessions attended per woman was 5.5 out of a total of eight. 
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Table 26: Attendance at each session of the intervention: in total eight 
sessions (S1-S8) for 19 participants 
 
Total number of sessions attended 
  
 i.d 
 
Centre 
 
Session 
1  
Session
2 
Session
3 
Session 
4  
Session 
5  
Session 
6 
Session 
7  
Session 
8 
1 CAN 0 1 0 1 1 0 1 0 
2 CAN 1 1 0 1 1 1 1 1 
3 CAN 1 1 0 1 1 1 0 1 
4 CAN 0 1 1 1 0 0 1 0 
5 CAN 1 1 1 1 0 1 1 1 
6 CAN 1 1 1 1 1 1 0 1 
7 CAN 1 1 0 1 0 1 1 0 
8 CAN 1 1 1 1 1 1 1 1 
9 CAN 2 2 2 2 2 2 2 2 
10 CAN 2* 0 2 2 2 2 0 0 
11 CAN 4 4 4 4 4 4 4 4 
12 CAN 2 2 2 2 2 2 2   
13 CAN 2* 2 0 2 2 2 2 0 
14 CAN 2 2 4 4 4 4 4 4 
15 CAN 2 2 2 2 2 2 2 2 
16 CAN 2* 2* 2* 2* 0 2* 0 2* 
17 CAN 1 2* 2* 0 2* 0 0 2* 
18 CAN 2 2 2 2 2 0 0 2 
19 CAN 1 4 4 4 4 4 4 4 
 
Code: 0=Did not attend, 1=Group session, 2=1:1 session, 2*=Only 1 woman 
possible, 3=Phone sessions only, 4=Drop-out   
 
9.3.2 Characteristics of intervention and control groups 
 
 Sociodemographic description of the CAN pilot study group is shown in 
Table 27. There were no major differences between groups in terms of age, 
BMI, ethnicity, parity or index of multiple deprivations. 
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Table 27: Sociodemographic characteristics of subjects at baseline by 
randomised group  
 
 Control Group  
N=20 
Intervention Group 
N=19 
P Value 
Age (Years) Mean (SD) 29.60 (4.66) 30.68 (6.17) 0.55 
BMI Mean (SD) 36.61 (6.45) 36.75 (6.14) 0.95 
Ethnicity    
 
0.81 
White  N (%) 7 (35) 7 (37) 
Black  N (%) 11 (55) 11 (58) 
Asian  N (%) 1 (5) 1 (5) 
Other N (%) 1 (5) 0 (0) 
Parity  
0.39 Primip N(%) 9 (45) 6 (32) 
Multip N (%) 11 (55) 13 (68) 
IMD (Index of Multiple Deprivation) - English addresses only 
N 19 19  
Mean (SD) 37.60 (7.81) 33.31 (11.65)    
English Quintiles of IMD   
1 (Least deprived) 0 (0%) 0 (0%)   
 
0.18 
 
2 0 (0%) 0 (0%) 
3 0 (0%) 3 (16%) 
4 6 (32%)              6 (32%)    
5 (Most deprived) 13 (68%)             10 (53%)             
  
 Although the sample sizes were small, resulting in low power to detect 
statistically significant differences, these data provide some evidence that 
randomisation and minimisation were robust. 
 
9.3.3 Dietary behaviour change 
 
 Conformity to dietary advice was assessed using structured 
questionnaires and validation was assessed using 24 hour dietary diaries. In 
order to minimise bias due to misreporting, the differences in the respective 
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food intakes were compared prior to randomisation and at 28 weeks of 
gestation, hence assessing the difference pre-intervention and post-intervention 
compared to the difference in the same time points in the non-intervention 
group.  
 
 The results presented in Table 28 demonstrate a significant reduction in 
dietary glycaemic load at 28 weeks gestation in the intervention group 
compared to the control group (P<0.05). This reduction in GL is concurrent with 
a reduction in total energy intake in the intervention group, with no differences 
found in percentage carbohydrate intake between the control and intervention 
groups. Although not statistically significant, there was a trend for a reduction in 
saturated fatty acid (SFA) (%E) intake (P=0.07) and improvement to the 
polyunsaturated fatty acid: saturated fatty acid ratio (P=0.085) in the 
intervention group only. Dietary glycaemic load remained unchanged. Despite a 
reduction of energy intake in the intervention group, no significant changes to 
key micronutrients were found between groups (Table 28). 
 
Table 28: Dietary glycaemic index, glycaemic load, energy, macro- and 
micronutrient intake following dietary and lifestyle intervention (28 weeks 
gestation) adjusted to baseline 
 
 Control 
(N=15) 
Mean (SD) 
Intervention 
(N=14) 
Mean (SD) 
P Value   
Energy intake (kcal) 2115 (325) 1647 (554) 0.01* 
Dietary GI 54.7 (8.1) 56.7 (7.1) 0.89 
Dietary GL 147 (30) 117 (38) 0.03* 
Dietary GL (%E) 26.3 (5.7) 27.7 (8.2) 0.59 
Carbohydrate (%E)  48.3 (9.8) 50.3 (7.5) 0.55 
Protein (%E) 16.3 (3.7) 15.7 (5.1) 0.71 
Total fat (%E) 35.1 (9.0) 33.9 (7.2) 0.69 
SFA (%E) 13.4 (4.0) 10.7 (3.8) 0.07 
MUFA (%E) 10.6 (3.5) 10.0 (3.0) 0.64 
PUFA (%E) 6.0 (3.7) 7.5 (4.2) 0.30 
P:S ratio 0.45 (0.25) 0.87 (0.88) 0.09 
Total sugar (%E) 22.0 (11.3) 18.7 (7.4) 0.38 
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 Control 
(N=15) 
Mean (SD) 
Intervention 
(N=14) 
Mean (SD) 
P Value   
Fibre (NSP) (g)  10.3 (4.1) 11.9 (6.3) 0.43 
Iron (mg) 11.6 (4.0) 10.7 (5.1) 0.60 
Zinc (mg) 9.6 (2.7) 7.5 (3.7) 0.09 
Vitamin D (µg) 3.0 (3.6) 2.0 (2.1) 0.39 
Folate (µg) 224 (123) 223 (96) 0.98 
Calcium (mg) 857 (329) 723 (391) 0.33 
 
*Significant P<0.05. SFA: saturated fatty acid, PUFA: polyunsaturated fatty acid, MUFA: 
monounsaturated fatty acid, GI: glycaemic index, GL: glycaemic load, PS: polyunsaturated fatty 
acid: saturated fatty acid ratio, NSP: non-starch polysaccharide. %E: estimated percentage 
contribution to total energy intake.  
 
9.3.4 Physical behaviour change 
 
 The accelerometer data was available for 12 out of the 39 participants 
(30%). Pregnant women found the accelerometers uncomfortable to wear and 
hence only a small proportion provided any results at all. There was no 
observed difference between the participants in the intervention versus the non-
intervention group, although little can be concluded because of lack of power 
(Table 29). 
 
Table 29: Physical activity measurements for the intervention and control 
subjects  
 
Level of activity 
Counts/minute 
Control group 
 
N=7 
Mean 
minutes/day (SD) 
Intervention 
group 
N=5 
Mean 
minutes/day (SD) 
P Value 
<100  (Sedentary) 1159 (53.11) 1140 (51.73)  0.55 
 Total activity 214 (69.88) 223 (41.84)  0.79 
100-1951  
(Light activity) 
171 (51.12) 188 (38.36)  0.53 
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Level of activity 
Counts/minute 
Control group 
 
N=7 
Mean 
minutes/day (SD) 
Intervention 
group 
N=5 
Mean 
minutes/day (SD) 
P Value 
1952-5724 
(moderate activity) 
43 (30.84) 35 (15.26)  0.57 
5725-9498 
(vigorous activity) 
0.4 (0.37) 0.2 (0.16)  0.24 
≥9499 
(very vigorous 
activity) 
0.00 (0.00) 0.01 (0.02)  0.33 
Combined 
moderate and 
vigorous activity 
44 (30.80) 36 (15.29)  0.57 
 
9.3.5 Clinical Outcomes 
 
 Obstetric outcomes of the pilot study are presented in Table 30. Overall, 
37% of women developed gestational diabetes according to the HAPO criteria 
and 8% had large for gestational age babies (LGA) (99). There was evidence of 
a trend towards lower prevalence of gestational diabetes in the intervention 
group compared to non-intervention as well as lower prevalence of large for 
gestational age babies although these differences were not statistically different.  
This being a pilot study, it was not powered to demonstrate effectiveness of the 
intervention.  
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Table 30: Clinical outcome (maternal and neonatal) data of participants in 
the intervention and control arm  
 
 Control 
 
Intervention 
 
P Value 
Weight at trial entry 
Mean(SD) 
99.64 Kg (14.61) 
N=20 
98.28 kg (15.1) 
N=19 
  
Weight at 28 weeks 
Mean(SD) 
105.49 (15.09) 
N=15 
102.16 (15.70) 
N=16 
0.10 
Fasting glucose at 28 
weeks (mM) 
Mean(SD) 
5.13 (0.94) 
N=15 
4.72 (1.30) 
N=15 
0.33 
1 hour glucose at 28 
weeks (mM) 
Mean (SD) 
8.66 (2.90) 8.48 (3.30) 0.88 
2 hour glucose at 28 
weeks (mM) 
Mean (SD) 
6.11 (2.50) 6.47 (3.06) 0.73 
Gestational diabetes 
based on HAPO 
definition (%) 
7/12 (46.7%) 3/15 (20%) 0.12 
Gestation at delivery 
Weeks(SD) 
39.73 (1.38) 
N=18 
39.50 (0.92) 
N=16 
0.57 
Newborn birth weight 
(kg) Mean (SD) 
3.429 (0.6) 
N=18 
3.370 (0.4) 
N=16 
0.74 
Customised birth weight 
centile Mean (SD) 
40.52 (33.01) 
N=17 
38.30 (26.61) 
N=14 
0.84 
LGA (greater than 90th 
birth weight centile (%) 
for gestation at delivery 
2/17 (11.8%) 0/14 (0.0) 0.19 
 
9.4 Discussion 
 
9.4.1 Summary of findings 
 
 This pilot trial has demonstrated that it is feasible to carry out the CAN 
intervention in Sure Start/children’s centres. However, fewer than expected 
potential participants were approached. A reason for this is that research 
midwifery time was focused on data collection, which was intensive, as opposed 
to recruitment. The proportion of those approached who agreed to take part in 
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the study was also small. Difficulty finding time because of work, inflexibility of 
the timing of the intervention and childcare were cited as major barriers. Of 
those who agreed, acceptability and attendance was good. Drop-out was due to 
lack of flexibility with regard to timing of the intervention, holidays or childcare. 
Assessment of activity using the accelerometer was very uncomfortable for 
obese women. It may be necessary to drop this assessment for the main trial.  
The dietary assessment yielded strong evidence of reduced glycaemic load and 
saturated fatty acid intake in those in the intervention arm compared to those in 
the non-intervention arm. Assessment of obstetric outcome, while not 
appropriately powered for this pilot study, showed a trend towards reduction in 
gestational diabetes and large for gestational age babies in the intervention 
compared to the non-intervention arm.  
 
9.4.2 Challenges 
 
Despite widespread evidence of maternal obesity being associated with 
adverse outcome, there is as yet no proven effective intervention to alleviate 
these associated adverse outcomes (22). This might be because none of the 
studies evaluating these interventions followed the MRC framework for 
developing a complex intervention (318).  
 
This chapter, which has focused on Phase II of the MRC framework, has 
demonstrated that it is feasible to deliver the complex lifestyle intervention CAN 
in community Sure Start children’s centres. But this has not been without 
challenges, particularly in the assessment of physical activity. With the 
published lifestyle interventions not showing a proven benefit, it may well be 
that these interventions did not result in a behaviour change in terms of 
improved dietary behaviour and improved physical activity. These published 
interventions failed to address the question of whether the intervention actually 
changed behaviour. This pilot focused on assessing behaviour change in terms 
of diet as well as activity and, despite the small sample size, provides some 
evidence that the CAN intervention may have changed behaviour in terms of 
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reduced glycaemic load (P=0.03) and reduced energy intake (p=0.01). This was 
assessed based on 24-hour dietary recall, which is an established validated tool 
for assessing dietary behaviour change. Recall may be a problem as pregnant 
women may be selective in recalling their dietary behaviour. Indeed, a recent 
systematic review and meta-analysis by Thangaratinam et al. showed that 
dietary interventions may be more significant in terms of improving outcome in 
obese overweight pregnant women compared to physical activities (222). In this 
chapter it has been demonstrated that it was difficult for participants to wear the 
accelerometers and because of the discomfort the results shown here are very 
sparse. Also, during the study timeframe media coverage of obesity and the 
need for improved lifestyles may have contaminated the behaviour of the non-
intervention group, bringing it closer to that of the intervention group. This may 
have diminished any true effect.  
 
Recruiting obese pregnant women in deprived communities is very 
challenging, and hence these populations feature less in published articles. A 
recent study concluded that programmes are needed to curb the excessive 
gestational weight gain in all racial groups and to help some subgroups ensure 
adequate weight gain (54). Due to perhaps the setting of this study i.e. in Sure 
Start children’s centres with the focus on local communities, the study was able 
to attract diverse applicants and findings from this work when completed may 
be able to be utilised in urbanised diverse communities. Findings from this pilot 
study have led to some recommendations for the follow-on study, as highlighted 
below.     
 
9.4.3  Implications and recommendations: 
 
From this pilot study, the following recommendations for the main trial are as 
follows: 
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1. Increase the number of midwives to improve recruitment and to promote 
the study by giving talks to midwife groups who run the booking clinics 
about the importance of the study and the eligibility criteria.   
2. Provide posters and leaflets about the study in all of the antenatal clinics, 
including those in the community. 
3. Follow the same process of randomisation and minimisation of 
participants in the main trial.    
4. Reduce the time required for qualitative measurements, such as dietary 
questionnaires and accelerometer measurements, so that research 
midwives have sufficient time to focus on recruitment and the merging of 
first and second visits. 
5. Allow flexibility of the timing of the sessions, particularly in the evening, 
being scheduled after working hours so that working mothers can attend. 
6. Allow flexibility with the delivery of the intervention i.e. via phone calls, 
texts and emails, or one-to-one or group-based sessions. 
7. Provision of crèche facilities to ensure that those with children will also 
be able to attend. Hopefully this will also reduce drop-out rates. 
8. Find alternative methods for the assessment of physical activity. Women 
found wearing the accelerometer uncomfortable and alternative 
approaches will be needed for the main trial.  
9. Regarding the sample size needed for main trial, and erring on the 
conservative side, the following calculation was made: Assuming an 
incidence of GDM of 30% in the control arm and 23% in the intervention 
arm (relative risk reduction of 30%), and a 20% lost to follow-up, it is 
estimated that approximately 770 women in each arm of the study (1540 
in total) will provide the study with 80% to detect this risk reduction using 
a p value of <0.05%.        
 
9.4.4  Conclusions 
 
 This pilot study has demonstrated that the CAN intervention is feasible in 
a high-risk diverse, low socioeconomic status population but that it is important 
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to make some adjustments to the protocol. The adjustments to be made include 
focusing the research midwives’ time on recruitment, and ensuring flexibility for 
the participants in terms of the way in which the intervention is delivered and the 
timing of the intervention delivery. Following this pilot study, sessions have been 
established out of hours, i.e. starting at 18.00, ensuring flexibility for participants 
who are working, while maintaining sessions in the morning and afternoon.  
More research midwives have been employed to aid with recruitment, so that 
recruitment within the main trial has improved. 
  
I found evidence that the CAN intervention results in a change of dietary 
behaviour in terms of reduced reported glycaemic load (p=0.03) and dietary 
energy intake (p=0.01) but it did not demonstrate a change in activity, possibly 
because of reduced uptake in the use of the accelerometer. 
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CHAPTER 10: Discussion 
 
This thesis aimed to assess the extent and potential for the prevention of 
adverse impacts of obesity in pregnancy. The work culminating from the thesis 
has gone some way to addressing this. The objectives of the thesis were as 
follows:   
 
(i) To summarise the literature on maternal obesity and the adverse 
impacts of maternal obesity on maternal and child  health outcomes in 
the UK and elsewhere, as reported in Chapter Two. 
 
(ii) To perform a descriptive epidemiological analysis of available local 
data on obesity in pregnancy. This would help to establish the 
association and impact of obesity on pregnancy outcomes in an 
ethnically diverse Inner London population using Guy’s and St 
Thomas’ data, as reported in Chapter Four. 
 
(iii) To conduct a systematic review of existing evidence on lifestyle 
interventions for obesity in pregnancy, as performed in Chapter Five. 
 
(iv) To develop a multi-component pilot study for a complex community-
based activity and nutrition (CAN) intervention for maternal obesity in 
South London, as shown in Chapters six, seven, and eight. 
 
(v) To conduct a pilot study of the CAN intervention in South London, as 
reported in Chapter Nine. 
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10.1 Summary of main findings  
 
10.1.1 Maternal obesity and maternal and infant  outcomes 
 
 The evidence presented in Chapter Two confirmed that obesity 
represents a major public health problem for the United Kingdom and most 
other countries. It showed that obesity is strongly associated with increased 
maternal  and perinatal mortality and morbidity and that reducing the prevalence 
of obesity in pregnancy could markedly reduce adverse outcomes. The 
evidence clearly indicated that interventions to address the adverse outcomes 
associated with maternal obesity are urgently needed and remain a public 
health priority. 
 
10.1.2 The epidemiology of maternal obesity in a South London population 
 
 The work described in this thesis estimated the prevalence of obesity in 
pregnancy in a South London population to be 15% (with some evidence of 
increasing prevalence over time). It demonstrated that Black pregnant women 
are over twice as likely to be obese compared to White women and that 
maternal BMI increased with increasing age and parity. The data showed a 
weak association between deprivation and obesity except at the highest quintile 
of deprivation, where the association was strong. These are new observations 
from a diverse community in South London. 
 
 In accordance with the established literature, this study showed a 
marked increase in adverse obstetric events in obese pregnant women 
including diabetes, Caesarean section, preterm delivery, postpartum 
haemorrhage and significant neonatal morbidity. The risks paralleled the 
increase in BMI. This showed that not only was obesity associated with adverse 
outcome but that BMI values in the overweight range were also associated with 
increased risk of adverse outcome. Of note, and a novel finding, is that the 
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association of obesity with gestational diabetes was more marked in obese 
women of Asian ethnic origin compared to the other ethnic groups.    
  
In this thesis, by calculating population attributable fractions, analysis 
showed that if it were possible to prevent or mitigate the effect of obesity in 
pregnancy, then approaching one-third of diabetes cases, one in eight 
Caesarean sections, one in 20 cases of postpartum haemorrhage and one in 12 
cases of macrosomia could theoretically be prevented in this population. Of 
particular importance, at a population level, is the differential impact of obesity 
on pregnancy outcome in particular ethnic groups. For example, for diabetes 
the avoidable proportion of cases is higher in Blacks (35%) compared to Whites 
(26%) due to the higher prevalence of obesity in this ethnic group. 
 
10.1.3 Systematic review on lifestyle interventions for obesity in pregnancy 
 
 Findings from the systematic review and meta-analysis in Chapter Five 
showed that antenatal lifestyle, dietary and activity advice for overweight and 
obese pregnant women modestly restricts maternal weight gain during 
pregnancy but has no significant effect on other clinical outcomes such as the 
prevalence of gestational diabetes in women who are overweight or obese.  
However, the quality of the study designs was generally poor and did not 
support an evidence-based intervention programme at the time of publication.  
The review showed that no lifestyle interventions had been trialled in the United 
Kingdom and a very small percentage of participants were from Black and 
ethnic minorities. This review was published in 2013, and the high number of 
citations (22) reflects the current interest in obesity amongst pregnant women 
because of the increasing health care burden. 
 
10.1.4  Development and evaluation of the CAN intervention 
  
 From stakeholder consultation, it was found that South London lacked 
dedicated services for tackling maternal obesity. Service providers recognised 
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and supported the need for the design and implementation of a multi-
component (healthy eating, physical activity and behaviour change) intervention 
both pre-pregnancy and antenatally. It was evident that obese pregnant women 
and those trying to conceive may benefit from a service dedicated to addressing 
the heightened adverse outcomes associated with obesity. Working in 
partnership with Professor Lucilla Poston and using the MRC framework for 
designing a complex intervention, the CAN intervention was developed prior to 
undertaking a pilot study in a community children’s centre /Sure Start setting.   
  
 Evaluation of this intervention in a pilot study on 39 obese pregnant 
women, randomised to the CAN intervention versus non-intervention in a 
diverse South East London population, showed that the CAN intervention was 
feasible when delivered in a community setting within an area of deprivation.  
The trial attracted participants from diverse ethnic backgrounds as well as the 
highest levels of deprivation, and showed a trend towards improvement of 
clinical outcomes. The pilot study also showed that the CAN intervention was 
associated with behaviour change as evidenced by reducing glycaemic load 
and energy intake, but it did not demonstrate a change in physical activity. 
Objective assessment of activity was difficult because of poor uptake in the use 
of the accelerometer.  
 
Pilot data were used to perform a power calculation for a definitive study which 
will address the effectiveness of the CAN intervention in improving two primary 
clinical outcomes, gestational diabetes for the mother and macrosomia for the 
baby. This trial is currently underway. 
 
10.2 What is already known? 
 
It is well recognised that obesity is a significant global health problem (1, 
319). It is also known that obesity is a major health issue for women during 
pregnancy, with approximately 15-20% of pregnant women said to be obese (3, 
44). The associated risks of obesity to the mother, fetus and infants has been 
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well reported (44, 320-321). There have been many publications on gestational 
weight gain and pregnancy outcomes which have been comprehensively 
summarised by the Institute of Medicine (48).  
 
 However, despite the numerous publications and reports on the adverse 
effects of obesity on pregnancy outcomes, there have been limited attempts to 
estimate the population attributable fraction for obesity and to establish the 
differential effect and impact of obesity on particular ethnic groups. There have 
also been limited reports on effective interventions that may be implemented to 
mitigate the adverse effects of obesity in pregnancy. 
 
10.3 What does this research add? 
 
This project has estimated the proportions of avoidable adverse 
outcomes associated with obesity in pregnancy, and has demonstrated that 
obesity has a differential effect and impact on Blacks and other ethnic groups.  
It has produced a detailed, contemporary systematic review and meta-analysis 
which showed limited effects of lifestyle interventions in pregnancy.  Similar 
studies have been published by others (177, 222) but none of them is current 
enough to incorporate the biggest and the most recent study (67).  
 
This research developed a feasible community-based lifestyle 
intervention, designed with a multidisciplinary group of stakeholders in the 
setting of Sure Start/children’s centres delivered by health trainers. The initial 
pilot study has demonstrated that it has potential to alter the dietary behaviour 
of obese pregnant women to reduce glycaemic load and caloric intake. The pilot 
study has led to nine recommendations, shown in Section 9.4.3, which may 
help other researchers designing an intervention for obese pregnant women as 
well as the design and conduct of the main CAN trial. The main trial to establish 
the effectiveness of the intervention is currently underway in a combination of 
hospital and community settings, and I will be responsible for undertaking a 
comparison of intervention delivery in the two settings.  
 193 
 
 
10.4 Successes and shortcomings of this research 
 
10.4.1 Successes 
 
The research described in this thesis demonstrates the ability to take a 
clinical problem, such as obesity in pregnancy within a local setting, to identify 
the extent and impact of the problem using local data, and to develop an 
intervention that attempts to mitigate or alleviate the impact of the problem.  
 
One of the main strengths of the project is the large sample size of the 
healthware database used for Chapter Four. This has created an opportunity to 
study and analyse rare outcomes such as perinatal mortality and to 
demonstrate its association with obesity with reasonable statistical power. The 
opportunity to analyse pregnancies from such an ethnically and socially diverse 
population was important and novel. The research identified ethnic differences 
in the impact of obesity in pregnancy and the interaction between ethnicity and 
obesity with regard to diabetes. The latter is a novel finding in the United 
Kingdom. Performing a systematic review and meta-analysis of lifestyle 
interventions in overweight and obese pregnant women contributed to the 
development of a local community-based intervention and a publication from 
this work has been well accessed by researchers and has provided a useful 
contribution to the literature (22).  
 
Conducting a pilot study for a complex intervention of activity and dietary 
behaviour change for obese pregnant women in a deprived diverse setting in 
London was not an easy task. To have conducted this pilot and demonstrated 
that it is feasible is a modest success and highlights useful lessons for the main 
trial and for other researchers who may want to consider similar work. The 
ability of the pilot study to show a favourable dietary behaviour change, in terms 
of reduced glycaemic load, may be considered a success as none of the studies 
included in the systematic review and meta-analysis took this approach for 
assessing behaviour change. 
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Evidence from the Marmot report, Fair Society Healthy Lives, (178) 
highlights the importance of early life intervention (in utero to three years) in 
addressing inequality in health outcomes and improving the life chances of an 
individual. Thus, an early-life in utero intervention such as CAN performed 
within the setting of diverse deprived communities may provide a proportionate 
engagement and benefit for Black and ethnic minorities who, as the study 
shows, are more afflicted with obesity than Whites. The most recent data from 
the ongoing main trial shows that 54% of the participants who have been 
recruited into the CAN study are Black. At a time when early life interventions 
and investment into in utero and early life programmes substantially boost adult 
health (175), CAN may play a role in the arena by addressing healthy nutritional 
behaviour in obese pregnant women with an aim to improve the health of 
children. Funding has been provided by the EU Framework 7 study Early 
Nutrition to undertake an evaluation of the health of children from the main trial, 
including all children born to the CAN participants. The CAN programme for 
delivery of the intervention in the community has also been incorporated into the 
recent successful Big Lottery bid by Lambeth council, which focuses on 
interventions in utero and in early childhood to prevent obesity and improve 
early learning, known as the LEAP study (Lambeth Early Action Partnership: 
Appendix D). 
 
10.4.2 Shortcomings 
 
There are important limitations in this research.   
 
  Chapter Two is a personal critical review and as such I could have 
inadvertently left out some publications which might compromise the 
comprehensiveness of the review. However, I have made every effort to review 
all of the available literature. I acknowledged the possibility of a publication bias 
and a lower contribution from the ‘grey’ literature, but I have attempted to add 
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the grey literature according to the recommendations of the relevant RCOG and 
Cochrane websites.   
 
The third chapter provides a robust rationale of the thesis.  My research 
does not include animal studies, which may be considered a limitation, but I 
hope the review of the human studies provides a clear rationale for the 
research, without the need to review animal studies. However, where 
appropriate, animal studies have been referenced.   
 
The fourth chapter has some limitations which have been acknowledged, 
with attempts made to minimise these. The major limitation of Chapter Four is 
the fact that almost one-fifth of BMI data were missing. Efforts have been made 
to minimise the impact of missing BMI data on the findings. I have shown that 
the missing BMI data were missing ‘not at random’ (322), and hence, imputation 
was not used. The recognition of this problem and my insistence that the BMI 
field on the Healthware system was made mandatory have reduced the 
proportion of missing BMI data since 2008.  
 
The shortcomings of Chapter Five relate to the fact that some of the 
included studies in the systematic review are of low quality and the review does 
not include unpublished data. Whilst I searched for publications from the ‘grey’ 
literature, this did not yield any new intervention studies. However, I may have 
inadvertently left out potentially eligible studies, which could bias the findings. 
 
Chapter Six focused on the development of the lifestyle intervention for 
obese women in pregnancy using the MRC framework.  The development of a 
complex lifestyle intervention for dietary and nutrition behaviour change requires 
input from many disciplines, including the social sciences, psychology, 
obstetrics and gynaecology and nutrition. The intervention was therefore jointly 
developed within a multidisciplinary team led by Professor Lucilla Poston. I 
played a major role from the outset as obstetric lead, and lead for the 
community-led delivery. The CAN programme, delivered in Sure Start children’s 
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centres, allowed the trial to be as closely embedded as possible in real early 
years pathways and practices in the community. 
 
However, working in a multidisciplinary team, whilst necessary, has the 
shortcomings of lack of clarity regarding ownership and external visibility of 
leadership. No individual ‘owns’ the intervention, and it may not be clear who 
leads what. Chapters One and Six make clear my role in developing the 
intervention. Following the development of the intervention, I set up CAN in 
three children’s centres and negotiated the recruitment of patients for the CAN 
intervention at King’s College Hospital. The initial recruitment was performed by 
myself until I employed a research midwife based at King’s College Hospital 
who helped to strengthen the recruitment pathway.  
 
Chapter Seven, which sought the views of service providers, has limitations 
in the methodology, as the interviews were not recorded. The sample size was 
also small and did not clearly delineate the point of saturation. However, despite 
the major shortcomings of this chapter, at the time it was published (298), it was 
amongst one of the first studies in the UK to have sought the views of providers 
in developing maternal obesity interventions in the community.   
 
Chapter Nine evaluates the pilot study. To the best of my knowledge, this 
describes the pilot study results of the first community-based lifestyle 
intervention for obese pregnant women in the UK. The limitations are mainly to 
do with numbers. The number of potential participants contacted was very small 
and only one-quarter of potentially eligible obese pregnant women was 
recruited to the study. This may raise questions about the external validity of the 
study. According to the MRC framework for evaluating a complex intervention, 
the purpose of a pilot study is to identify problems early and resolve them at an 
early stage before the main trial. Thus, the recommendations included in 
Chapter Nine provide solutions for improving the reach of the study to potential 
eligible patients. This challenge is not unusual when recruiting obese pregnant 
women to interventional studies (271).  
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Together, these shortcomings and my attempts to address them provide 
important lessons with regard to future work and may benefit other researchers.  
 
10.4.3 A summary of lessons learnt from the pilot study 
 
There is a value in doing pilot trials to highlight the important lessons for the 
future and also for other studies. The pilot study described here has provided 
clarity on how to bring about dietary behaviour change in obese pregnant 
women in terms of reduced glycaemic load and energy intake. It has also 
revealed barriers to recruitment which, if I had started the main trial straight 
away, could have resulted in failure in terms of recruitment and cost. The study 
did not measure adherence to the behaviour change advice or collection of 
blood profiles which could have contributed to the knowledge and 
understanding on mechanisms of the lifestyle intervention. The pilot study 
highlighted the need for flexibility of timing of the appointments for participants 
in order to aid recruitment and retention, and this was subsequently 
implemented. It also highlighted the importance of research midwifery time 
dedicated to recruitment, which is likely to improve the number of potential 
participants reached. 
 
Development of the intervention and the pilot in a community setting has 
demonstrated the importance of including ethnically diverse participants, 
particularly from Black and other minority groups, for whom there are very 
scanty data in the literature. 
 
Recent data from the ongoing main trial show that, of the 256 obese women 
recruited into CAN by 31st July 2014, 132 were Black, 78 were White, 4 Asian, 1 
Chinese and 55 Other. Thus, over half of participants in the current 
interventional study are Blacks, which is substantially different from other 
published trials (22). The development and evaluation of the trial has followed 
the MRC framework for developing and evaluating a complex intervention and, 
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importantly, the findings showed that once participants were recruited 
compliance to attendance was good. Almost three-quarters of participants 
attended 5 or more sessions, which is much higher than most previous 
interventions which did not show an  effect on clinical outcomes (67). Lack of 
compliance may be the reason why the published studies did not show a major 
change in terms of outcome.  
 
This pilot study demonstrated the importance of refining the protocol for 
delivery of the intervention, continuing with some aspects, and abandoning 
others in order to improve the delivery in the main trial.  
 
  10.5 Research recommendations from national policy documents 
 
Policy documents from the National Institute for Health and Clinical 
Excellence have highlighted several public health research recommendations 
including:  
 
1. A maternal child and nutrition guideline recommending research on 
dietary interventions which recognise the specific circumstances facing 
mothers from minority ethnic or disadvantaged groups as well as studies 
which provide contextual details (323). The research described in this 
thesis addresses this research gap. 
2. A cardiovascular disease prevention guideline recommending research 
on reducing population consumption of saturated fat including in children 
(324). This study showed that in a population of obese pregnant women 
the CAN intervention may reduce saturated fatty acid intake.  
3. The general obesity guideline stressing that multi-component intervention 
is the treatment of choice. The work from this thesis utilises a multi-
component intervention (325). 
4. The NICE obesity guideline also recommends the need for research into 
the effectiveness of interventions to manage obesity in varied population 
groups, including obese pregnant women, as well as the setting and the 
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source of delivery (326). This research has focused on obese women 
who are pregnant. 
5. A recent Department of Health White Paper on “Healthy Weight, Healthy 
People" recommends the life-course approach to tackling the obesity 
epidemic, starting from pregnancy, through to early life and into 
adulthood. This work has addressed the effect of obesity in pregnancy 
and the feasibility of a community-based intervention at the beginning of 
the life-course (219). 
6. The guideline on weight management before, during and after pregnancy 
has highlighted research gaps in the evidence, such as a lack of well-
designed UK intervention studies on weight management in pregnancy 
and after birth. The findings described in this thesis will contribute to 
addressing this gap. The guideline also stresses limited evidence of the 
effectiveness of weight management interventions in pregnancy and after 
childbirth for women from disadvantaged, low income and minority ethnic 
groups. The work from this thesis addresses this gap.   
  
10.6 Policy implications and research recommendations from this 
research 
 
 Policy makers in obstetrics and maternity care need to focus on obesity 
in pregnancy if they are to address its associated adverse outcomes, such as 
maternal and perinatal mortality and morbidity. Interventions to address the 
adverse outcomes associated with obesity need to be treated as a priority and 
need to be appropriately evaluated using the MRC framework for evaluating 
complex interventions. 
  
 This research suggests that in South East London interventions that 
target Black and ethnic minority groups may have more of an impact because 
the burden of obesity differentially affects these groups and they make up a 
considerable proportion of the population.  
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 Funding bodies need to prioritise funding for evaluating interventions that 
will improve outcomes in the obese population during pregnancy. These 
interventions will need to engage users and providers, including the third sector, 
in order to ensure the seamless translation of the interventions into standard 
practice if shown to be effective. Moreover, interventions that target deprived 
communities are urgently needed to address the inequality associated with 
maternal obesity. 
  
 Studies focusing on nutrition pertinent to specific ethnic groups may be 
needed, so that appropriate education with regard to healthy eating in the 
different ethnic groups can be effectively provided. Studies which focus on 
barriers to healthy eating and improved activity may need to be prioritised. 
Studies that address how cultural barriers, with regard to healthy lifestyle, can 
be addressed are likely to make a difference to the obesity prevalence in 
different ethnic groups. Research should also explore the education of partners 
or other significant persons in the lives of obese women as they may provide 
motivation for a favourable behaviour change for the mother and her family. At a 
time when WHO and world leaders are focusing on non-communicable 
diseases globally (319), with obesity contributing to a significant part of the 
burden, there is no earlier time to start intervention than in utero and pregnancy 
as this may hold the key to trans-generational change. 
  
 Future work should focus on seeking evidence on the effectiveness of 
lifestyle interventions in the pregnant obese woman, particularly in Black and 
ethnic minorities. The ongoing work with CAN will go some way to addressing 
this. Research should also investigate health literacy in pregnancy, particularly 
in the obese population, and we have recently been awarded a grant to explore 
this in detail, particularly in different ethnic groups during pregnancy. 
  
 It is recommended that more studies should focus on lifestyle 
interventions pre-pregnancy. Attached in Appendix C is a proposal to evaluate a 
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lifestyle intervention in the pre-pregnant, overweight and obese group, 
particularly in women with subfertility.  
 
 All of these studies and interventions highlight a future work programme 
which follows on from this work and which would engage users, particularly 
those from Black and ethnic minorities and those from deprived communities, 
ensuring that social inequality associated with obesity is proportionately 
considered and addressed. The cost-effectiveness of these interventions will be 
an essential part of the evaluation if in the future the intervention is to be 
implemented.   
 
10.7 Conclusion 
 
In conclusion, the research described in this thesis has shown that 
pregnant women who are obese are at an increased risk of adverse outcomes 
to themselves and their offspring. The most significant adverse outcome to the 
mother is diabetes and to the offspring is macrosomia. Data from a population 
in South London showed that the effect of obesity on the risk of diabetes was 
most pronounced in Asians. At the population level, eliminating obesity in 
pregnancy could potentially reduce diabetes in pregnancy by almost one-third, 
and slightly more in the Black population because of the high prevalence of 
obesity in this group. From the systematic review and meta-analysis, the 
evidence shows that a dietary and activity lifestyle intervention has a weak 
effect in terms of restricted weight gain but otherwise has no other benefit. The 
pilot study of CAN, a community-based activity and nutrition programme for 
obese pregnant women consisting of eight sessions delivered by health 
trainers, showed that recruitment was difficult but retention was good. Despite 
the small sample size, the intervention resulted in a significant reduction in the 
intake of carbohydrates rich in refined sugar as well as reduced energy intake. 
Measuring change in activity with an accelerometer was difficult as obese 
pregnant women found it uncomfortable to wear them.  
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Having shown the study was feasible, with evidence of a change in 
behaviour in terms of reduced glycaemic load, the trial is continuing to recruit. 
The trial will establish the effectiveness of the intervention in a diverse deprived 
community setting with engagement of the Black population, a group shown in 
this thesis to be disproportionately impacted by obesity in pregnancy. If 
effective, it is hoped the intervention will be adopted into mainstream obstetric 
care for obese pregnant women in this community and elsewhere.  
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EXECUTIVE SUMMARY 
 
 Obesity is increasingly becoming a matter of concern in both the general 
population and in relation to pregnancy, but maternal obesity has received 
limited emphasis compared to adult and childhood obesity. In order to fully 
understand and identify whether unmet health and health care needs exist 
within the maternal obese population of Lambeth (obese pregnant women and 
obese women trying to conceive), a health needs assessment was conducted.  
 
 The borough of Lambeth is densely populated with high levels of 
deprivation. The population is ethnically diverse with 38% of the population 
comprising of Black and Minority Ethnic groups. Although national or local data 
do not exist for the prevalence of maternal obesity, the overall synthetic 
prevalence of adult obesity amongst women in Lambeth is 21% and there are 
estimated to be approximately 14,195 obese women of childbearing age in 
Lambeth. Obesity rates are known to be higher in deprived areas and in certain 
ethnic groups (Black African and Black Caribbean). The prevalence of adult 
obesity in Lambeth is therefore likely to be above the estimated level of 21%. In 
addition, the prevalence of childhood obesity in Lambeth is higher than both the 
London and national average with 13.1% obese in reception year and 25.2% 
obese in year 6. The percentage of obese women trying to conceive and obese 
pregnant women in Lambeth is expected to increase as the current proportion 
of obese children reach childbearing age. Finally, the fertility rate in Lambeth is 
predicted to increase although projected figures on births must be interpreted 
with caution.  
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 The increased obesity levels within women of childbearing age impact 
negatively on the health of both the woman and baby during the pre-conceptual, 
antenatal, and postnatal periods. Pre-conceptually, women are less likely to 
conceive naturally and the effectiveness of infertility treatment is reduced. 
During the antenatal period, obesity has been linked to an increased risk of pre-
eclampsia, gestational diabetes, prolonged gestation, and Caesarean delivery. 
In addition, high maternal weight is associated with an increased risk of 
neonatal mortality. Postnatally, it has been reported that obese women are less 
likely to lactate and thus breastfeed their newborns.   
 
 The current service provision for obese women trying to conceive and 
obese pregnant women in Lambeth is limited and maternal obesity care 
pathways are not in place. Although obese women trying to conceive are being 
identified accurately within the fertility clinic, a high percentage of obese 
pregnant women (36%) are not having their BMI recorded accurately at their 
booking appointment. Furthermore, neither of the population groups receives 
adequate first line healthy eating and physical activity advice, and both groups 
receive either limited or no additional support to assist with weight 
management. In addition, prevention of maternal obesity via the promotion of 
pre-conceptual weight loss for all women of childbearing age is not supported 
across the borough. 
 
 There is some evidence on the effectiveness and cost effectiveness of 
interventions to treat maternal obesity. Extending the literature to include 
interventions that assist with tackling either childhood or adult obesity 
contributed to identifying successful elements that should be included in the 
design of new interventions to treat obese pregnant women and obese women 
trying to conceive. Furthermore, semi-structured interviews with key 
stakeholders (service providers and service users) provided insight into their 
views and recommendations, both of which enhance the evidence base. The 
recommendations focus on expanding existing services and developing new 
services to meet the unmet health needs of obese women trying to conceive 
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and obese pregnant women living in Lambeth. The key recommendations are 
outlined below: 
 
1. Implement pre-conceptual counselling and weight management services 
in primary care to ensure that obese women of childbearing age lose 
weight prior to conceiving. 
2. Develop and implement evidence-based maternal obesity care 
pathways.  
3. Implement protocols to improve the identification of obese pregnant 
women using the BMI measurement at the booking appointment (10-12 
weeks). 
4. Implement protocols to improve the identification of obese women trying 
to conceive in primary care prior to being referred for fertility treatment. 
5. Coordinate training for all relevant health care professionals involved with 
obese pregnant women and obese women trying to conceive to ensure 
that women receive accurate and consistent weight management advice.  
6. Develop and implement two new interventions: one for obese women 
trying to conceive and one for obese pregnant women.  
a. Both interventions should be multi-component to include interactive 
healthy eating, physical activity and behavioural change sessions.  
b. The information and activities provided should be culturally specific 
with particular emphasis on the Black African and Black Caribbean 
women to reduce inequalities between ethnic groups.  
c. The interventions should be group-based and in a community setting 
equitably distributed across the borough.  
d. A health care professional should be involved with the intervention (for 
example, a midwife) but non-health care professionals (for example, 
health trainers) should be recruited and trained to organise and lead 
the sessions. This is more cost-effective and increases the 
sustainability of the intervention. 
e. Robust monitoring and evaluation strategies should be developed 
during the design phase of the interventions to enable continuous 
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improvements to the service to take place and to increase the overall 
evidence base for managing maternal obesity. 
   
 Recent government publications, namely ‘Healthy Weight, Healthy Lives’ 
and the ‘Confidential Enquiry into Maternal and Child Health’ (CEMACH), have 
highlighted the issues associated with obesity in pregnancy, and the national 
recommendations from CEMACH and the National Institute for Health and 
Clinical Excellence guidance (Fertility, Diabetes in Pregnancy, Maternal and 
Child Nutrition, and Antenatal Care) will be incorporated into new national 
public health policies. At the local level, PCTs are expected to commission 
services which meet the recommendations set out in national guidance. The 
recommendations from the national guidance have, therefore, been 
incorporated into this current needs assessment. Finally, whilst specific 
maternal obesity targets do not currently exist, a number of related Public 
Service Agreement targets will benefit from interventions directed at reducing 
the prevalence of maternal obesity, such as reducing the childhood obesity rate, 
increasing breastfeeding initiation rates, and reducing health inequalities to 
tackle infant mortality by optimising maternal nutrition.  
 
The full report can be found at: 
http://www.gsttcharity.org.uk/grants/awarded_results.html 
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Appendix B: Obesity and low BMI in pregnancy  
 
 
Clinical Guidance  
Obesity and Low BMI in Pregnancy 
 
Summary  
Management of women with either high or low BMI in pregnancy. Focusing on 
high BMI, risks to the mother, referral for anaesthetic support, dietary advice, 
investigation for diabetes and hypertension. Ensuring appropriate equipment is 
available.  
 Document Detail  
Document Type  Guidelines  
Document name  Obesity and Low BMI in Pregnancy  
Document location  GTi Clinical Guidance Database  
Version  2.0  
Effective from  2012  
Review date   
Owner  Clinical Lead, Obstetrics and Gynaecology  
Author  Eugene Oteng-Ntim, Consultant Obstetrician and 
Gynaecologist  
Approved by date  Clinical Guidance Group, 2012  
Superseded documents   
Related documents   
Keywords  Obesity, pregnancy, BMI, morbidly obese  
Relevant external law, 
regulation, standards  
 
 
 Change History   
Date  Change details, since approval  Approved by  
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Pregnancy & BMI 
Introduction 1  
 
The prevalence of obesity, defined as a body mass index (BMI) greater than or 
equal to 30kg/m2, is estimated at 25% of the female population in England. 
1.8% of these women can be described as morbidly obese; that is, BMI ≥ 401.  
Body mass index is a tool used to classify whether a person is a healthy weight 
for their height. It is calculated by dividing weight in kilograms by the square of 
the height in metres.  
Body mass index BMI = weight in kg/height in metres²  
Classification of Obesity  
WHO Classification  Popular description  BMI Kg/m2  
Underweight  Thin  <18.5  
Normal range  Normal  18.5-24.9  
Overweight   >25  
Pre-obese  Overweight  25-29.9  
Obese Class I  Obese  30-34.9  
Obese Class II  Moderately Obese  35-39.9  
Obese Class III  Morbidly Obese  >40  
 
Women with a BMI > 30 are at increased risk of pregnancy complications and 
morbidity.  
Risks include:  
Pre-eclampsia
3
  
Thromboembolism
4, 5  
Gestational diabetes  
Failed induction  
Increased risk of instrumental deliveries
6
 and Caesarean section
7
  
Failed spinal/epidural
8
  
Failed intubation
9 
 
Postpartum haemorrhage
10 
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Post-operative infection  
Poor wound healing
3 
 
Increased risk of birth weight > 4 kg
7 
 
Increased perinatal loss  
Increased maternal mortality  
The triennial report by the Confidential Enquiry into Maternal and Child Health 
(CEMACH) “Why Mothers Die 2003-2005”
11
 indicates that 27% of women who 
had a pregnancy-related death were obese. Accurate risk assessment, early 
detection, appropriate referral and ongoing monitoring should minimise the 
preventable risks.  
 
ANTENATAL care for all women:  
BMI should be calculated at booking and documented in the hand-held 
maternity notes.   
There is no need to re-weigh women of normal weight or those who are pre-
obese (BMI between 18.5-30) once their BMI has been calculated from their 
booking weight.  
 
Guidelines for women with a low body mass index (BMI) <18.5 kg/m2  
Women with BMI <18 should be referred to their link consultant for discussion 
and development of an individual plan. The importance of taking a detailed 
history and then serially measuring BMI is to distinguish anorexia (and bulimia) 
from slim body habitus.  
Most of these women will have slim body habitus genetically and will be eating 
and gaining weight normally in pregnancy. So long as they are well and the 
SFH is normal they can be reassured that the pregnancy outcome is likely to be 
normal.  
Pregnant women with past or current eating disorders should be regarded as 
having high-risk pregnancies (Franko et al., 2001). Anorexia is not a temporary 
condition of adolescents, but can be a serious chronic disorder with a significant 
mortality rate. Anorexia is associated with an increased risk of IUGR, 
Caesarean section and postpartum depression.  In extreme cases women may 
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induce vomiting, purge themselves, abuse laxatives and develop electrolyte 
disorders or cardiac failure. Outcomes appear to be worse if women are 
symptomatic of their eating disorder during the pregnancy.  
It is important to enquire carefully whether the patient is currently experiencing 
symptoms. Asking questions about body image, food avoidance, food rules and 
dieting behaviours has effectively distinguished women with eating disorders 
from healthy controls (Franko et al. 2000). Examination findings may include 
excoriation of the hands or lanugo hair.  
Women with a past or current history of anorexia or bulimia (sufficient to be 
under the care of a psychiatrist) should be referred to MAPPIM. Some women 
may be seen by their previous psychiatrist or referred to the eating disorder 
service (at St Georges). MAPPIM should be aware of all women attending a 
previous psychiatrist or eating disorder service even if they do not review 
directly. It is important for the link midwife and consultant to liaise with the GP. 
Postpartum recurrence may be a problem.  
If BMI <18, it is worth monitoring weight monthly to observe normal weight gain 
– but beware that some anorexics resist and avoid weighing and it is important 
to develop a trusting relationship with maternity services.  
 
References  
Franko DL & Spurrell B. Detection and management of eating disorders in 
pregnancy. Am J Obstet Gynaecol 2000;95:942-946  
Franko DL, Blais MA, Becker AE et al. Pregnancy complications and 
neonatal outcomes in women with eating disorders. Am J Psych. 2001; 
158:1461-6  
 
Guidelines for women with a normal body mass index (BMI) 19-25 kg/m2  
Women should have their attention drawn to the usual dietary and exercise 
advice given in the Health Education Pregnancy Book.  
 
Guidelines for women with a pre-obese body mass index (BMI) 25-
30kg/m2  
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Patients should be given the usual dietary and exercise advice from the 
Sensible Eating leaflet/Health Education booklet.  
 
Guidelines for women with a body mass index (BMI) >30kg/m2  
If BMI >30kg/m
2
, these issues should be discussed during the antenatal 
consultation:   
1. What healthy diet is necessary to control sugar in pregnancy and for the 
mother’s long-term health  
2. The importance of 30 minutes’ regular daily activity for the mother’s 
health  
3. Regular attendance for BP and urinalysis  
4. Monitoring fetal movement/changes in fetal movement  
5. Difficulty in assessing fetal growth by palpation  
6. Imaging difficulty at ultrasound scan  
7. The possibility of the need for EFM in labour and possible failure in 
obese women  
8. Risk associated with thrombosis and prophylactic measures  
9. Difficulties associated with insertion of epidural  
 
A referral should be made to the patient’s consultant. Following antenatal 
consultation, an individualised plan of care should be clearly documented in the 
woman’s hand-held maternity notes.  
Where there are concerns regarding the assessment of fetal wellbeing and 
where fetal heart monitoring is not possible an ultrasound assessment should 
be considered.  
For women whose weight is above 150 kg, the HBC manager and senior birth 
centre ODP should be notified by email and a copy of the woman’s care plan 
and EDD should be included. This will ensure that the specialist equipment 
required is made available in a timely manner.  
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Care pathway relating to the three categories of obesity  
INTRAPARTUM CARE  
 Obese Class I BMI  
30-34.9  
Obese Class II BMI 
35.0-39.9  
Obese Class III 
Morbidly obese 
BMI>40.0  
Obstetric  Consultant referral 12 See before 24 weeks  
Anaesthetic   Anaesthetic referral 24-34 weeks  
Diet  Advice re healthy diet. Referral to dietician if woman agrees >35  
Nutritional 
supplements 
1. Advise 5mg folic acid supplementation daily at least one month before 
conception and continuing during first trimester of pregnancy 
2. Advise 10mcg of vitamin D supplementation daily during pregnancy and 
while breastfeeding 
Scans  Detailed anomaly scan 18-20+6 weeks and uterine artery Doppler 
 
Growth and wellbeing scan at 32 weeks for those with BMI greater than or 
equal to 35kg/m2 
Aspirin  Not routine - only if 
other indication  
Commence low-dose aspirin at booking  
GDM  Random blood glucose and HbA1C at booking and at 26 weeks (Refer to 
diabetic screening form)  
PET 
Screening  
BP and urinalysis 
should be assessed as 
per low-risk guideline in 
the absence of other 
risk factors for pre-
eclampsia 13,14 
Blood pressure and urinalysis should be 
assessed every 3 weeks (24-32 weeks 
gestation) and every 2 weeks after 32 weeks 
gestation 13,14  
> 30 weeks   Consultant review 32-34 weeks  Obstetric 
review at 37 weeks to discuss delivery 
Place of birth  Home-from-home only 
if   no other risk factors  
Advise Hospital Birth Centre for safety  
Fetal 
monitoring in 
labour  
Usual  Electronic fetal heart rate monitoring. Consider 
FSE if monitoring difficult  
Iv access  
Iv access on admission where clinician feels it may be difficult to do in 
emergency 
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Antacid  Ranitidine 150mg should be administered 6-hourly throughout labour  
Eating  Usual  Women should not eat in labour. They may 
drink water and isotonic ‘sports drinks’  
Admission  Usual  Inform coordinator, obstetric registrar, 
anaesthetic registrar  
Anaesthetics  Treat as normal  Anaesthetic alert when patient in labour  
Thrombopro-
phylaxis  
Thromboprophylaxis 
risk assessment should 
be carried out as per 
(RCOG green top 
guideline)  
Thromboprophylaxis required for all modes of 
delivery.  
90-130kg = enoxaparin 60mg od 
130-170kg = enoxaparin 80 mg od 
 
INTRAPARTUM CARE 
Each woman should be managed as an individual, considering her expressed 
wishes, her medical/obstetric history and her level of risk for surgery.  
Women with a BMI >35 at booking should be advised to be delivered in the 
Hospital Birth Centre.  
On admission the HBC co-ordinator, obstetric registrar and anaesthetist should 
be informed of all women with BMI of 35 or above. They may wish to inform the 
consultant obstetrician and anaesthetist.  
Electronic fetal monitoring should be recommended for women with a BMI 
>34.915. It may be necessary to use a fetal scalp electrode.  
Maintaining normality during labour minimises the risk of complications3. 
However, there is an increased risk of Caesarean section with increased BMI 
and therefore women with a BMI of >40 should not eat in labour. They may 
drink water and isotonic ‘sports drinks’.  
The Trust’s guidelines relating to moving and handling should be adhered to at 
all times.   
 
The following aids for moving the patient are available: 
1. Patient transfer device – theatre 
2. Sliding sheet  
3. Hoist  
 238 
 
 
Pain relief:  
If an epidural is anticipated insertion is made easier if the woman is able to 
maintain one position during the procedure i.e. before labour becomes 
advanced. Therefore, the catheter may be inserted in early labour. It is 
important to ensure that the epidural is fully effective throughout labour.  
 
Tissue Viability:  
Six-hourly risk assessment for BMI>35 should be carried out using the maternity 
risk assessment scoring system and action should be taken where appropriate. 
Advice may be sought from the tissue viability nurse if required (available by 
bleep via the switchboard). The Trust Tissue Viability guidance should be 
followed.  
 
INDUCTION OF LABOUR:  
Serious consideration should be given to avoiding induction of labour unless 
absolutely necessary. Induction of labour is only recommended when delivery is 
of greater benefit to the woman or baby than if the pregnancy continues.
17
  
Following induction of labour with vaginal prostaglandins (PGE2) fetal wellbeing 
should be established once contractions are detected or reported.
18
 See 
induction of labour guidelines. Consideration should be given to maternal size 
and the effectiveness of methods of monitoring fetal wellbeing.  
Where adequate assessment of fetal wellbeing is not possible and delivery is 
required, Caesarean section should be considered.  
 
Induction in women with BMI of >40   
Consider the following prior to deciding upon induction of labour:  
 Mobility of the woman  
 If immobile, use of TED stockings   
 Follow STH guidelines on thromboprophylaxis.  
 
If induction of labour has been agreed, consideration should be given to the 
following:  
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1. Induction should be arranged for a weekday morning (Mon-Thurs).  
2. The consultant on call should be informed.  
3. The consultant anaesthetist should be informed. The patients will have 
been assessed antenatally by a consultant anaesthetist. The feasibility of 
performing a crash Caesarean section (category 1) will have been 
assessed at this time.    
4. All staff involved in the care provision should be made aware of the 
forward plan and the possibility of Caesarean section should induction of 
labour fail.  
5. The induction of labour guidelines should be followed.
21
  
 
CAESAREAN SECTION for women with BMI >40  
Elective Caesarean section should be for the usual obstetric indications.   
Elective Caesarean section should be scheduled from Monday to Friday.   
The date and time must be agreed following discussion with the consultant 
obstetrician who will be doing the list; a specific care plan should be written and 
the MPL for theatre informed. A senior person (ST3 or above) should do the 
operation.  
 
The mode of anaesthesia should be discussed and decided antenatally. The 
appropriate arrangements should be made for specialist equipment i.e. long 
instruments prior to the procedure to avoid delay or distress to the woman.  
 
Any emergency Caesarean section carries an increased risk of morbidity and 
mortality. Therefore, the most senior person available should perform the 
surgery (i.e. ST 3 or above). At the anaesthetic assessment the feasibility of an 
emergency Caesarean must be considered and documented and the woman 
must be informed if it will be difficult to deliver her baby within 20 minutes (see 
HBC anaesthetic guidelines).  
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POSTPARTUM  
It is recommended that early mobilisation is encouraged and 
thromboprophylaxis is given in line with current guidelines, as the risk of 
thrombosis is increased. All women with BMI >40 require thromboprophylaxis 
regardless of the mode of delivery (enoxaparin 60mg od if 90-130kg, 80 mg od 
if 130-170kg). All women with BMI >30 having a Caesarean section require 
enoxaparin, with the dose depending on their weight (40mg od if < 90kg or 60 
mg od if 90-130kg). There is an increased risk of pressure sores, so they should 
therefore be closely monitored. Where necessary, the opinion of the tissue 
viability nurse should be sought (available by bleep via the switchboard).  
In addition, there is an increased risk of wound infection, so it is imperative that 
all wounds should be observed and advice given regarding care. Medical 
opinions on the ward (or from GP if in the community) should be sought 
immediately if wound infection/breakdown is suspected.  
 
Equipment  
Blood pressure cuffs:  
All clinical areas (including all community clinics) should have access to large 
blood pressure cuffs.  
 
Scales:  
The scales in the hospital antenatal clinic should go up to 180kg.  
All pregnant women should be weighed at booking. If the scales are inadequate 
it is likely that their BMI is >30 and they need to be referred to their link obstetric 
consultant. They can be weighed at this visit (or referred to the hospital if their 
consultant clinic is in the community). If the patient weighs >180kg, discuss with 
the site practitioner how to weigh.  
 
Beds:  
Normal beds can take women weighing <170kgs; the birthing beds can take 
<227kgs. For women weighing >170 kgs contact Huntleigh on *2282 to hire the 
contura1080 which takes up to 450kgs and has integral weighing scales.  
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Theatre Table:  
The theatre tables can take women <220kgs. For a larger theatre table contact 
the main theatres. For other equipment such as armchairs, commode, and 
wheelchairs, these can also be hired from Huntleigh. It is the responsibility of 
the midwifery manager for each area (wards, day unit, clinic and in the 
community) to ensure that suitable equipment is available for women of any 
size. Monthly spot checks will be done.  
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Appendix C: A community-based lifestyle intervention for weight loss in 
overweight and obese women planning pregnancy 
 
 
 
Study Protocol 
 
Scientific Title: A multi-component Community-based Lifestyle Intervention for 
weight loss in overweight and obese women planning pregnancy: CLIO Pre-
Pregnancy Randomised Controlled Trial 
 
Public Title: Community-based Lifestyle Intervention for weight loss in 
overweight and obese women planning pregnancy 
 
Acronym: CLIO 
 
Study Type    Randomised Controlled Trial 
Chief Investigator  Mr Eugene Oteng-Ntim 
Principle Investigators   
Dr Jacqueline E.A.K. Bamfo 
Dr Shree Datta 
Ms Nina Khazaezadeh  
Mr Arri Coomarasamy 
Dr Raj Mitra 
Dr Suzanne Barr  
Professor Pat Doyle 
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Correspondence  Mr Eugene Oteng-Ntim  
    Eugene.Oteng-Ntim@gstt.nhs.uk 
 
Expertise of Applicants 
 
Mr Eugene Oteng-Ntim MB BS PGDip FRCOG – Consultant in Obstetrics and 
Gynaecology at Guy’s and St Thomas’ NHS Foundation Trust. Area of expertise 
is obesity in pregnancy, currently doing a PhD in Obesity and Reproductive 
Health at the London School of Hygiene and Tropical Medicine (LSHTM).  
Coordinator of the project.  
 
Professor Pat Doyle, PhD – Professor of Epidemiology. Area of expertise is 
Reproductive Epidemiology, London School of Hygiene and Tropical Medicine, 
University of London. 
 
Mr Arri Coomarasamy, MD, MRCOG - Consultant in Obstetrics and 
Gynaecology. Area of expertise is Reproductive Medicine and HTA grant holder 
on obesity intervention during pregnancy. Birmingham Women’s Hospital. 
 
Nina Khazaezadeh MSc – Consultant midwife. Area of expertise is Public 
Health and Women’s Health, Guy’s and St Thomas’ NHS Trust. 
 
Dr Raj Mitra – General Practitioner, Lambeth. Member of Lambeth Clinical 
Commissioning Collaborative Board, Honorary Senior Lecturer in General 
Practice, King’s College London. 
 
Dr Jacqueline E. A. K. Bamfo, BSc, MRCOG, DFFP, MD, Diploma in Obstetric 
Ultrasound. Specialty Training Registrar in Obstetrics and Gynaecology, 
University College Hospital. 
 
Dr Shree Datta, MRCOG, Diploma in Leadership and Management, Leadership 
and Management, LLM, Medical Law and Ethics, Co-Chair, Junior Doctors 
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Committee at BMA, Specialist Registrar in Obstetrics and Gynaecology at 
Queen Mary's Hospital, Sidcup. 
 
Suzanne Barr PhD, Lecturer in Nutrition and Reproductive Health, King’s 
College, London. Expertise in Nutrition. 
 
Study Centres: Guy’s and St Thomas' NHS Foundation Trust 
 King’s College Foundation Trust  
 Birmingham Women’s Hospital 
 
Statistics:              The Maternal and Fetal Research Unit  
 Division of Reproductive Health Endocrinology, and 
 Development, KCL 
    Stata (version 7.0; Stata Corp, College Station, Texas) 
 
Laboratory:  The Maternal and Fetal Research Unit  
 Division of Reproductive Health Endocrinology, and  
Development, KCL. 
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Summary and the rationale for the trial 
 
We propose a multicentre randomised controlled trial in overweight and obese 
women which will examine the effectiveness and costs of a six-month structured 
multi-component community-based lifestyle programme for weight loss.  
 
We are asking the following questions: 
 
1. Will dietary intervention based upon reduction of dietary glycaemic load, 
reduced caloric intake, reduced saturated fats and reduced free sugars result in 
weight loss? 
2. What are the changes to dietary and physical activity behaviours from 0-6  
months? 
3. Will the interventions lead to: 
1. A ≥5% weight reduction over 6 months as the primary outcome? 
2. A change in insulin sensitivity using the HOMA model from 0-6 
months?  
3. Improved glucose homeostasis? 
4. Pregnancy rate within 12 months?  
5. A change in wellbeing and depression scores using the short form 36 
version 2 tool? 
4. Will one-to-one counselling or behavioural support increase physical activity, 
improve glucose haemostasis and cause weight loss?  
 
We aim to evaluate the process  and cost-effectiveness of the intervention. 
 
Background 
 
Obesity is a global epidemic and a major public health issue in today’s society.  
It is defined as ‘an accumulation of excess body fat to an extent that may impair 
health’. It is now commonly evaluated as body mass index (BMI, kg/m2). The 
World Health Organisation (WHO) defines a BMI of 18.5–24.9 kg/m2 as normal 
 248 
 
 
weight, BMI of < 18.5 kg/m2 as underweight, BMI of 25–29.9 kg/m2 as 
overweight, and BMI ≥ 30 kg/m2 as obese. A BMI ≥ 40 kg/m2 indicates morbid 
obesity. Obesity can also be classified by the presence of central obesity, as a 
waist circumference ≥ 80 cm for Europid women, with ethnicity-specific values 
(327).   
 
By 2050 the UK could be a mainly obese society (328). The cost of obesity to 
the UK Government was nearly £7 billion in 2002 and could reach £45 billion by 
2050 (328). There is a recognised health inequality associated with obesity, with 
obesity being higher in those of low socioeconomic status. There also  appears 
to be a high prevalence in some groups such as Africian and Black Caribbean 
women. Recent data from the Health Survey for England (HSE) suggests that 
24% of women aged 16-44 years in the UK are obese and 3% are morbidly 
obese (BMI>40) (329). Childhood obesity is becoming an increasing problem. 
Twenty-two percent of UK schoolgirls aged 11-15 had BMI>30kg/m2 in 2003; 
however, this number is predicted to rise to 27% in 2012 (330-332). Childhood 
overweight and obesity prevalence rates of children from manual social classes 
and children from lower income households appears to be increasing more 
rapidly than children from non-manual classes and higher income households, 
respectively (333). 
 
Obesity is related to adverse outcomes during pregnancy. In the recent 2006-
2008 confidential enquiries into maternal deaths, 47% of mothers who died from 
direct deaths were overweight or obese. Furthermore, in cardiac disease, the 
commonest cause of indirect deaths and deaths overall, 60% of those who died 
were overweight or obese (88). Whilst there was a fall in deaths from congenital 
heart lesions, a significant number of deaths were due to sudden adult death 
syndrome (SADS) and myocardial infarction (88). Obese pregnant women are 
at increased risk of pre-term labour, pre-eclampsia, gestational diabetes, 
thromboembolism, operative delivery and postpartum haemorrhage. The 
fetuses are at risk of miscarriage, congenital abnormalities, macrosomia and 
stillbirth (334). Furthermore, excessive weight gain in pregnancy is associated 
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with postpartum maternal overweight, which further compounds long-term 
obesity (335-338).  
 
Inflammation and obesity 
 
Obesity not only leads to cardiovascular disease and diabetes but also affects 
every major organ in the human body (339). It is a component of metabolic 
syndrome, a group of disorders characterised by visceral obesity, insulin 
resistance, dyslipidaemia, and hypertension. The literature suggests that the 
pathogenesis of the cellular and organ damage seen in obesity may instigate a 
complex process involving chronic low-grade inflammation with upregulation of 
proinflammatory cytokines, proatherogenic mediators and prothrombotic cells 
(340). Normal pregnancy is characterised by an increase in the systemic 
inflammatory response (341). Inflammation is common to obesity and 
pregnancy and if its effects are additive, this could possibly increase the risks of 
adverse outcomes.  
 
Obesity and pregnancy  
 
Subfertility and miscarriage 
 
Obesity impacts pregnancy from conception to the pastpartum period. 
Compared with women of normal weight, there is a lower natural and assisted 
conception rate in obese women (342-347). At Guy’s and St Thomas’ 
Foundation Trust, 30% percent of women seeking treatment for infertility were 
either overweight or obese (unpublished). Obesity-related subfertility may be a 
consequence of infrequent ovulation or anovulation, which occurs three times 
as commonly in obese women (348). A common cause of anovulation is 
polycystic ovarian syndrome (PCOS), a condition associated with obesity. 
Obese PCOS women are less likely to conceive compared to lean PCOS 
women (349-350). Miscarriage is frequent in obese women (351-352). Obese 
women have fewer normally fertilised oocytes and lower estradiol levels (351).  
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A study of 1644 obese women compared to 3288 age-matched normal weight 
controls found a higher risk of early miscarriage and recurrent miscarriage in 
obese patients with odds of 1.2 and 3.5, respectively (353).  
 
We have recently conducted a systematic review on the effect of BMI on the 
chance of pregnancy and risk of miscarriage following assisted conception 
treatment (accepted for poster presentation at the British Fertility Society 
meeting in January 2011). The literature search was conducted on MEDLINE 
and EMBASE from 1966-2010. Twenty-two studies, including 22733 patients 
having IVF treatment, were included in our review. Meta-analysis of these 
studies showed that women who were overweight or obese (BMI ≥25 kg/m2, 
n=7072) had significantly lower clinical pregnancy (RR = 0.87, 95% CI: 0.80-
0.94, P = 0.0006)) and live birth rates (RR = 0.81, 95% CI: 0.72-0.92, P = 
0.0006) and a significantly higher miscarriage rate (RR = 1.29, 95% CI: 1.14-
1.45, P<0.0001) compared to women with a normal BMI (18.5-25 kg/m2, n= 
15661), following IVF treatment. A subgroup analysis comparing women who 
had normal weight with women who were overweight (n=4062) revealed lower 
clinical pregnancy (RR=0.91, 95% CI: 0.86-0.96, P=0.0006) and live birth rates 
(RR=0.91, 95% CI: 0.84-0.99, P= 0.02) and higher miscarriage rates (RR= 1.20, 
95% CI: 1.07-1.35, P=0.002) in overweight women. 
 
Fetal congenital anomalies 
 
Maternal obesity increases the risk of fetal congenital abnormalities. These 
include neural tube defects and congenital heart disease (atrial septal defects, 
hypoplastic left heart syndrome, aortic stenosis, pulmonic stenosis, and 
tetralogy of fallot (354-355). Furthermore, a multicentre study has reported that 
maternal obesity doubles the risk of spina bifida, heart defects, anorectal 
atresia, hypospadias, limb reduction defects, diaphragmatic hernia, and 
omphalocele (356). The increased maternal habitus of obesity may limit 
visulisation during ultrasonography and therefore reduce the detection of fetal 
anomalies (357).  
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Adverse obstetric outcomes 
 
The confidential enquiries into maternal deaths and numerous studies have 
clearly shown that maternal mortality and morbidity are high in overweight and 
obese women (88, 154, 358). In addition to acquired heart disease, 
thromboembolism remains a risk for obese women. In the 2003-2005 
confidential enquiries into maternal deaths, 57% of the women who died from 
thromboembolism were obese (359). 
 
The FASTER Trial involving a database of 16,102 patients reported that obesity 
and morbid obesity were associated with increased odds of gestational 
hypertension (odds ratios [ORs] 2.5 and 3.2), preeclampsia (ORs 1.6 and 3.3), 
gestational diabetes (ORs 2.6 and 4.0), birth weight > 4000 g (ORs 1.7 and 1.9) 
and birth weight > 4500 g (ORs 2.0 and 2.4).  In nulliparous women, Caesarean 
section rates for obese and morbidly obese women were 33.8% and 47.4% 
respectively, compared to 20.7% for women with normal weight (360). These 
findings are supported by others (358). Preterm delivery is also increased for 
obese women. One study reported that neonatal mortality in infants born after 
preterm premature rupture of membranes (PROM) was significantly higher if 
infants were born to an overweight or obese mother (adjusted hazard ratios 3.5, 
CI 1.4-8.7, and 5.7, CI 2.2-14.8), respectively (361). Clearly, these adverse 
outcomes will have a huge cost and service provision commitment.  
 
Strong evidence now links obesity to stillbirth.  A recent systematic review and 
meta-analysis involving 96 population-based studies identified obesity as the 
highest-ranking modifiable risk factor for stillbirth. Maternal overweight and 
obesity had PARs (population attributable risk) of 8—18% across five countries. 
Five studies assessed overweight and four studies assessed obesity, revealing 
an increase in the odds of stillbirth of 23% and 60%, respectively. BMI higher 
than 40 kg/m2 doubled the odds of stillbirth (aOR 2·08 [95% CI 1·58–
2·73])(152) (154). 
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Neonatal and childhood complications 
 
Breastfeeding is impaired in obese women. Obesity increases short-term 
neonatal morbidity from hypoglycaemia and metabolic disturbance and 
increases admission to neonatal care (255, 362-363). In the long term, there is 
evidence of a link between health inequality and obesity. A recent retrospective 
cohort study of 8400 children found that among low-income children, maternal 
obesity in early pregnancy doubled the risk of childhood obesity at 2 to 4 years 
of age (364).  
 
Weight management and strategies 
 
Weight gain 
 
Currently, the National Institute for Clinical Excellence recommends that women 
normalise their weight before becoming pregnant. In pregnancy, there is a lack 
of clear recommendations for appropriate weight gain. Here, NICE cites 
recommendations from the American Institute of Medicine (IOM). In 2009, the 
IOM modified their original 1990 recommendations, in light of the increased 
prevalence of obesity. They suggest that healthy American women at BMI of 
18.5 to 24.9 should gain 11.5–16 kg (25–35 pounds) during pregnancy, 
underweight women (BMI less than 18.5) should gain 13-18 Kg (28 to 40 
pounds), and overweight women (BMI of 25 to 29.9) should gain 7– 11.5 kg (15 
to 25 pounds). Obese (BMI greater than 30) women should limit weight gain to 
5–9 kg (11-20 pounds) (365).  
 
Obstetricians need to be informed about what advice to give patients about 
appropriate weight gain (366). The Southampton Women's Survey (SWS), a 
longitudinal survey of 12,583 women living in Southampton, U.K), evaluated the 
gestational weight gain of 948 women, finding that 49% gained more weight in 
pregnancy than that recommended by the 2009 IOM guidance. A recent study 
surveyed 310 women at prenatal clinics in Ontario, Canada. Twenty-eight 
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percent of women recalled being informed about recommended weight gain and 
only 12.0% of the women achieved the recommended weight gain according to 
the IOM guidelines. Only one in four women recalled being told about the risks 
of excessive weight gain (367).  
 
Strategies 
 
The purpose of preventive medicine is to undertake measures to prevent 
disease. Historically, it is an effective method of health care and is potentially 
cost-effective. In the UK, NICE fertility guidelines published in 2004 
recommended that 'Women with BMI ≥30 are likely to take longer to conceive 
and those in this group who are anovulatory should be advised that losing 
weight is likely to increase their chance of conceiving'. The evidence for this is 
level 2b, being based on small studies; therefore, randomised trials are 
recommended (206-208). In infertile women, lifestyle intervention could improve 
spontaneous conception rates and prevent unnecessary fertility treatment as 
well as obstetric complications (368). Guidelines from NICE and the RCOG 
study group on Obesity and Reproductive Health  recommend  'investment into 
weight reduction programmes before providing fertility treatment' (206). A 
combined position document from the American Dietetic Association and the 
American Society of Nutrition (2009) supports the importance of nutrition and 
activity intervention prior to pregnancy, whether the planned pregnancy is 
natural or through assisted conception (209).   
 
Observational and small interventional studies show that modest weight loss is 
associated with restoration of ovulation in anovulatory women and improves the 
chances of pregnancy. Weight loss can be achieved through lifestyle 
intervention incorporating the combination of a healthy low caloric intake, low 
glycaemic index diet, increased physical activity and behavioural modification 
(210). Weight loss has been advised for the improvement of reproductive 
function in overweight women, specifically those suffering from polycystic 
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ovarian syndrome (PCOS) (369). However, the evidence of the effectiveness of 
lifestyle  weight reduction intervention is still limited.  
  
Few studies have evaluated pregnancy outcomes after weight loss pre-
pregnancy. A population-based, retrospective cohort analysis of data between 
1978 and 2005 evaluated the effects of pre-pregnancy changes in BMI between 
successive pregnancies on the risk of preterm birth. Compared with women 
who maintained normal inter-pregnancy BMI, women with BMI changes from 
normal weight to obese (OR 1.4, 95% CI 1.2 to 1.6) and normal weight to 
overweight (OR 1.2, 95% CI 1.1 to 1.3) were at increased risk of medically 
indicated preterm birth (211). Inter-pregnancy weight gain was associated with 
a dose-response increase in the risk of gestational and type 2 diabetes. Women 
moving from normal pre-pregnancy weight in the first pregnancy to obese pre-
pregnancy weight in the second pregnancy tripled their risk of developing 
diabetes. However, mothers who maintained their inter-pregnancy BMI weight 
category or who moved to a lower BMI category had reduced risk for gestational 
and type 2 diabetes (212). Inter-pregnancy weight gain of more than 10 lb in 
women with a history of gestational diabetes almost doubles the risk of 
Caesarean section in a future pregnancy (370). 
 
In a large nationwide Swedish study of 151 025 women, Vilamor et al. studied 
the association between inter-pregnancy BMI change from the first to the 
second pregnancies, and the risk of adverse outcomes. Compared with women 
whose BMI changed between -1.0 and 0.9 units, the odds for adverse outcomes 
for those who gained 3 or more units over two years were approximately 
doubled and were: pre-eclampsia, 1.78 (95% CI=1.52-2.08); gestational 
hypertension 1.76 (1.39-2.23); gestational diabetes 2.09 (1.68-2.61); Caesarean 
delivery 1.32 (1.22-1.44); stillbirth 1.63 (1.20-2.21); and large for gestational age 
birth 1.87 (1.72-2.04). The authors concluded that even a moderate increase in 
BMI could significantly increase poor pregnancy outcomes (213).  
 
These studies strongly suggest weight control between pregnancies and pre-
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pregnancy would be beneficial for reducing adverse outcomes and that this 
would even out the health disparities. Weight loss after pregnancy will improve 
the long-term health of the mother and the infant and reduce the impact of 
obesity-related complications on public health and health provision services.  
 
Currently, there is little in the literature to guide the best method of weight loss, 
either pre-pregnancy or in pregnancy. A Cochrane review of six trials involving 
245 women after childbirth found that dieting and exercise together were more 
effective than diet alone in achieving weight loss. There was insufficient 
evidence to comment about breastfeeding women (371). Careful nutritional 
monitoring in obese women during pregnancy has not been found to have 
deleterious effects (263).  
 
There have been few randomised trials evaluating weight loss pre-pregnancy 
and during pregnancy. The LIFESTYLE study is a randomised trial in the 
Netherlands for overweight and obese subfertile women, which will compare a 
six-month structured weight loss lifestyle programme followed by conventional 
fertility care (intervention group) to conventional fertility care only (control 
group). The delivery of a healthy term singleton beyond 37 weeks gestation, 
pregnancy complications, the need for fertility treatment and cost analysis will 
be the outcome measures (372). There is an ongoing pregnancy intervention 
trial in the UK. The UK Pregnancies Better Eating and Activity Trial (UPBEAT) 
trial aims to develop an intervention based on diet and physical activity to 
reduce adverse pregnancy outcomes in obese pregnant women and also 
improve maternal glucose sensitivity during pregnancy (373).  
 
There is a need for studies in the UK and internationally to evaluate the best 
interventions that address obesity pre-pregnancy and during pregnancy. Health 
disparity may exacerbate the problems of obesity, and this provides an added 
incentive for reducing the prevalence of obesity. The obstetric unit at St 
Thomas’ Hospital is a tertiary referral centre for South East England; it also 
serves the boroughs of Southwark and Lambeth. The community of Lambeth 
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includes areas of high deprivation, with 16 out of its 21 wards in the most 
deprived areas in England (374). The population is ethnically diverse with a high 
percentage of Black African and Black Caribbean people. In 2008 
approximately 62% of the Lambeth populations were White and 38% were from 
Black and Minority Ethnic communities (GLA 2005 Round Interim Ethnic Group 
Projections). In future, these proportions are predicted to remain stationary. By 
2008, the overall synthetic prevalence of adult obesity amongst women in 
Lambeth was 21% and there were an estimated 14,195 obese women of 
childbearing age. In view of the increasing rates of obesity, the prevalence of 
adult obesity is likely to be well above this by now (375). Notably, the 
prevalence of obesity in women is currently greatest in the Black Caribbean and 
Black African populations and lowest in the Chinese (376). In the 2008 
confidential enquiries into maternal deaths, 42% of direct maternal deaths and 
24% of indirect deaths were in women of Black and Minority Ethnic groups (88). 
Whilst there were multiple factors involved in the cases, this still highlights that 
women in these communities have increased risks of adverse outcomes. 
 
A study of the Maternity and Gynaecology database at Guy’s and St Thomas’ 
Hospital NHS Trust (GSTT) in 2005 (377) evaluated the effects of pre-
pregnancy BMI on obstetric outcomes. Obesity was not only an independent 
risk factor for adverse obstetric outcomes and Caesarean delivery, but a cost 
analysis also revealed that for every woman requiring a Caesarean delivery 
instead of a normal delivery there was an additional cost of £1,693. Prevention 
of obesity will reduce poor obstetric outcomes, positively impact health 
inequality and reduce costs to the health system. Reducing maternal obesity in 
these groups can only have added benefit.  
  
Hypothesis 
 
In this proposal, we hypothesise that combined intervention with dietary and 
physical advice combined with behavioural support will alter dietary and 
exercise behaviour in overweight and obese women, which will result in weight 
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reduction of at least 5% in 6 months and have a positive impact on glucose 
tolerance and wellbeing in 6 months as well as pregnancy rates over one year. 
We propose a multicentre randomised controlled trial to test this hypothesis. 
 
We will examine the effectiveness and costs of a six-month structured multi-
component lifestyle programme for weight loss and improvements in pregnancy. 
The dietary intervention to be used in this study is based upon reduction of 
dietary glycaemic load, reduced caloric intake and reduced saturated fats and 
reduced free sugars. Restriction of dietary ‘non-milk extrinsic sugars’, especially 
sugar rich beverages, will not only reduce calorific intake but also improve 
insulin sensitivity, particularly since the consumption of these beverages is so 
high amongst women living in the UK (378). Lowering dietary saturated fatty 
acids will have similar effects and increased consumption of fibre-rich foods or 
complex carbohydrates will also reduce insulin resistance (379-381); the 
intervention will also include recommendations for greater physical activity 
which will promote weight loss and also improve glucose homeostasis.34 One-
to-one counselling will be included as this form of behavioural support increases 
physical activity and is effective in improving glucose haemostasis and weight 
loss (210, 382-383). We shall also offer group counselling which can play an 
important role in a model of combined diet and physical activity intervention 
(384-386). 
 
Study design 
 
The aims of this research are to: 
i. Implement a low glycaemic index dietary intervention alongside 
increased physical activity for delivery to obese women attending 
subfertility services.  
ii. Assess patient acceptability to the intervention. 
iii. Evaluate changes to dietary and physical activity behaviours from 0-6 
months. 
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iv. Evaluate the effectiveness of the intervention using the following 
outcome measures: 
a. ≥5% weight reduction over 6 months as the primary outcome 
b. A change in insulin sensitivity using the HOMA model from 0-6 
months  
c. Pregnancy rate within 12 months with or without fertility treatment 
d. A change in wellbeing and depression scores using the short form 
36 version 2 tool  
e. Process evaluation 
v. Evaluate the cost effectiveness of the intervention 
 
Population 
 
Women will be recruited through General Practitioners or from among women 
attending pre-pregnancy planning clinics or gynaecology clinics in the 
catchment area of Guy’s and St Thomas' NHS Foundation Trust, King’s College 
Foundation Trust and Birmingham Women’s Hospital. The study population will 
be women who are overweight and obese, defined according to the WHO 
criteria.  
 
Ethics 
 
Securing all necessary ethical review and regulatory approvals is planned in the 
pre-recruitment phase over a period of at least three months through the Local 
Research Ethics Committees.  
 
With at least 100 women in the active treatment arm, we will be able to estimate 
the likely rate of compliance to within 10% of the true value with 95% 
confidence. With regard to pregnancy, this study will have 90% power to detect 
a trebling in the proportion of women becoming pregnant in the 12-month 
follow-up period, estimated to be around 10% in the control arm. We will include 
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pregnancies resulting from both natural and assisted conception, but will stratify 
the data by type of conception.   
 
Inclusion criteria: Women aged 18-40 years, BMI>/=30kg/m2, healthy women, 
normotensive women (BP<140/90 mmHg), premenopausal. 
 
Exclusion criteria: Contraindications to dietary intervention or exercise, obese 
women with other indicators of infertility (e.g. tubal disease or male factor 
infertility, azoospermia). Medical co-morbidity such as hypercholesterolemia, 
diabetes, hypertension, stroke or myocardial infarction, systemic lupus 
erythematosus, chronic infectious disease or overt psychiatric condition. 
Endocrine disorders such as thyroid dysfunction or hyperprolactinaemia. 
Medication use or substance misuse. History of bariatric surgery. 
 
Data Collection and Analysis 
 
The study will have three phases; the first two are for data collection and the 
last is for analysis and writing-up (Figure 1). 
 
PHASE ONE 
 
Months 1 to 6. The first 3 months will consist of preliminary work. The objective 
of this phase is to assess the appropriateness and acceptability of the 
intervention in a target group to inform the content and delivery of the 
intervention. During this period the study will be set up, and semi-structured 
qualitative interviews will be conducted with 10 obese volunteers from the 
clinics to assess the acceptability of the proposed intervention (see below). 
Interviews will explore obese women's beliefs about diet and activity while trying 
to conceive. 
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A Standard Operation Procedure Manual, Patient Information Leaflet and 
training packages to support the intervention delivery will be developed and 
modified if required and piloted during Phase One. 
 
PHASE TWO 
 
Months 7 to 31. The objective of this phase is to trial a combined diet and 
activity intervention using established behaviour-changing principles. 
Randomisation will start in month 7 and continue to month 16, depending on the 
rate of accrual. Follow-up (at 6 and 12 months following recruitment) will be 
completed between months 23 and 31.  
 
(i) Recruitment and randomisation 
The study will recruit obese women attending these clinics (see later section on 
sample size and power). We will also recruit women who are planning 
pregnancy from GP surgeries, gynaecology clinics and fertility clinics. We 
estimate that 40 new patients per month with anovulatory or unexplained 
infertility, and who are obese, will be seen. All new patients fulfilling these 
inclusion criteria will be approached by the nursing sister in charge of the clinic, 
and given an information leaflet about the study. An opt-in approach will be 
taken, and the patient will be contacted the next day by the research nurse via 
telephone and recruited into the study if consent is given and if eligibility is 
confirmed. All essential information (age, address, postcode, ethnicity, cigarette 
smoking, GP address) including weight and height and BMI will be recorded on 
the study database (web-based). 
 
Once consent is given, intervention will be allocated using a randomisation 
procedure incorporated within the online database to balance treatment groups 
by ethnicity (ONS categories: Black, Caucasian, Asian, Other), BMI group (30-
35kg/m2, 36-40, greater than 40) and age (18-25, 26-30, 31-35, 36-40). The 
computer software will inform the health trainer of the next study number and 
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allocation. The research nurse will arrange appropriate visits and training 
sessions. 
 
(ii) The intervention 
We will use an integrated diet and activity behaviour-change intervention which 
will be delivered over three months followed by a nine-month follow-up period 
(Figure 1). The intervention will be delivered using a combination of one-to-one 
(six one-to-one sessions, every other week) and group-based activities (six 
sessions fortnightly, as well as telephone contacts, SMS text message, e-mail 
and web-based support provided in a structured and systematic way. Dietary 
advice will focus on 1) reduction of dietary glycaemic index (GI), 2) reduction of 
saturated fat and 3) restriction on added sugars. In addition, the diet will be 
designed as reduced-energy (caloric restricted diet). No speciﬁc energy 
restriction will be prescribed; however, guided information on reduction in 
portion sizes will be provided with the aim of leading to weight loss. All dietary 
advice will be given in the context of Department of Health dietary 
recommendations. 
 
Restriction of added sugars, especially sugar-sweetened beverages, will reduce 
calorific intake as consumption is high amongst UK women (386). The 
glycaemic index classifies carbohydrate-containing foods based on their 
potential to raise blood glucose. The Cochrane review, which investigated the 
use of low GI diets on weight management, concluded that mean reduction in 
weight was significantly greater in participants receiving low GI diets compared 
to control diets (standard low fat diet) (387). This is confirmed in a recent 
controlled trial in subfertile women (with PCOS) comparing a low-GI energy 
restricted diet or a conventional energy restricted diet (387). Both diets resulted 
in weight loss; however, insulin sensitivity and menstrual cyclicity improved to a 
greater extent following the low GI diet compared to the conventional diet. 
Reduction of dietary GI will be provided in the context of exchanging high GI 
foods and drinks for low GI alternatives. Examples include using granary bread 
or basmati rice in place of white bread or white rice, new potatoes in place of 
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old potatoes (due to amylose: amylopectin ratio), and recommending low 
glycaemic index breakfast cereals rather than high. Reduction of added sugars 
will be achieved both in the context of low glycaemic index and by the exchange 
of sugar-sweetened beverages for non-sugar containing varieties (386). A 
reduction in dietary saturated fats will be acheived by instructing participants to 
reduce consumption of foods with high saturated fat content and partially 
replacing these with unsaturated fats sources, leading to a reduced total fat 
intake and concurrently reduced energy intake. Lowering dietary saturated fatty 
acids has also been shown to improve insulin sensitivity (388). 
 
Dietary compliance will be monitored by a registered dietitian using 24-hour 
dietary recalls at three timepoints on six occasions (two pre-intervention, two 
post-intervention and two halfway through the intervention phase, one week 
apart) and by the use of a validated food frequency questionnaire at three 
timepoints. Levels of under-reporting will be calculated. Energy, nutrient and GI 
data will be assessed using dietary analysis software (WISP version 3.0 
(Tinuviel software)) to provide percentage and absolute (kilocalorie/ gram/ 
miligram) energy and nutrient intakes. This will include, for example, dietary 
intake of folate and other nutrients relevant to pre-conception. The researcher 
will be blinded to the arm of the study in which the participant is enrolled. 
Activity advice will be targeted towards increasing total activity levels and 
reducing time spent in sedentary activities. Advice will be individualised and 
tailored to participants’ interests and lifestyle and delivered by a trained health 
facilitator in a community health/leisure centre setting. It is anticipated that 
walking, in particular, and swimming will be the preferred activities but 
strategies will also include discussion of how activity can be incorporated into 
routine lifestyle such as at work and at home. The activity intervention will aim 
to achieve 30 minutes’ moderate intense activity on at least 5 days per week. 
This is similar to strategies used in other studies and in line with general 
population guidance (389). They will be given individualised tailored guidance 
and support to achieve increases in activity and encouraged to set goals. 
Monitoring will be addressed through accelerometry and self-reporting. 
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The most practical and widely used form of objective activity measure is the 
accelerometer, a motion sensor worn over several days. Accelerometers have 
been used extensively to objectively measure activity levels in diverse free-
living settings. Accelerometry has a high degree of validity for quantifying 
activity duration and intensity, but only moderate correlation with total energy 
expenditure (390).   
 
(iii) Care in the control group 
Patients allocated to the non-intervention group will have routine existing care 
which consists of referral by the fertility specialist to a hospital-based dietician 
for diet and healthy lifestyle advice. 
(iv) Follow-up and outcome measurement (see later). 
 
Biomarkers of metabolic syndrome 
 
Blood will be sampled through randomisation, three months and six months 
after the intervention in both arms. Insulin sensitivity will be determined using 
the HOMA model from and fasting blood glucose and insulin. Markers of 
metabolic syndrome such as C-reactive protein, lipid levels, blood pressure, 
waist circumference and blood pressure will be assessed. 
 
PHASE THREE 
 
Months 32 to 35. The objective of this phase of the study is to complete data 
entry, data checking and analysis. 
 
(i) Data management  
All data will be entered onto dedicated study databases shortly after being 
obtained and will be checked for consistency and accuracy at regular intervals. 
A member of the research team will be responsible for making back-up copies 
of the database and ensuring confidentiality of access and storage of both 
electronic and paper information. 
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(ii) Analysis 
The main analysis will compare proportions of women with the outcomes of 
interest in the intervention and the control arms of the study. For example, the 
proportions of women in the two arms of the study who achieved a 5% 
reduction in weight 6 months following randomisation will be compared. 
Appropriate adjustments for confounding will be made using multiple 
regression. Similar analysis will include comparisons of the proportions of 
women achieving a pregnancy within 12 months of follow-up, and the proportion 
of women with improved glycaemic control, changes in activity and dietary 
habits and measures of improved wellbeing 6 months after recruitment. All 
analysis will be conducted using STATA.  
 
Outcomes 
 
a. The primary RCT outcome will be a 5% reduction in weight 6 months 
following randomisation to the intervention arm. Weight change will be 
assessed in study-specific visits to the research nurse at recruitment and 
every two weeks (at group sessions). In the control group, women’s weight 
will be measured at recruitment and at 6 months. 
b. The secondary RCT outcome will be a change in insulin sensitivity using the 
HOMA model from 0-6 months. Fasting blood glucose and insulin will be 
evaluated through randomisation, three months and six months after the 
intervention in both arms, including markers of metabolic syndrome. 
c. Evaluation of the intervention acceptability and fidelity of delivery: the 
success, accessibility and acceptability of the intervention delivery and 
compliance with the protocol of the intervention will be assessed by 
monitoring attendance at contact points and via telephone calls. Semi-
structured qualitative interviews will be conducted for the proposed sample 
of around 20 in the intervention group and 10 in the control group to obtain 
feedback regarding interviews, aiming to explore the women’s views, their 
understanding of the advice provided in both arms of the trial, and their 
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experience of the implementation. Data will be taped and transcribed and 
analysed using framework analysis using Nvivo CAQDAS package.  
d. Progesterone: At day 21 post-menstruation plasma progesterone will be 
measured as part of routine clinical care prior to the intervention and six 
months through randomisation in all women.  
e.  All pregnancies based on first trimester ultra-sound and fertility treatments 
occurring in the year following randomisation will be recorded for all women. 
Data will be obtained via telephone interview and transcription from clinic 
records. Term live birth rate and adverse pregnancy outcomes will be 
evaluated. 
f. Wellbeing will be assessed prior to randomisation and 6 months after the 
intervention in all women using the SF36 health status measure. A change 
in wellbeing and depression scores using the short form 36 version 2 tool 
will be evaluated. 
g. An estimate of health care costs (delivery of the intervention only) will be 
evaluated. The whole process and cost-effectiveness of the intervention will 
be evaluated.  
 
Budget and justification 
 
The total requested budget is £486,699.83. A detailed description of the budget 
is outlined in Appendix 3. 
 
Research nurses are required to identify, recruit and follow up eligible women 
for the study. Due to the pressure of services provision, clinic nurses cannot 
fulfil these roles. The clinics run on different days for the 2 London-based 
centres; hence, the research nurse will work at both units. A full-time salary is 
requested for the two research nurses. Two health trainers are required to 
deliver the intervention in Phase Two. A nutritionist and research assistant with 
nutritional background will be employed on a part-time basis to analyse the 
dietary and physical activity questionnaires. Statistical support is requested at 
the onset of the study (Phase 1) for writing the data analysis plan, and in the 
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final stage to work with the nutritionist and physical activity assistants, and to 
undertake the final analyses. All samples will be analysed; therefore, technical 
assistance is requested for the final stages of the study. Database design and 
maintenance cost is requested as well as costs for consumables. 
 
The findings of this trial will provide an evidence-based intervention to facilitate 
weight loss in obese women, which we believe is likely to be generalisable, at 
least to urban populations in the UK and other countries. This will benefit the 
NHS because not only will it improve the women's health, but it will also  
improve their fertility, particularly for those with obesity-related anovulatory cycle 
infertility. This will avoid assisted reproductive techniques, which can cost the 
NHS large amounts of money with their associated risk of multiple pregnancy 
and preterm delivery and the need for neonatal special care cots. Those who 
become pregnant with a reduced BMI as a result of the intervention will benefit 
from reduced risk of miscarriage, gestational diabetes, pre-eclampsia, 
macrosomia, shoulder dystocia and difficult deliveries, Caesarean section, and 
long hosptial stays. For the babies born, a reduced risk of  macrosomia and 
associated insulin resistance implies a lower probability of obesity in childhood, 
and in turn, in adult life. A reduction in this transgenerational obesity risk has 
profound implications for improvements in health, and reduced costs to the NHS 
of obesity-related morbidity.  
 
Supporting this trial, which has incorporated a detailed user and stakeholder 
consultation, could ensure a feasible, effective, multi-component community-
based intervention to address obesity in women of reproductive age. 
 
Sample size and power calculation 
 
This study is powered to be sufficient to detect a statistically significant 
difference in the proportion of women who achieve a 5% reduction in weight in 
the intervention arm, compared to the control arm, after 6 months’ follow-up. 
The rationale for using a 5% weight reduction is that this has been shown to 
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improve fertility (44, 208, 369, 380). Gadde et al. assessed the efficacy and 
safety of two doses of phentermine plus topiramate controlled-release 
combination as an adjunct to diet and lifestyle modification for weight loss and 
metabolic risk reduction in individuals who were overweight and obese, with two 
or more risk factors. Twenty-one percent of subjects randomised to placebo 
achieved at least a 5% weight loss. Rates in the active arm were 62% and 70%, 
depending on the dose of phentermine (391). We believe similar rates can be 
achieved by a lifestyle intervention (392). We therefore set out to achieve at 
least a doubling of the rate of 5% weight loss in the active arm (21% compared 
to 42%). Complete data on 111 women in each arm would give 90% power to 
detect such an effect at the 5% significance level. Eleven women per arm are 
needed. To allow for a maximum 20% loss to follow-up, we will recruit 278 in 
total (139 in each arm). This is fewer than we hope to achieve, but represents 
an estimated minimum clinically important difference. 
 
Timetable of the Project (Gantt chart) 
 
The detailed timetable is outlined in Appendix 2. 
  
Phase 1:  0 - 6months. 
 
Preliminary and pilot phase. To determine the best approach and delivery for 
the proposed intervention. To develop and standardise the content and delivery 
method and assess the feasibility and acceptability to obese women and 
providers with a view to optimising the intervention for use in Phase 2. 
 
Phase 2:  7-31 months.  
 
RCT of overweight and  obese women  
 
Phase 3:  32-35 months. Analysis and report writing. 
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With at least 100 women in the active treatment arm, we will be able to estimate 
the likely rate of compliance to within 10% of the true value with 95% 
confidence. With regard to pregnancy, this study will have 90% power to detect 
a trebling in the proportion of women becoming pregnant in the 12-month 
follow-up period, estimated to be around 10% in the control arm. We will include 
pregnancies resulting from both natural and assisted conception, but will stratify 
the data by type of conception.   
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Women identified as 
eligible for study  
by checking clinical lists 
and local referral systems  
 
Assess eligibility, verbal 
explanation & PIS 
 
Declines participation Accepts participation 
Informed consent obtained 
baseline data collected 
(weight, glucose and insulin) 
 
No further contact 
 
Randomised  
 
Routine care 
Individualised dietary and 
physical activity regime  
(0 – 24 weeks). First twelve 
shown here. Weight (kg) 
recorded fortnightly 
 
Non-intervention 
 (0-6 months) 
Intervention  
(0-6 months) 
Individual (face to face or telephone) 
session. Additional SMS text message/ 
e-mail or web-based support (week 1) 
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U 
P 
P 
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R 
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S
E
S
S
I
O
N
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Group session (wk 0) 
Outcome data (week 26-31) 
Group session (wk 4) 
) 
Group session (wk 6) 
) 
Group session (wk 8) 
) 
Group session (wk 10) 
) 
Group session (wk 12) 
) 
Individual (face to face or telephone) 
session. Additional SMS text message/ e-
mail or web-based support (week 3) 
Individual (face to face or telephone) 
session. Additional SMS text message/ e-
mail or web-based support (week 5) 
Individual (face to face or telephone) 
session. Additional SMS text message/ e-
mail or web-based support (week 7) 
Individual (face to face or telephone) 
session. Additional SMS text message/ e-
mail or web-based support (week 9) 
Group session (wk 2) 
) 
Individual (face to face or telephone) 
session. Additional SMS text message/ e-
mail or web-based support (week 11) 
Glucose and 
insulin, and 
dietary data 
collected at 3 
months. 
 
 
Figure 1: Protocol Timeline 
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Appendix D: Lambeth Early Action Partnership 
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Appendix E: Search Strategy 
 
Box 1 Search strategy 
1. *pregnancy/ 
2. pregnan$.ti,ab. 
3. matern$.ti,ab. 
4. gravid$.ti,ab. 
5. mother.ti,ab. 
6. parent.ti,ab. 
7. or/1–5 
8. or/1–6 
9. *obesity/ or *obesity, morbid/ 
10. obes$.ti,ab. 
11. *Weight Gain/ph [Physiology] 
12. (overweight or over weight or weight gain).ti,ab. 
13. (bmi or body mass index).ti,ab. 
14. or/9–13 
15. (cohort or observation$ or prospective or 
longitudinal).ti,ab. 
16. 7 and 14 
17. 8 and 14 
18. 16 and 15 
19. 17 and 15 
20. animal/ 
21. humans/ 
22. 20 not (20 and 21) 
23. 18 not 22 
24. 19 not 22 
25. fertil$.ti,ab. 
misc 
hypertension 
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pre-eclampsia 
diabetes 
thromboembolism 
caesarean section 
postpartum haemorrhage 
anaesthetics 
H1N1 
Intensive care admission 
28. or/25–27 
29. 23 not 28 
30. 24 not 28 
31. limit 29 to english language 
32. limit 30 to english language 
33. limit 31 to year = 1990–2013 
34. limit 32 to year = 1990–2013 
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Appendix F: A complex intervention to improve pregnancy outcomes in 
obese women; the UPBEAT randomised controlled trial 
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Appendix G: CAN Participant Manual  
 
Details of the CAN intervention programme participant manual are attached to 
this electronic thesis submission.  
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Appendix H: Figure showing the prevalence of obesity (BMI≥30 kg/m2) 
among adult women (WHO) 2008 
 
Figure 1:  
 
 
 
 - Above 40% obese    - 30-40%         - 20-30%         - 10-20%    - <10% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alaska    
 Alaska    
USA 
 
USA 
Egypt 
 
Egypt 
Gulf State 
Gulf State 
United Kingdom 
United Kingdom 
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Appendix I: Table of background characteristics of the mothers by year of 
delivery 
 
BMI category Year 
2004 
N(%) 
Year 
2005 
N(%) 
Year 
2006 
N(%) 
Year 
2007 
N(%) 
Year 
2008 
N(%) 
Year 
2009 
N(%) 
Year 
2010 
N(%) 
Year 
2011 
N(%) 
Year 
2012 
N(%) 
Total 
 
N(%) 
<18.5 N  
% 
113  
3.1 
159 
3.8 
188 
4.1 
160 
3.5 
175 
3.3 
 153 
2.8 
171 
2.8 
204 
3.3 
107 
3.4 
1430 
3.3 
18.5-24.9  2082 
56.6 
2392 
57.3 
2630 
57.4 
2642 
57.8 
3083 
57.5 
3214 
58.2 
3527 
58.2 
3438 
56.0 
1735 
54.7 
24743 
57.2 
25-29.9 919 
25.0 
1026 
24.6 
1126 
24.6 
1096 
24.0 
1331 
24.8 
1349 
24.4 
1499 
24.7 
1525 
24.8 
776 
24.5 
10647 
24.6 
30-34.9 359 
9.8 
381 
 9.1 
408 
8.9 
449 
9.8 
523 
9.8 
522 
9.5 
579 
9.5 
650 
10.6 
368 
11.6 
4239 
9.8 
35-39.9 151 
4.0 
153  
3.5 
148 
3.2 
164 
3.6 
164 
3.1 
189 
3.4 
193 
3.2 
214 
3.5 
122 
3.9 
1498 
3.5 
>40 57       
1.5 
61    
 1.4 
79  
1.7 
58  
1.3 
86  
1.6 
94 
1.7 
94 
1.6 
104 
1.7 
59 
1.9 
692 
1.6 
Obese 
category 
567 
15.4 
595 
14.3 
635 
13.9 
671 
14.7 
773 
14.4 
805  
14.6 
866 
14.3 
968 
15.8 
549 
17.3 
6429 
14.9 
Total Non-
missing 
3681 
 
4172 
 
4579 4569 5362 5521 6063 6135 3167 43249 
Missing 1856 
33.5 
1654 
28.4 
1583 
25.7 
1619 
26.2 
1456  
21.4 
902 
14 
699 
10.3 
581 
8.7 
318 
9.1 
10668 
19.8 
Total 5537 
100 
5826 
100 
6162 
100 
6188 
100 
6818  
100 
6423 
100 
6762 
100 
6716 
100 
3485 
100 
53917 
100 
Maternal age Year 
2004 
Year 
2005 
Year 
2006 
Year 
2007 
Year 
2008 
Year 
2009 
Year 
2010 
Year 
2011 
Year 
2012 
Total 
<20 N 
% 
275 
5.0 
285 
4.9 
270 
4.4 
277 
4.5 
278 
4.1 
223 
3.5 
190 
2.8 
163 
2.4 
81 
2.3 
2042 
3.8 
20-24 N 
% 
821 
14.8 
868 
14.9 
911 
14.8 
863 
14 
950 
13.9 
824 
12.9 
849 
12.6 
788 
11.7 
382 
10 
7260 
13.5 
25-29 N 
% 
1300 
23.5 
1381 
23.7 
1420 
23 
1433 
23.2 
1553 
22.8 
1454 
22.6 
1423 
21 
1494 
22.2 
792 
22.7 
12250 
22.7 
30-34 N 
% 
1742 
31.5 
1810 
31.1 
1919 
31 
1981 
32 
2225 
32.6 
2149 
33.5 
2355 
34.8 
2313 
34.4 
1201 
34.5 
17695 
32.8 
35-39 N 
% 
1131 
20.4 
1173 
20.1 
1280 
20.8 
1314 
21.2 
1440 
21.1 
1434 
22.3 
1525 
22.6 
1520 
22.6 
773 
22.2 
11590 
21.5 
>40 N 
% 
268 
4.8 
309 
5.3 
362 
5.9 
320 
5.2 
372 
5.5 
335 
5.2 
420 
6.2 
438 
6.5 
256 
7.4 
3080 
5.7 
Total N 
% 
5537 
100 
5826 
100 
6162 
100 
6188  
100 
6818 
100 
6423 
100 
6762 
100 
6716 
100 
3485 
100 
53917 
100 
Parity Year 
2004 
Year 
2005 
Year 
2006 
Year 
2007 
Year 
2008 
Year 
2009 
Year 
2010 
Year 
2011 
Year 
2012 
Total 
0 N 
% 
3050 
55.1 
3218 
58.3 
3467 
56.3 
3710 
60 
4084 
60 
3889 
60.1 
3977 
58.8 
3811 
56.8 
2004 
57.5 
31210 
58 
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1-3 
% 
2304 
41.6 
2424 
43.9 
2528 
41.0 
2311 
37.4 
2541 
37.3 
2378 
37.0 
2631 
38.9 
2755 
41.0 
1410 
40.5 
21282 
39.5 
4 plus N 
% 
173 
3.1 
180 
3.3 
163 
2.7 
158 
2.6 
178 
2.6 
150 
2.3 
142 
2.1 
143 
2.1 
64 
1.8 
1351 
2.5 
Total non-
missing (%) 
5527 
(100) 
5522 
(100) 
6158 
(100) 
6179 
(100 
6813 
(100) 
6417 
(100) 
6750 
(100) 
6709 
(100) 
3478 
(100) 
53843 
(100) 
Missing  N 
% 
10 
0.2 
4 
0.1 
4 
0.1 
9 
0.2 
15 
0.2 
6 
0.1 
12 
0.2 
7 
0.1 
7 
0.2 
74 
0.1 
Total  N 5537 5826 6162 6188 6818 6423 
 
6762 6716 3485 53917 
Ethnicity Year 
2004 
Year 
2005 
Year 
2006 
Year 
2007 
Year 
2008 
Year 
2009 
Year 
2010 
Year 
2011 
Year 
2012 
Total 
White   N 
% 
2908 
52.6 
2985 
51.9 
3212 
5.1 
3240 
52.3 
3668 
55.1 
3546 
55.9 
3731 
55.8 
3662 
55.3 
1847 
53.8 
28799 
54.3 
Asian  N 
% 
288 
5.2 
299 
5.2 
294 
4.8 
307 
5.0 
373 
5.6 
377 
5.9 
413 
6.2 
404 
6.1 
249 
7.2 
3004 
5.7 
Black   N 
% 
2092 
37.8 
2217 
38.6 
2310 
38.2 
2241 
36.2 
2334 
35.0 
2157 
34.0 
2274 
34.0 
2263 
34.2 
1188 
34.6 
19076 
35.9 
Chinese  N 
% 
201 
3.6 
212 
3.7 
203 
3.3 
207 
3.4 
237 
3.6 
231 
3.6 
236 
3.5 
258 
3.9 
141 
4.1 
1926 
3.6 
Other  N 
% 
40 
0.7 
35 
0.6 
30 
0.5 
28 
0.5 
48 
0.7 
34 
0.5 
32 
0.5 
31 
0.5 
10 
0.3 
288 
0.5 
Total non-
missing 
5529 
100 
5748 
100 
6049 
100 
6023 
100 
6660 
100 
6345 
100 
6686 
100 
6618 
100 
3435 
100 
53093 
100 
Missing  N 
% 
8 
0.1 
78 
1.3 
113 
1.8 
165 
2.7 
158 
2.3 
78 
1.2 
76 
1.1 
98 
1.5 
50 
1.4 
824 
1.5 
Total  N 
 
5537 
 
5826 
 
6162 
 
6188 
 
6818 
 
6423 
 
6762 
 
6716 
 
3485 
 
53917 
 
Smoking  Year 
2004 
Year 
2005 
Year 
2006 
Year 
2007 
Year 
2008 
Year 
2009 
Year 
2010 
Year 
2011 
Year 
2012 
Total 
Smoking N 
% 
459 
10.6 
365 
7.2 
422 
7.7 
375 
7.1 
339 
5.7 
365 
6.4 
437 
7.0 
400 
6.4 
195 
6.0 
3357  
7.0 
Non-smoking 
N % 
4313 
90.4 
4723 
92.8 
5089 
92.3 
4939 
92.9 
5623 
94.3 
5370 
93.6 
5811 
93 
5847 
93.6 
3038 
94.0 
44753  
93.0 
Total non-
missing % 
4772 
100 
5088 
100 
5511 
100 
5314 
100 
5962 
100 
5735 
100 
6248 
100 
6247 
100 
3233 
100 
48110 
100 
Missing N 
% 
765 
13.8 
738 
12.7 
651 
10.6 
874 
14.1 
856 
12.6 
688 
10.7 
514 
7.6 
469 
7.0 
252 
7.2 
5807  
10.8 
Total  N 
 
5537 
 
5826 
 
6162 
 
6188 
 
6818 
 
6423 
 
6762 
 
6716 
 
3485 
 
53917 
  
IMD Quintile Year 
2004 
Year 
2005 
Year 
2006 
Year 
2007 
Year 
2008 
Year 
2009 
Year 
2010 
Year 
2011 
Year 
2012 
Total 
1      N 
% 
126 
2.3 
165 
2.8 
179 
2.9 
208 
3.4 
226 
3.3 
213 
3.3 
213 
3.2 
216 
3.2 
117 
3.4 
1663  
3.2 
2 N 
% 
277 
5.0 
298 
5.2 
350 
5.7 
358 
5.8 
416 
6.2 
400 
6.3 
406 
6.0 
395 
5.9 
194 
5.6 
3,094 
5.8 
3 N 570 595 631 696 857 760 862 765 412 6,148 
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% 10.4 10.3 10.3 11.3 12.7 11.8 12.8 11.5 11.9 11.4  
4 N 
% 
2,573 
46.9 
2,662 
46.1 
2,741 
44.8 
2,730 
44.5 
3,000 
44.4 
2,869 
44.9 
3,034 
45.1 
3,100 
46.4 
1,560 
45.0 
24,269  
45.3 
5 N 
% 
1,943 
35.4 
2,050 
35.5 
2,214 
36.2 
2,144 
34.9 
2,262 
33.5 
2,148 
33.6 
2,208 
32.8 
2,202 
33.0 
1,180 
34.1 
18,351  
34.3 
Total non-
missing % 
5489 
100 
5770 
100 
6115 
100 
6136 
100 
6761 
100 
6390 
100 
6723 
100 
6678 
100 
3463 
100 
53525 
100 
Missing  N 
% 
48 
0.9 
56 
1.0 
47 
0.8 
52 
0.8 
57 
0.8 
33 
0.5 
39 
0.6 
38 
0.6 
22 
0.6 
392 
0.7  
Total  N 
 
5,537 
 
5,826 
 
6,162 
 
6,188 
 
6,818 
 
6,423 
 
6,762 
 
6,716 
 
3,485 
 
53,917 
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Appendix J: Development of the CAN Project 
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